Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Guideline Summary Archive

This feature provides a complete list of National Guideline Clearinghouse™ (NGC™) Guideline Summaries (with NGC accession numbers) that have been withdrawn from the Web site. Information regarding a current NGC Summary, where available, is provided. The listing is organized alphabetically, by organization name.

WITHDRAWN NGC SUMMARIES

The list below identifies those NGC Summaries that have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

The National Guideline Clearinghouse™ currently contains 504 guidelines in the withdrawn archive.

Academy of Psychosomatic Medicine

  1. Practice guidelines for psychiatric consultation in the general medical setting. (NGC-0928)
    • Bronheim HE, Fulop G, Kunkel EJ, Muskin PR, Schindler BA, Yates WR, Shaw R, Steiner H, Stern TA, Stoudemire A. The Academy of Psychosomatic Medicine practice guidelines for psychiatric consultation in the general medical setting. The Academy of Psychosomatic Medicine. Psychosomatics 1998 Jul-Aug;39(4):S8-30. [138 references] PubMed

Agency for Healthcare Research and Quality

  1. Acute low back problems in adults. (NGC-0090)
    • Agency for Health Care Policy and Research (AHCPR). Acute low back problems in adults. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Dec. 160 p. (Clinical practice guideline; no. 14). [360 references]

  2. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. (NGC-0086)
    • Agency for Health Care Policy and Research (AHCPR), Heart Failure Guideline Panel. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1994 Jun. 122 p. (Clinical practice guideline; no. 11). [237 references]

  3. Management of cancer pain. (NGC-0087)
    • Agency for Health Care Policy and Research (AHCPR). Management of cancer pain. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994. 257 p. (Clinical practice guideline; no. 9).

  4. Otitis media with effusion in young children. (NGC-0088)
    • Agency for Health Care Policy and Research (AHCPR), Otitis Media Guideline Panel. Otitis media with effusion in young children. Clinical practice guideline . Rockville (MD): U. S. Department of Health and Human Service, Public Health Service, AHCPR ; 1994. 108 p. (Clinical practice guideline; no. 12).

  5. Post-stroke rehabilitation. (NGC-0092)
    • Agency for Health Care Policy and Research (AHCPR), Post-Stroke Rehabilitation Guideline Panel. Post-stroke rehabilitation. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1995 May. 248 p. (Clinical practice guideline; no. 16). [334 references]

  6. Quality determinants of mammography. (NGC-0089)
    • Agency for Health Care Policy and Research (AHCPR). Quality determinants of mammography. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Oct. 153 p. (Clinical practice guideline; no. 13). [307 references]

  7. Recognition and initial assessment of Alzheimer's disease and related dementias. (NGC-0095)
    • Agency for Health Care Policy and Research (AHCPR). Recognition and initial assessment of Alzheimer's disease and related dementias. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Nov. 128 p. (Clinical practice guideline; no. 19). [302 references]

  8. Unstable angina: diagnosis and management. (NGC-0085)
    • Agency for Health Care Policy and Research (AHCPR), National Heart, Lung, and Blood Institute. Unstable angina: diagnosis and management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1994 Mar. 154 p. (Clinical practice guideline; no. 10).

  9. Urinary incontinence in adults: acute and chronic management. (NGC-0078)
    • Agency for Health Care Policy and Research (AHCPR), Urinary Incontinence Guideline Panel. Urinary incontinence in adults: Acute and chronic management. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Mar. 125 p. (Clinical practice guideline; no. 2).

For more information, please refer to the Agency for Healthcare Research and Quality Web site.

American Academy of Allergy, Asthma and Immunology

  1. Diagnosis and management of rhinitis. (NGC-1102)
    • Diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 1998 Nov;81(5 Pt 2):478-518. [297 references]

  2. Parameters for the diagnosis and management of sinusitis. (NGC-1103)
    • Parameters for the diagnosis and management of sinusitis. Ann Allergy Asthma Immunol 1998 Dec;102(6 Pt 2):S107-S144. [377 references]

  3. The diagnosis and management of anaphylaxis. (NGC-0673)
    • Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis. J Allergy Clin Immunol 1998 Jun;101(6 Pt 2):S465-S528. [337 references]

For more information, please refer to the American Academy of Allergy, Asthma and Immunology Web site.

American Academy of Child and Adolescent Psychiatry

  1. Practice parameters for child custody evaluation. (NGC-0317)
    • Practice parameters for child custody evaluation. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):57S-68S. [55 references]

  2. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. (NGC-0320)
    • Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):69S-84S. [161 references]

  3. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. (NGC-0319)
    • Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):157S-177S. [120 references]

  4. Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. (NGC-0322)
    • Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):122S-139S. [225 references]

  5. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. (NGC-0757)
    • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):63S-83S. [231 references] PubMed

  6. Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. (NGC-0756)
    • Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):46S-62S. [130 references] PubMed

  7. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. (NGC-0324)
    • Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):27S-45S. [184 references]

  8. Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. (NGC-0314)
    • Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):4S-26S. [99 references]

  9. Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. (NGC-0316)
    • Practice parameters for the assessment and treatment of children and adolescents with substance abuse disorders. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):140S-56S. [99 references]

  10. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. (NGC-0323)
    • Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):85S-121S. [396 references]

  11. Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. (NGC-0318)
    • Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry 1997 Mar;36(3):423-42. [184 references]


    • Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):37S-56S. [184 references]

  12. Practice parameters for the psychiatric assessment of children and adolescents. (NGC-0313)
    • Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):4S-20S. [84 references]

  13. Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). (NGC-0315)
    • Practice parameters for the psychiatric assessment of infants and toddlers (0-36 months). J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):21S-36S. [100 references]

For more information, please refer to the American Academy of Child and Adolescent Psychiatry Web site.

American Academy of Clinical Toxicology

  1. Position statement: cathartics. (NGC-1165)
    • Barceloux D, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists, McGuigan M, Hartigan-Go K. Position statement: cathartics. J Toxicol Clin Toxicol 1997;35(7):743-52. [32 references] PubMed

  2. Position statement: gastric lavage. (NGC-1163)
    • Vale JA, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: gastric lavage. J Toxicol Clin Toxicol 1997;35(7):711-9. [38 references] PubMed

  3. Position statement: ipecac syrup. (NGC-1167)
    • American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: ipecac syrup. Clin Toxicol 1997;35(7):699-709. [41 references]

  4. Position statement: single-dose activated charcoal. (NGC-1164)
    • American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: single-dose activated charcoal. Clin Toxicol 1997;35(7):721-41. [112 references]

  5. Position statement: whole bowel irrigation. (NGC-1166)
    • Tenenbein M, European Association of Poisons Centres and Clinical Toxicologists. Position statement: whole bowel irrigation. European Association of Poisons Centres and Clinical Toxicologists European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35(7):753-62. [29 references] PubMed

For more information, please refer to the American Academy of Clinical Toxicology Web site.

American Academy of Family Physicians

  1. AAFP policy on antepartum oxytocin privileges. (NGC-0439)
    • 1997-1998 AAFP reference manual - clinical policies. Kansas City (MO): AAFP; 1997. AAFP policy on antepartum oxytocin priveleges. p. 8 p. [9 references]

  2. Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. (NGC-0440)
    • Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Am Fam Physician 1995 Nov 1;52(6):1763-5. [60 references]

For more information, please refer to the American Academy of Family Physicians Web site.

American Academy of Neurology

  1. Assessment of brain SPECT. (NGC-0640)
    • American Academy of Neurology. Assessment of brain SPECT. Neurology 1996 Jan;46(1):278-85. [97 references] PubMed

  2. Assessment of digital EEG, quantitative EEG, and EEG brain mapping. (NGC-0651)
    • American Academy of Neurology, American Clinical Neurophysiology Society. Assessment of digital EEG, quantitative EEG, and EEG brain mapping. Neurology 1997 Jul;49(1):277-92. [325 references] PubMed

  3. Assessment of plasmapheresis. (NGC-0647)
    • Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996 Sep;47(3):840-3. [33 references] PubMed

  4. Assessment: clinical autonomic testing. (NGC-0641)
    • Assessment: Clinical autonomic testing. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996 Mar;46(3):873-80. [101 references] PubMed

  5. Assessment: dermatomal somatosensory evoked potentials. (NGC-0653)
    • American Academy of Neurology, Therapeutics and Technology Assessments Subcommittee. Assessment: dermatomal somatosensory evoked potentials. Neurology 1997 Oct;49(4):1127-30. [325 references] PubMed

  6. Assessment: electronystagmography. (NGC-0643)
    • Assessment: electronystagmography. Report of the Therapeutics and Technology Assessment Subcommittee. Neurology 1996 Jun;46(6):1763-6. [9 references] PubMed

  7. Assessment: melodic intonation therapy. (NGC-0630)
    • American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Assessment: melodic intonation therapy. Neurology 1994 Mar;44(3 Pt 1):566-8. [27 references] PubMed

  8. Assessment: neurological evaluation of male sexual dysfunction. (NGC-0639)
    • Assessment: neurological evaluation of male sexual dysfunction. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1995 Dec;45(12):2287-92. [77 references] PubMed

  9. Assessment: neuropsychological testing of adults. Considerations for neurologists. (NGC-0645)
    • Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996 Aug;47(2):592-9. [57 references] PubMed

  10. Evaluation and management of intracranial mass lesions in AIDS. (NGC-0654)
    • American Academy of Neurology, Quality Standards Subcommittee. Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998 Jan;50(1):21-6. [52 references] PubMed

  11. Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. (NGC-0633)
    • Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994 Aug;44(8):1537-40. [15 references] PubMed

  12. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole. (NGC-0652)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole. Neurology 1997 Sep;49(3):657-9. [325 references] PubMed

  13. Practice advisory: thrombolytic therapy for acute ischemic stroke. (NGC-0646)
    • Practice advisory: thrombolytic therapy for acute ischemic stroke-- summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 Sep;47(3):835-9. [6 references] PubMed

  14. Practice parameter: carpal tunnel syndrome. (NGC-0629)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter for carpal tunnel syndrome (summary statement). Neurology 1993 Nov;43(11):2406-9. [27 references] PubMed

  15. Practice parameter: diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). (NGC-0642)
    • Practice parameter: Diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)-Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996 Mar;46(3):881-2. [1 reference] PubMed

  16. Practice parameter: management issues for women with epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology. (NGC-2053)
    • American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia 1998 Nov;39(11):1226-31. PubMed


    • American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998 Oct;51(4):944-8. PubMed

  17. Practice parameter: neuroimaging in the emergency patient presenting with seizure. (NGC-0644)
    • Quality Standards Subcommittee of the American Academy of Neurology, American College of Emergency Physicians, American Association of Neurological Surgeons, American Society of Neuroradiology. Practice parameter: neuroimaging in the emergency patient present with seizure. Neurology 1996 Jul;47(1):288-91. PubMed

  18. Practice parameter: the electroencephalogram in the evaluation of headache. (NGC-0638)
    • Practice parameter: the electroencephalogram in the evaluation of headache. Neurology 1995 Jul;45(7):1411-3. [1 reference]

  19. Practice parameter: the management of concussion in sports. (NGC-0649)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter: the management of concussion in sports (summary statement). Neurology 1997 Mar;48(3):581-5. [66 references] PubMed

  20. Practice parameters for determining brain death in adults. (NGC-0636)
    • Practice parameters for determining brain death in adults (summary statement). The Quality Standards Subcommittee of the American Academy of Neurology [comment]. Neurology 1995 May;45(5):1012-4. PubMed

  21. Practice parameters: magnetic resonance imaging in the evaluation of low back syndrome. (NGC-0631)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameters: magnetic resonance imaging in the evaluation of low back syndrome (summary statement). Neurology 1994 Apr;44(4):767-70. [27 references] PubMed

  22. Review of the literature on spinal ultrasound for the evaluation of back pain and radicular disorders. (NGC-0655)
    • American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Review of the literature on spinal ultrasound for the evaluation of back pain and radicular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1998 Aug;51(2):343-4. [12 references] PubMed

  23. Silicone breast implants and neurologic disorders. (NGC-0650)
    • Ferguson JH. Silicone breast implants and neurologic disorders. Report of the Practice Committee of the American Academy of Neurology. Neurology 1997 Jun;48(6):1504-7. [16 references] PubMed

  24. The utility of neuroimaging in the evaluation of headache in patients with normal neurological examinations. (NGC-0632)
    • American Academy of Neurology, Quality Standards Subcommittee. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Neurology 1994 Jul;44(7):1353-4. [27 references] PubMed

For more information, please refer to the American Academy of Neurology Web site.

American Academy of Orthopaedic Surgeons

  1. Clinical guideline on ankle injury. (NGC-0935)
    • American Academy of Orthopaedic Surgeons. Clinical guideline on ankle injury. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1997. 7 p. [34 references]

For more information, please refer to the American Academy of Orthopaedic Surgeons Web site.

American Academy of Otolaryngic Allergy

  1. Allergic rhinitis: clinical practice guideline. (NGC-1349)
    • American Academy of Otolaryngic Allergy, Fornadley JA, Corey JP, Osguthorpe JD, Powell JP, Emanuel IA, Watson TA, Hurst DS, Bryant JL, Pershall KE, Renfro BL. Allergic rhinitis: clinical practice guideline. Committee on Practice Standards, American Academy of Otolaryngic Allergy. Otolaryngol Head Neck Surg 1996 Jul;115(1):115-22. [105 references] PubMed

For more information, please refer to the American Academy of Otolaryngic Allergy Web site.

American Academy of Pediatrics

  1. Breastfeeding and the use of human milk. (NGC-1039)
    • American Academy of Pediatrics. Breastfeeding and the use of human milk. American Academy of Pediatrics. Work Group on Breastfeeding. Pediatrics 1997 Dec;100(6):1035-9. [111 references] PubMed

  2. Evaluation and preparation of pediatric patients undergoing anesthesia. (NGC-0999)
    • American Academy of Pediatrics (AAP), Section on Anesthesiology. Evaluation and preparation of pediatric patients undergoing anesthesia. Pediatrics 1996 Sep;98(3 Pt 1):502-8. [54 references] PubMed

  3. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. (NGC-0998)
    • American Academy of Pediatrics (AAP), Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993 Aug;92(2):295-6. [10 references] PubMed

  4. Immunizations for Native American children. (NGC-1360)
    • American Academy of Pediatrics, Comm on Native American Child Health and Comm on Infectious Dis. Immunizations for Native American children. Pediatrics 1999 Sep;104(3 Pt 1):564-7. [21 references] PubMed

  5. Managing otitis media with effusion in young children. (NGC-0119)
    • Managing otitis media with effusion in young children. Pediatrics 1994 Nov;94(5):766-73. [13 references]

  6. Newborn and infant hearing loss: detection and intervention. (NGC-1382)
    • Newborn and infant hearing loss: Detection and intervention. Pediatrics 1999 Feb;103(2):527-30. [30 references]

  7. Practice parameter: the management of acute gastroenteritis in young children. (NGC-0120)
    • Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996 Mar;97(3):424-35. [85 references]

  8. Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. (NGC-0436)
    • Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. Pediatrics 1996 May;97(5):769-72. [15 references] PubMed

  9. Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. (NGC-1990)
    • Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics. Pediatrics 1999 Dec;104(6):1404-6. [12 references]

  10. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. (NGC-0919)
    • American Academy of Pediatrics (AAP). Prevention of rotavirus disease: guidelines for use of rotavirus vaccine (RE9840). American Academy of Pediatrics. Pediatrics 1998 Dec;102(6):1483-91. [73 references] PubMed

  11. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. (NGC-1002)
    • American Academy of Pediatrics (AAP). Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics 1996 Apr;97(4):590-4. [35 references] PubMed

For more information, please refer to the American Academy of Pediatrics Web site.

American Academy of Periodontology

  1. Parameter on supportive periodontal treatment (SPT). (NGC-0981)
    • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on supportive periodontal treatment (SPT). p. 20-3. [16 references]

For more information, please refer to the American Academy of Periodontology Web site.

American Academy of Sleep Medicine

  1. Practice parameters for the indications for polysomnography and related procedures. (NGC-0902)
    • Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997 Jun;20(6):406-22. [12 references] PubMed

  2. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. (NGC-0901)
    • American Sleep Disorders Association. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. Sleep - Europe 1996 Feb;19(2):152-5. [6 references] PubMed

  3. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. (NGC-0900)
    • American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep - Europe 1995 Jul;18(6):511-3. [3 references] PubMed

  4. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. (NGC-0896)
    • American Sleep Disorders Association. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. Sleep - Europe 1994 Jun;17(4):372-7. PubMed

For more information, please refer to the American Academy of Sleep Medicine Web site.

American Association for Respiratory Care

  1. Application of continuous positive airway pressure to neonates via nasal prongs or nasopharyngeal tube. (NGC-0362)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Application of continuous positive airway pressure to neonates via nasal prongs or nasopharyngeal tube. Respir Care 1994 Aug;39(8):817-23. [64 references]

  2. Assessing response to bronchodilator therapy at point of care (NGC-0375)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Assessing response to bronchodilator therapy at point of care. Respir Care 1995 Dec;40(12):1300-7. [67 references]

  3. Capillary blood gas sampling for neonatal and pediatric patients. (NGC-0371)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capillary blood gas sampling for neonatal & pediatric patients. Respir Care 1994 Dec;39(12):1180-3. [30 references]

  4. Defibrillation during resuscitation. (NGC-0372)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Defibrillation during resuscitation. Respir Care 1995 Jul;40(7):744-8. [50 references]

  5. Delivery of aerosols to the upper airway. (NGC-0363)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Delivery of aerosols to the upper airway. Respir Care 1994 Aug;39(8):803-7. [25 references]

  6. Directed cough (NGC-0343)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Directed cough. Respir Care 1993 May;38(5):495-9. [22 references]

  7. Discharge planning for the respiratory care patient (NGC-0376)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Discharge planning for the respiratory care patient. Respir Care 1995 Dec;40(12):1308-12. [43 references]

  8. Endotracheal suctioning of mechanically ventilated adults and children with artificial airways (NGC-0347)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Endotracheal suctioning of mechanically ventilated adults and children with artificial airways. Respir Care 1993 May;38(5):500-4. [33 references]

  9. Fiberoptic bronchoscopy assisting. (NGC-0360)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Fiberoptic bronchoscopy assisting. Respir Care 1993 Dec;38(12):1173-8. [33 references]

  10. Humidification during mechanical ventilation. (NGC-0356)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Humidification during mechanical ventilation. Respir Care 1992 Aug;37(8):887-90. [39 references]

  11. In-vitro pH and blood gas analysis and hemoximetry (NGC-0344)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. In-vitro pH and blood gas analysis and hemoximetry. Respir Care 1993 May;38(5):505-10. [25 references]

  12. Incentive spirometry. (NGC-0348)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Incentive spirometry. Respir Care 1991 Dec;36(12):1402-5. [25 references]

  13. Infant/toddler pulmonary function tests. (NGC-0373)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Infant/toddler pulmonary function tests. Respir Care 1995 Jul;40(7):761-8. [36 references]

  14. Long-term invasive mechanical ventilation in the home (NGC-0377)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Long-term invasive mechanical ventilation in the home. Respir Care 1995 Dec;40(12):1313-20. [86 references]

  15. Management of airway emergencies (NGC-0374)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Management of airway emergencies. Respir Care 1995 Jul;40(7):749-60. [186 references]

  16. Metabolic measurement using indirect calorimetry during mechanical ventilation. (NGC-0368)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Metabolic measurement using indirect calorimetry during mechanical ventilation. Respir Care 1994 Dec;39(12):1170-5. [57 references]

  17. Nasotracheal suctioning (NGC-0341)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Nasotracheal suctioning. Respir Care 1992 Aug;37(8):898-901. [36 references]

  18. Neonatal time-triggered, pressure-limited, time-cycled mechanical ventilation. (NGC-0364)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Neonatal time-triggered, pressure-limited, time-cycled mechanical ventilation. Respir Care 1994 Aug;39(8):808-16. [117 references]

  19. Oxygen therapy in the home or extended care facility. (NGC-0354)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Oxygen therapy in the home or extended care facility. Respir Care 1992 Aug;37(8):918-22. [25 references]

  20. Patient-ventilator system checks (NGC-0342)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Patient-ventilator system checks. Respir Care 1992 Aug;37(8):882-6. [22 references]

  21. Polysomnography (NGC-0380)
    • American Association for Respiratory Care (AARC), Association of Polysomnography Technologists (APT). AARC-APT clinical practice guideline. Polysomnography. Respir Care 1995 Dec;40(12):1336-43. [34 references]

  22. Postural drainage therapy. (NGC-0349)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Postural drainage therapy. Respir Care 1991 Dec;36(12):1418-26. [64 references]

  23. Pulse oximetry. (NGC-0352)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Pulse oximetry. Respir Care 1991 Dec;36(12):1406-9. [34 references]

  24. Resuscitation in acute care hospitals. (NGC-0358)
    • American Association for Respirator Care (AARC). AARC clinical practice guideline. Resuscitation in acute care hospitals. Respir Care 1993 Dec;38(12):1179-88. [129 references]

  25. Selection of a device for the delivery of aerosol to the lung parenchyma (NGC-0382)
    • American Association of Respiratory Care (AARC). AARC clinical practice guideline. Selection of a device for delivery of aerosol to the lung parenchyma. Respir Care 1996 Jul;41(7):647-53. [62 references]

  26. Selection of aerosol delivery device. (NGC-0351)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Selection of aerosol delivery service. Respir Care 1992 Aug;37(8):891-7. [69 references]

  27. Selection of an aerosol delivery device for neonatal and pediatric patients (NGC-0379)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Selection of an aerosol delivery device for neonatal and pediatric patients. Respir Care 1995 Dec;40(12):1325-51. [114 references]

  28. Spirometry, 1996 update. (NGC-0339)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Spirometry, 1996 update. Respir Care 1996 Jul;41(7):629-36. [34 references]

  29. Surfactant replacement therapy. (NGC-0366)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Surfactant replacement therapy. Respir Care 1994 Aug;39(8):824-9. [62 references]

  30. Transcutaneous blood gas monitoring for neonatal & pediatric patients. (NGC-0369)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Transcutaneous blood gas monitoring for neonatal & pediatric patients. Respir Care 1994 Dec;39(12):1176-9. [25 references]

  31. Use of positive airway pressure adjuncts to bronchial hygiene therapy (NGC-0345)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Use of positive airway pressure adjuncts to bronchial hygiene therapy. Respir Care 1993 May;38(5):516-21. [45 references]

  32. Ventilator circuit changes. (NGC-0367)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Ventilator circuit changes. Respir Care 1994 Aug;39(8):797-802. [38 references]

For more information, please refer to the American Association for Respiratory Care Web site.

American Association of Clinical Endocrinologists

  1. AACE clinical practice guidelines for the diagnosis and management of thyroid nodules. (NGC-0050)
    • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the diagnosis and management of thyroid nodules. Jacksonville (FL): AACE; 1996. 16 p. (AACE clinical guidelines; no. 1996). [16 references]

  2. AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. (NGC-0976)
    • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE/ACE position statement on the prevention, diagnosis and treatment of obesity (1998 revision). Jacksonville (FL): American Association of Clinical Endocrinologists; 1998. 35 p. [270 references]

For more information, please refer to the American Association of Clinical Endocrinologists Web site.

American Association of Critical-Care Nurses

  1. Family visitation and partnership in the critical care unit. (NGC-1147)
    • Family visitation and partnership in the critical care unit. Aliso Viejo (CA): American Association of Critical-Care Nurses (AACN); 1997. 46 p. [33 references]

For more information, please refer to the American Association of Critical-Care Nurses Web site.

American Association of Electrodiagnostic Medicine

  1. The electrodiagnostic medicine consultation. (NGC-0450)
    • American Association of Electrodiagnostic Medicine (AAEM). The electrodiagnostic medicine consultation. Rochester (MN): American Association of Electrodiagnostic Medicine (AAEM); 1996. 17 p. [63 references]

For more information, please refer to the American Association of Electrodiagnostic Medicine Web site.

American College of Cardiology Foundation

  1. ACC/AHA guidelines for ambulatory electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). (NGC-1334)
    • American College of Cardiology, American Heart Association, Crawford MH, Bernstein SJ, Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TH, Smith SC Jr. ACC/AHA Guidelines for ambulatory electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). J Am Coll Cardiol 1999 Sep;34(3):912-48. [304 references] PubMed

  2. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). (NGC-1161)
    • Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). J Am Coll Cardiol 1999 May;33(6):1756-824. [549 references] PubMed

  3. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). (NGC-0032)
    • Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Committee on Clinical Application of Echocardiography. Circulation 1997 Mar 18;95(6):1686-744. [514 references]

  4. ACC/AHA Task Force Report. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). (NGC-0216)
    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. Circulation 1995 Aug 1;92(3):673-91. [182 references]


    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. J Am Coll Cardiol 1995 Aug;26(2):555-73. [182 references]


    • Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic. J Cardiovasc Electrophysiol 1995 Aug;6(8):652-79. [182 references]

  5. Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging). (NGC-0031)
    • Guidelines for the clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging). J Nucl Cardiol 1995 Mar;2(2 Pt 1):172-92. [274 references]


    • Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, O'Rourke RA, Parisi AF, Verani MS. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging). J Am Coll Cardiol 1995 Feb;25(2):521-47. [274 references] PubMed


    • Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, Orourke RA, Parisi AF, Verani MS, Cheitlin MD, et al. Guidelines for clinical use of cardiac radionuclide imaging - a report of the American Heart Association American College of Cardiology task force on assessment of diagnostic and therapeutic cardiovascular procedures, committee on radionuclide imaging. Circulation 1995 Feb 15;91(4):1278-303. [274 references]

  6. Guidelines for electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography). (NGC-0237)
    • Guidelines for electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography). J Am Coll Cardiol 1992 Mar 1;19(3):473-81. [34 references]

  7. Management of patients with valvular heart disease. (NGC-1024)
    • American College of Cardiology (ACC), American Heart Association (AHA), Task Force on Practice Guidelines, (Committee on Management of Patients with Valvular Heart Disease). ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998 Nov;32(5):1486-588. [737 references] PubMed

For more information, please refer to the American College of Cardiology Foundation Web site.

American College of Chest Physicians

  1. Managing cough as a defense mechanism and a symptom. (NGC-1229)
    • Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O'Byrne P, Poe RH, Prakash UB, Pratter MR, Rubin BK. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998 Aug;114(2 Suppl Managing):133S-181S. [325 references] PubMed

  2. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. (NGC-1228)
    • Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997 Nov 5;112(5):1363-96. [185 references] PubMed

For more information, please refer to the American College of Chest Physicians Web site.

American College of Foot and Ankle Surgeons

  1. Adult dysfunctional flatfoot. (NGC-0847)
    • American College of Foot and Ankle Surgeons. Adult dysfunctional flatfoot. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 34 p. (Preferred practice guideline; no. 1/97). [106 references]

  2. Central metatarsalgia. (NGC-0848)
    • American College of Foot and Ankle Surgeons. Central metatarsalgia. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1998. 37 p. (Preferred practice guideline; no. 1/98). [98 references]

  3. Hallux rigidus in the healthy adult. (NGC-0849)
    • American College of Foot and Ankle Surgeons. Hallux rigidus in the healthy adult. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1994. 35 p. (Preferred practice guidelines; no. 1/94). [80 references]

  4. Hallux valgus in the healthy adult. (NGC-0850)
    • American College of Foot and Ankle Surgeons. Hallux valgus in the healthy adult. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1998. 24 p. (Preferred practice guideline; no. 1/98). [90 references]

  5. Ingrown toenail. (NGC-0852)
    • American College of Foot and Ankle Surgeons. Ingrown toenail. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1996. 22 p. (Preferred practice guideline; no. 1/96). [37 references]

  6. Intermetatarsal neuroma. (NGC-0853)
    • American College of Foot and Ankle Surgeons. Intermetatarsal neuroma. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1996. 21 p. (Preferred practice guideline; no. 1/96). [47 references]

  7. Lateral ankle sprain. (NGC-0854)
    • American College of Foot and Ankle Surgeons. Lateral ankle sprain. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 34 p. (Preferred practice guideline; no. 1/97). [140 references]

  8. Pediatric dysfunctional flatfoot. (NGC-0855)
    • American College of Foot and Ankle Surgeons. Pediatric dysfunctional flatfoot. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1997. 41 p. (Preferred practice guideline; no. 1/97). [138 references]

  9. Tailor's bunion and associated fifth metatarsal conditions. (NGC-0856)
    • American College of Foot and Ankle Surgeons. Tailor's bunion and associated fifth metatarsal conditions. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1994. 25 p. (Preferred practice guideline; no. 1/94). [69 references]

For more information, please refer to the American College of Foot and Ankle Surgeons Web site.

American College of Obstetricians and Gynecologists

  1. Emergency oral contraception. (NGC-0422)
    • Emergency oral contraception. Washington (DC): American College of Obstetricians and Gynecologists; 1996 Dec. 8 p. (ACOG practice patterns; no. 3). [34 references]

  2. External cephalic version. (NGC-0434)
    • External cephalic version. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Jul. 8 p. (ACOG practice patterns; no. 4). [33 references]

  3. Management of postterm pregnancy. (NGC-0392)
    • American College of Obstetricians and Gynecologists (ACOG). Management of postterm pregnancy. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Oct. 6 p. (ACOG practice patterns; no. 6). [21 references]

  4. Routine ultrasound in low-risk pregnancy. (NGC-1068)
    • Routine ultrasound in low-risk pregnancy. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Aug. 5 p. (ACOG practice patterns; no. 5). [12 references]

  5. Shoulder dystocia. (NGC-1069)
    • Shoulder dystocia. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Oct. 7 p. (ACOG practice patterns; no. 7). [26 references]

For more information, please refer to the American College of Obstetricians and Gynecologists Web site.

American College of Physicians

  1. Automated ambulatory blood pressure and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. (NGC-0096)
    • American College of Physicians. Automated ambulatory blood pressure devices and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. [comment]. Ann Intern Med 1993 Jun 1;118(11):889-92. PubMed


    • Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993 Jun 1;118(11):867-82. [140 references] PubMed

  2. Diagnosing syncope. (NGC-0034)
    • Diagnosing syncope, Part 1: Value of history, physical examination and electrocardiography. Ann Intern Med 1997 Jun 15;126(12):989-96. [34 references]


    • Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997 Jul 1;127(1):76-86. [110 references]

  3. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. (NGC-0002)
    • American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997 Aug 15;127(4):309-12. [5 references] PubMed


    • Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997 Aug 15;127(4):313-28. [187 references] PubMed

  4. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. (NGC-0272)
    • American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997 Dec 15;127(12):1106-8. PubMed


    • Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, Hayward R, Lightfoot R, Baker P, Steere AC. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997 Dec 15;127(12):1109-23. [67 references] PubMed

  5. Guidelines for medical treatment for stroke prevention. (NGC-0015)
    • American College of Physicians. Guidelines for medical treatment for stroke prevention. Ann Intern Med 1994 Jul 1;121(1):54-5. PubMed


    • Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention [published erratum appears in Ann Intern Med 1994 Sep 15;121(6):470 and 1995 Jun 1;122(11):885]. Ann Intern Med 1994 Jul 1;121(1):41-53. [77 references] PubMed

  6. Guidelines for risk stratification after myocardial infarction. (NGC-0001)
    • American College of Physicians. Guidelines for risk stratification after myocardial infarction. Ann Intern Med 1997 Apr 1;126(7):556-60. [11 references] PubMed


    • Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997 Apr 1;126(7):561-82. [280 references]

  7. Guidelines for the treatment of gallstones. (NGC-0097)
    • American College of Physicians. Guidelines for the treatment of gallstones. Ann Intern Med 1993 Oct 1;119(7 Pt 1):620-2. PubMed


    • Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med 1993 Oct 1;119(7 Pt 1):606-19. [92 references] PubMed

  8. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. (NGC-0244)
    • American College of Physicians. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Part 1. Ann Intern Med 1996 Mar 1;124(5):515-7. [8 references] PubMed


    • Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med 1996 Mar 1;124(5):518-31. [121 references] PubMed

  9. Magnetic resonance imaging of the brain and spine: a revised statement. (NGC-0243)
    • American College of Physicians. Magnetic resonance imaging of the brain and spine: a revised statement. Ann Intern Med 1994 May 15;120(10):872-5. PubMed

  10. Screening for prostate cancer. (NGC-0100)
    • American College of Physicians. Screening for prostate cancer. Ann Intern Med 1997 Mar 15;126(6):480-4. [52 references] PubMed


    • Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. Ann Intern Med 1997 Mar 15;126(6):468-79. PubMed


    • Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. Ann Intern Med 1997 Mar 1;126(5):394-406. [181 references]

  11. Screening for thyroid disease. (NGC-0289)
    • American College of Physicians. Clinical guideline, part 1. Screening for thyroid disease. Ann Intern Med 1998 Jul 15;129(2):141-3. [3 references] PubMed


    • Helfand M, American College of Physicians, Redfern CC. Clinical guideline, part 2. Screening for thyroid disease: an update. Ann Intern Med 1998 Jul 15;129(2):144-58. [73 references] PubMed

  12. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. (NGC-0046)
    • Clinical guideline: part I. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Ann Intern Med 1997 May 15;126(10):808-10.


    • Ransohoff DF, Lang CA. Clinical guideline: part II. Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Intern Med 1997 May 15;126(10):811-22. [82 references]

For more information, please refer to the American College of Physicians Web site.

American College of Preventive Medicine

  1. Adult immunizations. (NGC-0556)
    • Fingar AR, Francis BJ. American College of Preventive Medicine practice policy statement: adult immunizations. Am J Prev Med 1998 Feb;14(2):156-8. [17 references] PubMed

  2. Cervical cancer screening. (NGC-0562)
    • Hawkes AP, Kronenberger CB, MacKenzie TD, Mardis AL, Palen TE, Schulter WW, Shah SA, Steele AW, Marine WM. Cervical cancer screening: American College of Preventive Medicine practice policy statement. Am J Prev Med 1996 Sep-Oct;12(5):342-4. [22 references] PubMed

  3. Perimenopausal and postmenopausal hormone replacement therapy. (NGC-1346)
    • Perimenopausal and postmenopausal hormone replacement therapy. Am J Prev Med 1999;17(3):250-4. [43 references]

  4. Screening asymptomatic women for ovarian cancer. (NGC-0559)
    • Ferrini R. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy. Am J Prev Med 1997 Nov-Dec;13(6):444-6. [17 references] PubMed

  5. Screening for prostate cancer in American men. (NGC-0555)
    • Ferrini R, Woolf SH. American College of Preventive Medicine Practice Policy: screening for prostate cancer in American men. Am J Prev Med 1998 Jul;15(1):81-4. [43 references]

  6. Screening for skin cancer. (NGC-0558)
    • Ferrini RL, Perlman M, Hill L. American College of Preventive Medicine policy statement: screening for skin cancer. Am J Prev Med 1998 Jan;14(1):80-2. [23 references] PubMed

  7. Screening mammography for breast cancer. (NGC-0561)
    • Ferrini R, Mannino E, Ramsdell E, Hill L. Screening mammography for breast cancer: American College of Preventive Medicine practice policy statement. Am J Prev Med 1996 Sep-Oct;12(5):340-1. [14 references] PubMed

  8. Skin protection from ultraviolet light exposure. (NGC-0557)
    • Ferrini RL, American College of Preventive Medicine, Perlman M, Hill L. American College of Preventive Medicine Practice Policy Statement: skin protection from ultraviolet light exposure. Am J Prev Med 1998 Jan;14(1):83-6. [46 references] PubMed

  9. Tobacco-cessation patient counseling. (NGC-0730)
    • Kattapong VJ, Locher TL, Secker-Walker RH, Bell TA. American College of Preventive Medicine practice policy. Tobacco-cessation patient counseling. Am J Prev Med 1998 Aug;15(2):160-2. [24 references] PubMed

For more information, please refer to the American College of Preventive Medicine Web site.

American College of Radiology

  1. ACR Appropriateness Criteria™ for workup of palpable breast mass. (NGC-0837)
    • American College of Radiology (ACR), Expert Panel on Women's Imaging. Workup of palpable breast mass. Reston (VA): American College of Radiology (ACR); 1996 Sep. 7 p. (Appropriateness criteria of imaging and treatment decisions; no. 9/96). [21 references]

  2. American College of Radiology guidelines for breast cancer screening. (NGC-0745)
    • American College of Radiology (ACR). American College of Radiology guidelines for breast cancer screening. AJR Am J Roentgenol 1998 Jul;171(1):29-33. [61 references]

For more information, please refer to the American College of Radiology Web site.

American College of Rheumatology

  1. Guidelines for monitoring drug therapy in rheumatoid arthritis. (NGC-0679)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996 May;39(5):723-31. [68 references] PubMed

  2. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. (NGC-0680)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. Arthritis Rheum 1996 Jan;39(1):1-8. [41 references] PubMed

  3. Guidelines for the management of rheumatoid arthritis. (NGC-0681)
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996 May;39(5):713-22. [66 references] PubMed

  4. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. (NGC-2161)
    • Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000 Sep;43(9):1905-15. [91 references]

For more information, please refer to the American College of Rheumatology Web site.

American Diabetes Association

  1. Aspirin therapy in diabetes. (NGC-2801)
    • Colwell JA. Aspirin therapy in diabetes. Diabetes Care 2003 Jan;26(Suppl 1):S87-8. [4 references] PubMed

  2. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. (NGC-2810)
    • Smith SA, Poland GA. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S126-8. [24 references] PubMed

  3. Preventive foot care in people with diabetes. (NGC-2798)
    • Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S78-9. [2 references] PubMed

  4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (NGC-2791)
    • Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003 Jan;26 (Suppl 1):S5-20. [143 references] PubMed

  5. Treatment of hypertension in adults with diabetes. (NGC-2799)
    • Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabetes Care 2003 Jan;26(Suppl 1):S80-2. [2 references] PubMed

For more information, please refer to the American Diabetes Association Web site.

American Gastroenterological Association

  1. Guidelines for the use of enteral nutrition. (NGC-0532)
    • American Gastroenterological Association Medical Position Statement: guidelines for the use of enteral nutrition. Gastroenterology 1995 Apr;108(4):1280-1. PubMed

For more information, please refer to the American Gastroenterological Association Web site.

American Medical Association

  1. Guidelines for adolescent preventive services (GAPS). (NGC-0676)
    • Guidelines for adolescent preventive services. Arch Pediatr Adolesc Med 1997 Feb;151(2):123-8.

For more information, please refer to the American Medical Association Web site.

American Medical Directors Association

  1. Pharmacotherapy companion to the depression clinical practice guideline. (NGC-1033)
    • Pharmacotherapy companion to the depression clinical practice guideline. Columbia (MD): American Medical Directors Association; 1998. 26 p. [28 references]

For more information, please refer to the American Medical Directors Association Web site.

American Optometric Association

  1. Care of the patient with amblyopia. (NGC-1213)
    • American Optometric Association. Care of the patient with amblyopia. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 57 p. (Optometric clinical practice guideline; no. 4). [177 references]

  2. Care of the patient with primary angle closure glaucoma. (NGC-1214)
    • American Optometric Association. Care of the patient with primary angle closure glaucoma. 2nd ed. St. Louis (MO): American Optometric Association; 1997. 54 p. (Optometric clinical practice guideline; no. 5). [121 references]

  3. Care of the patient with retinal detachment and related peripheral vitreoretinal disease. (NGC-1222)
    • American Optometric Association. Care of the patient with retinal detachment and related peripheral vitreoretinal disease. St. Louis (MO): American Optometric Association; 1995. 79 p. (Optometric clinical practice guideline; no. 13). [201 references]

  4. Comprehensive adult eye and vision examination. (NGC-1210)
    • American Optometric Association (AOA). Comprehensive adult eye and vision examination: reference guide for clinicians. St. Louis (MO): American Optometric Association (AOA); 1994. 16 p. (Optometric clinical practice guideline; no. 1). [69 references]

For more information, please refer to the American Optometric Association Web site.

American Pharmacists Association

  1. Management of hypertension in adults. (NGC-1106)
    • American Pharmaceutical Association. Management of hypertension in adults. Washington (DC): American Pharmaceutical Association; 1998. 8 p. [19 references]

  2. Self-care of the common cold. (NGC-1112)
    • American Pharmaceutical Association. Self-care of the common cold. Washington (DC): American Pharmaceutical Association; 1998. 11 p. [27 references]

For more information, please refer to the American Pharmacists Association Web site.

American Psychiatric Association

  1. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. (NGC-0668)
    • American Psychiatric Association (APA). Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997 May;154(5 Suppl):1-39. [243 references] PubMed


    • American Psychiatric Association (APA). Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. Washington (DC): American Psychiatric Press, Inc.; 1997 May. 93 p. [243 references]

  2. Practice guideline for the treatment of patients with nicotine dependence (NGC-0666)
    • American Psychiatric Association (APA). Practice guideline for the treatment of patients with nicotine dependence. Washington (DC): American Psychiatric Press, Inc; 1996. 64 p. (APA practice guidelines; no. 1996). [219 references]


    • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association (APA). Am J Psychiatry 1996 Oct;153(10 Suppl):1-31. [219 references] PubMed

  3. Practice guideline for the treatment of patients with panic disorder. (NGC-0669)
    • American Psychiatric Association (APA). Practice guideline for the treatment of patients with panic disorder. Washington (DC): American Psychiatric Press, Inc; 1998. 86 p. [273 references]


    • Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association (APA). Am J Psychiatry 1998 May;155(5 Suppl):1-34. [273 references] PubMed

  4. Practice guideline for treatment of patients with substance use disorders: alcohol, cocaine, opioids. (NGC-0664)
    • American Psychiatric Association (APA). Practice guideline for treatment of patients with substance abuse disorders: alcohol, cocaine, opioids. Washington (DC): American Psychiatric Press, Inc; 1995. 116 p. [481 references]


    • Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association (APA). Am J Psychiatry 1995 Nov;152(11 Suppl):1-59. [481 references] PubMed

For more information, please refer to the American Psychiatric Association Web site.

American Society for Parenteral and Enteral Nutrition

  1. Nutrition support for adults with specific diseases and conditions. (NGC-1325)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section IV: nutrition support for adults with specific diseases and conditions. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):12SA-26SA. [136 references]

  2. Nutrition support for infants and children with specific diseases and conditions. (NGC-1329)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VIII: nutrition support for infants and children with specific diseases and conditions. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):39SA-49SA. [84 references]

  3. Nutrition support for low-birth-weight infants. (NGC-1328)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VII: nutrition support for low-birth-weight infants. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):33SA-38SA. [46 references]

  4. Rationale for adult nutrition support guidelines. (NGC-1323)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section II: rationale for adult nutrition support guidelines. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):5SA-6SA. [10 references]

  5. Routes to deliver nutrition support in adults. (NGC-1324)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section III: routes to deliver nutrition support in adults. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):7SA-11SA. [19 references]

  6. Routes to deliver nutrition support in pediatric patients. (NGC-1327)
    • American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section VI: routes to deliver nutrition support in pediatric patients. JPEN J Parenter Enteral Nutr 1993 Jul-Aug;17(4 Suppl):29SA-32SA. [12 references]

For more information, please refer to the American Society for Parenteral and Enteral Nutrition Web site.

American Society of Addiction Medicine

  1. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. (NGC-0502)
    • Mayo-Smith MF, Am Soc of Addiction Med Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997 Jul 9;278(2):144-51. [175 references] PubMed

  2. The role of phenytoin in the management of alcohol withdrawal syndrome. (NGC-0503)
    • ASAM Committee on Practice Guidelines. Graham AW, Schultz TK, editor(s). Chevy Chase (MD): American Society of Addiction Medicine (AASM); 1998. The role of phenytoin in the management of alcohol withdrawal syndrome. p. 9. [64 references]

For more information, please refer to the American Society of Addiction Medicine Web site.

American Society of Anesthesiologists

  1. Practice guidelines for acute pain management in the perioperative setting. (NGC-0754)
    • Practice guidelines for acute pain management in the perioperative setting. A report by the American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section. Anesthesiology 1995 Apr;82(4):1071-81. [2 references] PubMed

  2. Practice guidelines for blood component therapy. (NGC-0748)
    • Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996 Mar;84(3):732-47. [162 references] PubMed

  3. Practice guidelines for cancer pain management. (NGC-0751)
    • American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section. Practice guidelines for cancer pain management. Anesthesiology 1996 May;84(5):1243-57. [0 references] PubMed

  4. Practice guidelines for chronic pain management. (NGC-0755)
    • Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Anesthesiology 1997 Apr;86(4):995-1004. [0 references] PubMed

  5. Practice guidelines for management of the difficult airway. (NGC-0750)
    • Practice guidelines for management of the difficult airway. A report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 1993 Mar;78(3):597-602. PubMed

  6. Practice guidelines for perioperative transesophageal echocardiography. (NGC-0749)
    • Practice guidelines for perioperative transesophageal echocardiography. A report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 1996 Apr;84(4):986-1006. [21 references] PubMed

  7. Practice guidelines for pulmonary artery catheterization. (NGC-0753)
    • Practice guidelines for pulmonary artery catheterization. A report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 1993 Feb;78(2):380-94. [89 references] PubMed

  8. Practice guidelines for sedation and analgesia by non-anesthesiologists. (NGC-0752)
    • Practice guidelines for sedation and analgesia by non- anesthesiologists. A report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non- Anesthesiologists. Anesthesiology 1996 Feb;84(2):459-71. [0 references] PubMed

For more information, please refer to the American Society of Anesthesiologists Web site.

American Society of Clinical Oncology

  1. Recommended breast cancer surveillance guidelines. (NGC-0026)
    • American Society of Clinical Oncology. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999 Mar;17(3):1080-2. [5 references]


    • American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 1997 May;15(5):2149-56. [38 references] PubMed

For more information, please refer to the American Society of Clinical Oncology Web site.

American Society of Colon and Rectal Surgeons

  1. Practice parameters for the management of anal fissure. (NGC-1353)
    • American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissure. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 4 p. [40 references]

  2. Practice parameters for the treatment of hemorrhoids. (NGC-1352)
    • American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of hemorrhoids. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1993. 4 p. [0 references]

  3. Practice parameters for the treatment of rectal carcinoma. (NGC-1354)
    • American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of rectal carcinoma. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 3 p. [0 references]

  4. Practice parameters for treatment of fistula-in-ano. (NGC-1358)
    • Practice parameters for treatment of fistula-in-ano. The Standards Practice Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1996 Dec;39(12):1361-2. [1 reference] PubMed

  5. Practice parameters for treatment of mucosal ulcerative colitis. (NGC-1359)
    • Wexner SD, Rosen L, Lowry A, Roberts PL, Burnstein M, Hicks T, Kerner B, Oliver GC, Robertson HD, Robertson WG, Ross TM, Senatore PJ, Simmang C, Smith C, Vernava AM, Wong WD. Practice parameters for the treatment of mucosal ulcerative colitis--supporting documentation. Standards Practice Task Force. American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1997 Nov;40(11):1277-85. [99 references] PubMed

For more information, please refer to the American Society of Colon and Rectal Surgeons Web site.

American Society of Health-System Pharmacists

  1. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. (NGC-0600)
    • American Society of Health-System Pharmacists. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. Am J Health Syst Pharm 1997 Feb 1;54(3):299-313. [109 references]

For more information, please refer to the American Society of Health-System Pharmacists Web site.

American Society of Plastic Surgeons

  1. Abdominoplasty. (NGC-0794)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Abdominoplasty. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996 Nov. 8 p. [13 references]

  2. Brow lift. (NGC-0938)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: brow lift. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 7 p. [16 references]

  3. Carpal tunnel syndrome. (NGC-0798)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: carpal tunnel syndrome. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 10 p. [31 references]

  4. CO2 laser surgery of the face and eyelids. (NGC-0939)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: CO2 laser surgery of the face and eyelids. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 10 p. [16 references]

  5. Dupuytren's contracture (update). (NGC-0951)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guideline: Dupuytren's contracture (update). Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 6 p. [10 references]

  6. Endoscopic procedures in plastic surgery. (NGC-0940)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: endoscopic procedures in plastic surgery. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 5 p. [9 references]

  7. Explantation of breast implants. (NGC-0941)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: explantation of breast implants. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 8 p. [10 references]

  8. Facial lacerations. (NGC-0952)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: facial lacerations. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1998. 7 p. [3 references]

  9. Female breast hypertrophy/breast reduction. (NGC-0942)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: female breast hypertrophy/breast reduction. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1993. 10 p. [7 references]

  10. Female breast hypoplasia/micromastia. (NGC-0943)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: female breast hypoplasia/micromastia. Arlinton Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996. 6 p. [6 references]

  11. Free flap reconstruction of the mandible. (NGC-0944)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: free flap reconstruction for the mandible. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 6 p. [6 references]

  12. Gynecomastia. (NGC-0802)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: gynecomastia. Arlington (VA): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1996. 7 p. [10 references]

  13. Lipoplasty. (NGC-0945)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: lipoplasty. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 9 p. [21 references]

  14. Lower extremity ulceration. (NGC-0946)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: lower extremity ulceration. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1998. 9 p. [14 references]

  15. Nasal deformity. (NGC-0947)
    • American Society of Plastic and Reconstructive Surgeons (ASPRS). Clinical practice guidelines: nasal deformity. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgeons (ASPRS); 1993. 7 p. [14 references]

  16. Pressure sores. (NGC-0948)
    • American Society of Plastic and Reconstructive Surgery (ASPRS). Clinical practice guidelines: pressure sores. Arlington Heights (IL): American Society of Plastic and Reconstructive Surgery (ASPRS); 1996. 8 p. [10 references]

For more information, please refer to the American Society of Plastic Surgeons Web site.

American Thyroid Association

  1. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. (NGC-0918)
    • Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995 Mar 8;273(10):808-12. [13 references] PubMed

  2. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. (NGC-0916)
    • Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996 Oct 28;156(19):2165-72. [21 references] PubMed

For more information, please refer to the American Thyroid Association Web site.

American Urological Association, Inc.

  1. The management of clinically localized prostate cancer. (NGC-0793)
    • American Urological Association (AUA), Prostate Cancer Clinical Guidelines Panel. Report on the management of clinically localized prostate cancer. Baltimore (MD): American Urological Association, Inc; 1995. 49 p. (Clinical practice guidelines; no. 1/95).

  2. The management of primary vesicoureteral reflux in children. (NGC-0781)
    • American Urological Association (AUA), Pediatric Vesicoureteral Reflux Clinical Guidelines Panel. Report on the management of primary vesicoureteral reflux in children. Baltimore (MD): American Urological Association, Inc; 1997 Apr. 88 p. (Clinical practice guidelines; no. 4/97). [249 references]

  3. The management of ureteral calculi. (NGC-0553)
    • American Urological Association (AUA), Ureteral Stones Guidelines Panel. Report on the management of ureteral calculi. Baltimore (MD): American Urological Association, Inc; 1997 Sep. 72 p. (Clinical practice guidelines; no. 9/97). [72 references]

  4. The surgical management of female stress urinary incontinence. (NGC-0777)
    • American Urological Association (AUA), Female Stress Urinary Incontinence Clinical Guidelines Panel. Report on the surgical management of female stress urinary incontinence. Baltimore (MD): American Urological Association, Inc; 1997 Jun. 72 p. (Clinical practice guidelines; no. 4/97). [483 references]

  5. The treatment of organic erectile dysfunction. (NGC-0792)
    • American Urological Association (AUA), Erectile Dysfunction Clinical Guidelines Panel. Report on the treatment of organic erectile dysfunction. Baltimore (MD): American Urological Association, Inc; 1996 Jul. 73 p. (Clinical practice guidelines; no. 7/96). [390 references]

For more information, please refer to the American Urological Association, Inc. Web site.

Association of Community Cancer Centers

  1. Breast carcinoma. (NGC-1017)
    • Association of Community Cancer Centers (ACCC). Breast carcinoma. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 20 p. [35 references]

  2. Colon cancer. (NGC-1020)
    • Association of Community Cancer Centers (ACCC). Colon cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 9 p. [38 references]

  3. Colony-stimulating factors (CSFs). (NGC-1023)
    • Association of Community Cancer Centers (ACCC). Colony-stimulating factors (CSF's). Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 2 p. [17 references]

  4. Erythropoietin. (NGC-1022)
    • Association of Community Cancer Centers (ACCC). Erythropoietin. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 2 p.

  5. Metastatic (stage IV) breast cancer. (NGC-1018)
    • Association of Community Cancer Centers (ACCC). Metastatic (Stage IV) breast cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 7 p. [26 references]

  6. Rectal cancer. (NGC-1021)
    • Association of Community Cancer Centers (ACCC). Rectal cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 5 p. [18 references]

  7. Small cell lung cancer. (NGC-1019)
    • Association of Community Cancer Centers (ACCC). Oncology Patient Management Guidelines. Rockville (MD): Association of Community Cancer Centers (ACCC); 2000 Apr 12. Small cell lung cancer (initial therapy). (Version 3.0). p. 8. [15 references]


    • Association of Community Cancer Centers (ACCC). Small cell lung cancer. Rockville (MD): Association of Community Cancer Centers (ACCC); 1999. 11 p. [15 references]

For more information, please refer to the Association of Community Cancer Centers Web site.

Canadian Task Force on Preventive Health Care

  1. Acetylsalicylic acid and the primary prevention of cardiovascular disease. (NGC-1288)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Acetylsalicylic acid and the primary prevention of cardiovascular disease. p. 680-90. [13 references]

  2. Administration of pneumococcal vaccine. (NGC-1266)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Administration of pneumococcal vaccine. p. 386-95. [25 references]

  3. Asymptomatic carotid disease. (NGC-1289)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Asymptomatic carotid disease. p. 692-704. [34 references]

  4. Childhood immunizations. (NGC-1265)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Childhood immunizations. p. 372-84. [29 references]

  5. Children of alcoholics. (NGC-1273)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Children of alcoholics. p. 470-85. [57 references]

  6. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. (NGC-1270)
    • Canadian Task Force on Preventive Health Care. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. p. 436-45. [41 references]

  7. Disadvantaged children. (NGC-1264)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Disadvantaged children. p. 356-68. [28 references]

  8. Early detection and counselling of problem drinking. (NGC-1274)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994 . Early detection and couselling of problem drinking. p. 488-98. [20 references]

  9. Early detection of depression. (NGC-1271)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Early detection of depression. p. 450-4. [8 references]

  10. Hepatitis B immunization in childhood. (NGC-1267)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hepatitis B immunization in childhood. p. 398-404. [13 references]

  11. Hypertension in the elderly: case-finding and treatment to prevent vascular disease. (NGC-1311)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hypertension in the elderly: case-finding and treatment to prevent vascular disease. p. 944-51. [15 references]

  12. Interventions other than smoking cessation to prevent lung cancer. (NGC-1296)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Interventions other than smoking cessation to prevent lung cancer. p. 780-6. [36 references]

  13. Intrapartum electronic fetal monitoring. (NGC-1247)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Intrapartum electronic fetal monitoring. p. 158-65. [15 references]

  14. Lowering the blood total cholesterol level to prevent coronary heart disease. (NGC-1286)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Lowering the blood total cholesterol level to prevent coronary heart disease. p. 650-9. [43 references]

  15. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. (NGC-1281)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. p. 586-99. [41 references]

  16. Physical activity counselling. (NGC-1279)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Physical activity counselling. p. 560-9. [24 references]

  17. Prenatal screening and diagnosis for Down syndrome prevention. (NGC-1240)
    • Canadian Task Force on Preventive Health Care, Dick PT. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. CMAJ 1996 Feb 15;154(4):465-79. [158 references] PubMed

  18. Preschool screening for developmental problems. (NGC-1258)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Preschool screening for developmental problems. p. 290-6. [20 references]

  19. Prevention of dental caries. (NGC-1268)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 2. Prevention of dental caries. CMAJ 1995 Mar 15;152(6):836-46. [70 references] PubMed

  20. Prevention of gonorrhea. (NGC-1291)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of gonorrhea. p. 720-9. [23 references]

  21. Prevention of hearing impairment and disability in the elderly. (NGC-1312)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of hearing impairment and disability in the elderly. p. 954-63. [29 references]

  22. Prevention of household and recreational injuries in adults. (NGC-1277)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in adults. p. 526-37. [23 references]

  23. Prevention of household and recreational injuries in children (<15 years of age). (NGC-1260)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in children (<15 years of age). p. 306-17. [29 references]

  24. Prevention of household and recreational injuries in the elderly. (NGC-1308)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in the elderly. p. 912-20. [22 references]

  25. Prevention of influenza. (NGC-1293)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of influenza. p. 744-51. [19 references]

  26. Prevention of iron deficiency enemia in infants. (NGC-1255)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinica Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Prevention of iron deficiency enemia in infants. p. 244-55. [21 references]

  27. Prevention of low birth weight/preterm birth. (NGC-1236)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of low birth weight/preterm birth. p. 38-50. [28 references]

  28. Prevention of motor vehicle accident injuries. (NGC-1276)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of motor vehicle accident injuries. p. 514-24. [18 references]

  29. Prevention of neonatal herpes simplex. (NGC-1242)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of neonatal herpes simplex. p. 108-14. [8 references]

  30. Prevention of osteoporotic fractures in women by estrogen replacement therapy. (NGC-1284)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of osteoporotic fractures in women by estrogen replacement therapy. p. 620-31. [46 references]

  31. Prevention of pancreatic cancer. (NGC-1303)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of pancreatic cancer. p. 850-9. [20 references]

  32. Prevention of periodontal disease. (NGC-1269)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of periodontal disease. p. 420-31. [36 references]

  33. Prevention of preeclampsia. (NGC-1245)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of preeclampsia. p. 136-43. [24 references]

  34. Prevention of skin cancer. (NGC-1302)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of skin cancer. p. 850-9. [43 references]

  35. Prevention of suicide. (NGC-1272)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of suicide. p. 456-67. [42 references]

  36. Prevention of tobacco-caused disease. (NGC-1275)
    • Taylor MC, Dingle JL. Prevention of tobacco-caused disease. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. p. 500-11. [45 references]

  37. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. (NGC-1278)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. p. 540-57. [31 references]

  38. Primary and secondary prevention of neural tube defects. (NGC-1239)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary and secondary prevention of neural tube defects. p. 74-81. [16 references]

  39. Primary prevention of fetal alcohol syndrome. (NGC-1237)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary prevention of fetal alcohol syndrome. p. 52-61. [28 references]

  40. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. (NGC-1248)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. p. 168-75. [9 references]

  41. Routine iron supplementation during pregnancy. (NGC-1238)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine iron supplementation during pregnancy. p. 64-72. [11 references]

  42. Routine prenatal ultrasound screening. (NGC-1233)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine prenatal ultrasound screening. p. 4-14. [18 references]

  43. Routine preschool screening for visual and hearing problems. (NGC-1259)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine preschool screening for visual and hearing problems. p. 298-304. [11 references]

  44. Screening and isoniazid prophylactic therapy for tuberculosis. (NGC-1294)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and isoniazid prophylactic therapy for tuberculosis. p. 754-65. [19 references]

  45. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. (NGC-1244)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. p. 126-33. [19 references]

  46. Screening children for lead exposure in Canada. (NGC-1257)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening children for lead exposure in Canada. p. 268-88. [80 references]

  47. Screening for abdominal aortic aneurysm. (NGC-1287)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for abdominal aortic aneurysm. p. 672-8. [19 references]

  48. Screening for asymptomatic bacteriuria in pregnancy. (NGC-1241)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in pregnancy. p. 100-6. [15 references]

  49. Screening for asymptomatic bacteriuria in the elderly. (NGC-1313)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in the elderly. p. 966-73. [19 references]

  50. Screening for bladder cancer. (NGC-1300)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for bladder cancer. p. 826-36. [20 references]

  51. Screening for breast cancer. (NGC-1297)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Screening for breast cancer. p. 788-95. [31 references]

  52. Screening for cervical cancer. (NGC-1305)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cervical cancer. p. 870-81. [41 references]

  53. Screening for childhood obesity. (NGC-1262)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for childhood obesity. p. 334-44. [33 references]

  54. Screening for chlamydial infection. (NGC-1292)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. CMAJ 1996 Jun 1;154(11):1631-44. [201 references] PubMed

  55. Screening for congenital hypothyroidism. (NGC-1250)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for congenital hypothyroidism. p. 190-4. [10 references]

  56. Screening for cystic fibrosis. (NGC-1251)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cystic fibrosis. p. 196-204. [25 references]

  57. Screening for D (Rh) sensitization in pregnancy. (NGC-1243)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for D (Rh) sensitization in pregnancy. p. 116-24. [12 references]

  58. Screening for diabetes mellitus in the non-pregnant adult. (NGC-1282)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for diabetes mellitus in the non-pregnant adult. p. 602-9. [19 references]

  59. Screening for gestational diabetes mellitus. (NGC-1234)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for gestational diabetes mellitus. p. 16-23. [19 references]

  60. Screening for hemoglobinopathies in Canada. (NGC-1252)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hemoglobinopathies in Canada. p. 206-18. [25 references]

  61. Screening for HIV antibody. (NGC-1290)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for HIV antibody. p. 708-18. [37 references]

  62. Screening for human papillomavirus infection. (NGC-1295)
    • Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for human papillomavirus infection. p. 768-76. [33 references]

  63. Screening for hypertension in young and middle-aged adults. (NGC-1285)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hypertension in young and middle-aged adults. p. 636-48. [43 references]

  64. Screening for idiopathic adolescent scoliosis. (NGC-1263)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for idiopathic adolescent scoliosis. p. 346-54. [37 references]

  65. Screening for ovarian cancer. (NGC-1304)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for ovarian cancer. p. 870-81. [41 references]

  66. Screening for phenylketonuria. (NGC-1249)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for phenylketonuria. p. 180-8. [29 references]

  67. Screening for prostate cancer. (NGC-1299)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for prostate cancer. p. 812-23. [29 references]

  68. Screening for testicular cancer. (NGC-1306)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for testicular cancer. p. 892-8. [22 references]

  69. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. (NGC-1283)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. p. 612-8. [14 references]

  70. Screening for urinary infection in asymptomatic infants and children. (NGC-1253)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994. Screening for urinary infection in asymptomatic infants and children. p. 220-30. [36 references]

  71. Screening for visual impairment in the elderly. (NGC-1310)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. CMAJ 1995 Apr 15;152(8):1211-22. [102 references] PubMed

  72. Secondary prevention of elder abuse. (NGC-1309)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Secondary prevention of elder abuse. p. 922-9. [20 references]

  73. Smoking and pregnancy. (NGC-1235)
    • Canadian Task Forceon Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Smoking and pregnancy. p. 26-36. [35 references]

  74. The use of home uterine activity monitoring to prevent preterm birth. (NGC-1246)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Use of home uterine activity monitoring to prevent preterm birth. p. 146-55. [15 references]

  75. Well-baby care in the first 2 years of life. (NGC-1256)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Well-baby care in the first 2 years of life. p. 258-66. [12 references]

For more information, please refer to the Canadian Task Force on Preventive Health Care Web site.

Centers for Disease Control and Prevention

  1. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. (NGC-1378)
    • Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations. MMWR Recomm Rep 1997 Sep 5;46(RR-15):1-10. [49 references] PubMed

  2. Combination vaccines for childhood immunization. (NGC-1205)
    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Am Fam Physician 1999 May 1;59(9):2565-74. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. MMWR Recomm Rep 1999 May 14;48(RR-5):1-14. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Pediatrics 1999 May;103(5 Pt 1):1064-77. [80 references] PubMed

  3. Guideline for infection control in hospital personnel. (NGC-0844)
    • Center for Disease Control and Prevention (CDC). Guideline for infection control in health care personnel, 1998. Springfield (VA): Hospital Infections Program, NTIS U.S. Dept of Commerce, Center for Disease Control and Prevention (CDC); 1998. 42 p. [81 references]

  4. Guidelines for isolation precautions in hospitals. (NGC-0842)
    • Centers for Disease Control and Prevention (CDC), Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospital infection control advisory committee. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1996 Jan 1. 38 p. (CDC prevention guidelines; no. 1/96). [97 references]

  5. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. (NGC-0906)
    • Centers for Disease Control and Prevention (CDC). Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998 Sep 25;47(RR-17):1-14. [56 references] PubMed

  6. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. (NGC-0042)
    • Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Jan 24;46(RR-3):1-25. [64 references]

  7. Prevention and control of tuberculosis in correctional facilities: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0102)
    • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis. Prevention and control of tuberculosis in correctional facilities. MMWR Recomm Rep 1997 Jun 7;45(RR-8):1-27. [49 references]

  8. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0062)
    • Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 Dec 13;45(RR-14):1-15. [37 references]

  9. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0057)
    • Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Apr 4;46(RR-8):1-24. [123 references] PubMed

  10. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. (NGC-0744)
    • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998 Oct 16;47(RR-19):1-39. [158 references]

  11. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. (NGC-1381)
    • Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. MMWR Recomm Rep 1998 Sep 18;47(RR-16):1-29. [18 references] PubMed

  12. Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0063)
    • Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993 Sep 17;42(RR-13):1-15.

  13. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. (NGC-0049)
    • Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus [published erratum appears in MMWR Morb Mortal Wkly Rep 1994 Aug 12;43(31):531]. MMWR Morb Mortal Wkly Rep 1994 Aug;43(RR-11):1-20.

  14. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0073)
    • Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995 Sep 8;44(RR-11):19-34. PubMed

  15. Screening young children for lead poisoning: guidance for state and local public health officials. (NGC-1965)
    • Centers for Disease Control and Prevention (CDC). Screening young children for lead poisoning: guidance for state and local public health officials. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1997 Nov. 205 p. [23 references]

  16. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. (NGC-0074)
    • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis, Advisory Committee on Immunization Practices. Role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996 Apr 26;45(RR-4):1-18. [87 references] PubMed

  17. Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0069)
    • Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994 Dec;43(RR-14):1-7. [37 references]

For more information, please refer to the Centers for Disease Control and Prevention Web site.

College of American Pathologists

  1. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. (NGC-1186)
    • Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch Pathol Lab Med 1999 Feb;123(2):106-7. PubMed

  2. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. (NGC-1405)
    • College of American Pathologists, American College of Rheumatology, Clinical Immunology Society and Clinical Center. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens . Arch Pathol Lab Med 2000 Jan;124(1):71-81. [53 references]

  3. Practice guidelines for examination of the placenta. (NGC-0218)
    • Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, Murtagh C, Cox S, Glenn G. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997 May;121(5):449-76. [66 references] PubMed

  4. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. (NGC-1409)
    • College of American Pathologists. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. Arch Pathol Lab Med 2000 Jan;124(1):61-70. [38 references]

  5. Practice parameter for the use of red blood cell transfusions. (NGC-0598)
    • Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, Gould SA, Harrison CR, Milam JD, Moise KJ Jr, Rodwig FR Jr, Sherman LA, Shulman IA, Stehling L. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998 Feb;122(2):130-8. [69 references] PubMed

  6. The preoperative bleeding time test lacks clinical benefit. (NGC-0599)
    • Peterson P, Hayes TE, Arkin CF, Bovill EG, Fairweather RB, Rock WA Jr, Triplett DA, Brandt JT. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998 Feb;133(2):134-9. [80 references] PubMed

For more information, please refer to the College of American Pathologists Web site.

Commission for the Establishment of Guidelines for Chiropractic Quality Assurance and Practice Parameters

  1. Guidelines for chiropractic quality assurance and practice parameters. (NGC-1048)
    • Guidelines for chiropractic quality assurance and practice parameters. Burlingame (CA): Aspen Publishers, Inc; 1993. 222 p. [1182 references]

Community Collaboration on Healthcare Quality

  1. Long term management of asthma by classification in children < 5 years old. (NGC-1390)
    • Community Collaboration on Healthcare Quality (CCHQ). Long term management of asthma by classification in children less than or equal to 5 years old. Milwaukee, WI: Medical Society of Milwaukee County; 1998. 3 p. [0 references]

Consortium for Spinal Cord Medicine

  1. Depression following spinal cord injury. A clinical practice guideline for primary care physicians. (NGC-0903)
    • Depression following spinal cord injury. A clinical practice guideline for primary care physicians. Washington (DC): Paralyzed Veterans of America; 1998. 35 p. [112 references]

  2. Neurogenic bowel management in adults with spinal cord injury. (NGC-0394)
    • Neurogenic bowel management in adults with spinal cord injury. Washington (DC): Paralyzed Veterans of America; 1998. 39 p. [139 references]

Eastern Association for the Surgery of Trauma

  1. Practice management guidelines for penetrating intraperitoneal colon injuries. (NGC-0926)
    • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for Penetrating Colon Injury Management. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for penetrating intraperitoneal colon injuries. p. 50-65. [42 references]

  2. Practice management guidelines for screening of blunt cardiac injury. (NGC-0924)
    • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for Screening of Blunt Cardiac Injury. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for screening of blunt cardiac injury. p. 7-31. [56 references]

  3. Practice management guidelines for violence prevention programs. (NGC-2022)
    • EAST Practice Management Guidelines Work Group. Practice management guidelines for violence prevention programs. Winston-Salem (NC): Eastern Association for the Surgery of Trauma (EAST); 1998. 8 p. [11 references]

European Society of Cardiology

  1. Clinical role of magnetic resonance in cardiovascular disease. (NGC-1155)
    • European Society of Cardiology, Association of European Paediatric Cardiologists. The clinical role of magnetic resonance in cardiovascular disease. Eur Heart J 1998 Jan;19(1):19-39. PubMed

  2. Driving and heart disease. (NGC-1156)
    • European Society of Cardiology, Petch MC. Driving and heart disease. Eur Heart J 1998 Aug;19(8):1165-77. [28 references] PubMed

  3. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. (NGC-1160)
    • European Society of Cardiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996 Mar;17(3):354-81. [181 references] PubMed

  4. Management of stable angina pectoris. (NGC-1151)
    • Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997 Mar;18(3):394-413. [121 references] PubMed

  5. Prevention of coronary heart disease in clinical practice. (NGC-1149)
    • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998 Oct;19(10):1434-503. PubMed


    • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Blood Press 1998 Nov;7(5-6):262-9. PubMed


    • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998 Oct;16(10):1407-14. PubMed


    • Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998 Oct;140(2):199-270. [472 references] PubMed

  6. The pre-hospital management of acute heart attacks. (NGC-1157)
    • Recommendations of a Task Force of the European Society of Cardiology and the European Resuscitation Council on the Pre-hospital Management of Acute Heart Attacks. Resuscitation 1998 Aug;38(2):73-98. PubMed


    • The pre-hospital management of acute heart attacks. Recommendations of a Task Force of the European Society of Cardiology and European Resuscitation Council. Eur Heart J 1998 Aug;19(8):1140-64. PubMed

For more information, please refer to the European Society of Cardiology Web site.

Florida Agency for Health Care Administration

  1. Management of pain using dangerous drugs and controlled substances. (NGC-1028)
    • Agency for Health Care Administration (AHCA). Management of pain using dangerous drugs and controlled substances. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Oct 25. 16 p. (Medical practice guidelines).

  2. Universe of Florida patients with low back pain or injury. (NGC-1026)
    • Agency for Health Care Administration (AHCA). Universe of Florida patients with low back pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Feb 2. 32 p. (Medical practice guideline). [464 references]

  3. Universe of Florida patients with neck pain or injury. (NGC-1025)
    • Agency for Health Care Administration (AHCA). Universe of Florida patients with neck pain or injury. Tallahassee (FL): State of Florida, Agency for Health Care Administration; 1996 Mar 15. 23 p. (Medical practice guidelines). [401 references]

For more information, please refer to the Florida Agency for Health Care Administration Web site.

Harvard Pilgrim Health Care, Inc.

  1. Guidelines for lipid screening and management for primary and secondary prevention of coronary heart disease (CHD) in adults. (NGC-0549)
    • Harvard Pilgrim Health Care. Guidelines for lipid screening and management for primary and secondary prevention of CHD in adults. Wellesley (MA): Harvard Pilgrim Health Care Inc.; 1997. 6 p. [14 references]

  2. Management of menopause and perimenopause. (NGC-0551)
    • Harvard Pilgrim Healthcare. Management of menopause and perimenopause. Key recommendations. Wellesley (MA): Harvard Pilgrim Health Care, Inc; 1997 Jul. 43 p.

For more information, please refer to the Harvard Pilgrim Health Care, Inc. Web site.

Horizon Healthcare

  1. Domestic violence. (NGC-0500)
    • Horizon Healthcare, Inc. Domestic Violence. Milwaukee (WI): Horizon Healthcare, Inc; 1997 Oct. 18 p.

  2. Preoperative testing: healthy, asymptomatic patient prior to elective surgery. (NGC-0499)
    • Horizon Healthcare, Inc. Preoperative testing healthy, asymptomatic patient prior to elective surgery. Milwaukee (WI): Horizon Healthcare, Inc; 1996 May. 7 p.

Infectious Diseases Society of America

  1. Guidelines for the prevention of antimicrobial resistance in hospitals. (NGC-0700)
    • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997 Sep;25(3):584-99. [84 references]


    • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997 Apr;18(4):275-91. [84 references]

  2. Primary care of patients infected with human immunodeficiency virus. (NGC-0695)
    • Primary care of patients infected with human immunodeficiency virus. Clin Infect Dis 1998 Feb;26(2):275-6. [9 references]

  3. Quality standard for antimicrobial prophylaxis in surgical procedures. (NGC-0688)
    • Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis 1994 Mar;18(3):422-7. [49 references]


    • Quality standard for antimicrobial prophylaxis in surgical procedures. Infect Control Hosp Epidemiol 1994 Mar;15(3):182-8. [49 references]

  4. Quality standard for assurance of measles immunity among health care workers. (NGC-0690)
    • Quality standard for assurance of measles immunity among health care workers. Clin Infect Dis 1994 Mar;18(3):431-6. [36 references]


    • Quality standard for assurance of measles immunity among health care workers. Infect Control Hosp Epidemiol 1994 Mar;15(3):193-9. [36 references]

  5. Quality standard for the treatment of bacteremia. (NGC-0689)
    • Quality standard for the treatment of bacteremia. Clin Infect Dis 1994 Mar;18(3):428-30. [19 references]


    • Quality standard for the treatment of bacteremia. Infect Control Hosp Epidemiol 1994 Mar;15(3):189-92. [19 references]

For more information, please refer to the Infectious Diseases Society of America Web site.

Institute for Clinical Systems Improvement

  1. Preterm birth prevention. (NGC-3201)
    • Institute for Clinical Systems Improvement (ICSI). Preterm birth prevention. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 58 p. [88 references]

  2. Vaginal birth after cesarean. (NGC-2729)
    • Institute for Clinical Systems Improvement (ICSI). Vaginal birth after cesarean. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Oct. 23 p.

For more information, please refer to the Institute for Clinical Systems Improvement Web site.

Institute for Healthcare Quality, Inc

  1. QualityFIRST® coronary artery disease with myocardial infarction. (NGC-0731)
    • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst coronary artery disease with myocardial infarction. [80 references]

  2. QualityFIRST® diabetes mellitus (adult). (NGC-0732)
    • Institute for Healthcare Quality, Inc.. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc.; 2000 May . QualityFIRST diabetes mellitus (adult). [49 references]

  3. QualityFIRST® dysfunctional uterine bleeding. (NGC-0733)
    • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst dysfunctional uterine bleeding. [40 references]

  4. QualityFIRST® pancreatitis (adult). (NGC-0734)
    • Institute for Healthcare Quality, Inc. QualityFirst guidelines [Medical Risk Management Software]. Minneapolis (MN): Institute for Healthcare Quality, Inc; 1998 Dec. QualityFirst pancreatitis (adult). [38 references]

For more information, please refer to the Institute for Healthcare Quality, Inc Web site.

Joint Council of Allergy, Asthma and Immunology

  1. Disease management of atopic dermatitis: a practice parameter. (NGC-0670)
    • Joint Council of Allergy, Asthma and Immunology. Disease management of atopic dermatitis: a practice parameter. Ann Allergy Asthma Immunol 1997 Sep;79(3):197-211. [107 references]

  2. Practice parameters for allergy diagnostic testing. (NGC-0674)
    • Joint Council of Allergy, Asthma and Immunology. Practice parameters for allergy diagnostic testing. Ann Allergy Asthma Immunol 1995 Dec;75(6 Pt 2):543-625. [316 references]

  3. Practice parameters for the diagnosis and management of immunodeficiency. (NGC-0672)
    • Joint Council of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and management of immunodeficiency. Ann Allergy Asthma Immunol 1996 Mar;76(3):282-94. [47 references]

  4. Practice parameters for the diagnosis and treatment of asthma. (NGC-0675)
    • Joint Council of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995 Nov;96(5 Pt 2):707-870. [1195 references]

For more information, please refer to the Joint Council of Allergy, Asthma and Immunology Web site.

Kaiser Permanente Health Plan, Inc. Mid-Atlantic Permanente Medical Group

  1. BRCA1 genetic screening. (NGC-0461)
    • BRCA1 genetic screening. Rockville (MD): Kaiser Permanente; 1998. 4 p. [38 references]

  2. Elective repeat cesarean sections. (NGC-0462)
    • Elective repeat cesarean sections. Rockville (MD): Kaiser Permanente; 1998. 2 p. [2 references]

  3. Pediatric preventive care: health assessments and anticipatory guidance. (NGC-0466)
    • Pediatric preventive care: health assessments and anticipatory guidance. Rockville (MD): Kaiser Permanente; 1997. 4 p. [4 references]

  4. Prenatal care. (NGC-0467)
    • Prenatal care. Rockville (MD): Kaiser Permanente; 1997. 4 p. [7 references]

  5. Proactive management of labor for term, singleton, vertex presentations. (NGC-0470)
    • Proactive management of labor for term, singleton, vertex presentations. Rockville (MD): Kaiser Permanente; 1998. 3 p. [3 references]

For more information, please refer to the Kaiser Permanente Health Plan, Inc. Mid-Atlantic Permanente Medical Group Web site.

Mount Auburn Hospital (Cambridge, MA)

  1. Fibrinolysis guidelines. (NGC-0687)
    • Mount Auburn Hospital. Fibrinolysis guidelines. Cambridge (MA): Mount Auburn Hospital; 1998. 10 p. [17 references]

National Association of Neonatal Nurses

  1. Care of the premature infant with a patent ductus arteriosus. (NGC-1372)
    • National Association of Neonatal Nurses. Care of the premature infant with a patent ductus arteriosus. Glenview (IL): National Association of Neonatal Nurses; 1999. 21 p. [16 references]

For more information, please refer to the National Association of Neonatal Nurses Web site.

National Heart, Lung, and Blood Institute (U.S.)

  1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. (NGC-0660)

    • National High Blood Pressure Education Program Working Group report on hypertension in diabetes. (NGC-0594)
      • National High Blood Pressure Education Program, Working Group on Hypertension in Diabetes. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1995 Apr. 26 p.

    • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. (NGC-0595)
      • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994 Mar;23(3):275-85. [49 references]

    • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. (NGC-0597)
      • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992 Mar;89(3 Pt 2):525-84. [230 references]

    • Transfusion alert: use of autologous blood. (NGC-0593)
      • Transfusion alert: use of autologous blood. Transfusion 1995 Aug;35(8):703-11. [81 references]

    For more information, please refer to the National Heart, Lung, and Blood Institute (U.S.) Web site.

    National Hospice and Palliative Care Organization

    1. Medical guidelines for determining prognosis in selected non-cancer diseases. (NGC-0626)
      • National Hospice Organization. Medical guidelines for determining prognosis in selected non-cancer diseases. Hosp J 1996;11(2):47-63. [214 references]

    For more information, please refer to the National Hospice and Palliative Care Organization Web site.

    New Zealand Guidelines Group

    1. (1) Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. (2) Guideline update: hormone replacement therapy. (NGC-2333)
      • New Zealand Guidelines Group. Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2001 May. 185 p. [470 references]


      • New Zealand Guidelines Group. Hormone replacement therapy: guideline update. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Sep. 2 p.

    For more information, please refer to the New Zealand Guidelines Group Web site.

    New Zealand National Health Committee

    1. Guidelines for the management of heavy menstrual bleeding. (NGC-1410)
      • New Zealand Guidelines Group. An evidence-based guideline for the management of heavy menstrual bleeding. Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. N Z Med J 1999 May 28;112(1088):174-7. PubMed

    Office of Medical Applications of Research (NIH)

    1. Acupuncture. (NGC-0416)
      • Acupuncture. NIH Consens Statement Online 1997 Nov 3-5;15(5):1-34. [67 references] PubMed

    2. Breast cancer screening for women ages 40-49. (NGC-0423)
      • NIH Consensus Statement. Breast cancer screening for women ages 40-49. NIH Consens Statement Online 1997 Jan 21-23;15(1):1-35. [94 references] PubMed

    3. Cervical cancer. (NGC-0417)
      • Cervical cancer. NIH Consens Statement Online 1996 Apr 1-3;14(1):1-38. [82 references] PubMed

    4. Cochlear implants in adults and children. (NGC-0415)
      • Cochlear implants in adults and children. NIH Consens Statement Online 1995 May 15-17;13(2):1-30. PubMed

    5. Diagnosis and treatment of attention deficit hyperactivity disorder. (NGC-1331)
      • Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement Online 1998 Nov 16-18;16(2):1-37. [110 references]

    6. Early identification of hearing impairment in infants and young children. (NGC-0431)
      • Early identification of hearing impairment in infants and young children. NIH Consens Statement Online 1993 Mar 1-3;11(1):1-24.


      • NIDCD Information Clearinghouse. Recommendations of the NIDCD Working Group on Early Identification of Hearing Impairment on Acceptable Protocols for Use in State-Wide Universal Newborn Hearing Screening Programs. Bethesda (MD): National Institute on Deafness and Other Communication Disorders (NIDCD); 1997 Sep. 2 p.

    7. Effective medical treatment of opiate addiction. (NGC-0420)
      • Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998 Dec 9;280(22):1936-43. [63 references] PubMed


      • Effective medical treatment of opiate addiction. NIH Consens Statement Online 1997 Nov 17;15(6):1-38. [66 references]

    8. Genetic testing for cystic fibrosis. (NGC-0419)
      • Genetic testing for cystic fibrosis. NIH Consens Statement Online 1997 Apr 14-16;15(4):1-37. [64 references] PubMed

    9. Helicobacter pylori in peptic ulcer disease. (NGC-0428)
      • Helicobacter pylori in peptic ulcer disease. NIH Consens Statement Online 1994 Feb 7-9;12(1):1-23. PubMed


      • National Institutes of Health (NIH), Consensus Development Panel. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994 Jul 6;272(1):65-9. PubMed

    10. Infectious disease testing for blood transfusions. (NGC-0414)
      • Infectious disease testing for blood transfusions. NIH Consens Statement Online 1995 Jan 9-11;13(1):1-27. [0 references] PubMed

    11. Management of temporomandibular disorders. (NGC-0516)
      • Management of temporomandibular disorders. National Institutes of Health Technology Assessment Conference Statement. J Am Dent Assoc 1996 Nov;127(11):1595-606. PubMed


      • Management of temporomandibular disorders. NIH Technol Assess Statement Online 1996 Apr 29-May 1;:1-31.


      • National Institutes of Health Technology Assessment Conference on Management of Temporomandibular Disorders. Bethesda, Maryland, April 29-May 1, 1996. Proceedings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Jan;83(1):49-183. PubMed

    12. Morbidity and mortality of dialysis. (NGC-0432)
      • Morbidity and mortality of dialysis. NIH Consens Statement Online 1993 Nov 1-3;11(2):1-33. PubMed

    13. Optimal calcium intake. (NGC-0425)
      • NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994 Dec 28;272(24):1942-8. PubMed


      • Optimal calcium intake. NIH Consens Statement Online 1994 Jun 6-8;12(4):1-31. PubMed

    14. Ovarian cancer: screening, treatment, and followup. (NGC-0426)
      • Ovarian cancer: screening, treatment, and followup. NIH Consens Statement Online 1994 Apr 5-7;12(3):1-30. PubMed

    15. Physical activity and cardiovascular health. (NGC-0430)
      • Physical activity and cardiovascular health. NIH Consens Statement Online 1995 Dec 18-20;13(3):1-33. [71 references] PubMed

    16. Rehabilitation of persons with traumatic brain injury. (NGC-1330)
      • NIH Consensus Development Panel. Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. JAMA 1999 Sep 8;282(10):974-83. [67 references] PubMed


      • Rehabilitation of persons with traumatic brain injury. NIH Consens Statement Online 1998 Oct 26-28;16(1):1-41. [67 references]

    17. The effect of antenatal steroids for fetal maturation on perinatal outcomes. (NGC-0427)
      • The effect of antenatal steroids for fetal maturation on perinatal outcomes. NIH Consens Statement Online 1994 Feb 28-Mar 2;12(2):1-24.

    18. Total hip replacement. (NGC-0413)
      • Total hip replacement. NIH Consens Statement Online 1994 Sep 12-14;12(5):1-31. PubMed

    For more information, please refer to the Office of Medical Applications of Research (NIH) Web site.

    Oncology Nursing Society

    1. Access device guidelines: recommendations for nursing practice and education. (NGC-0909)
      • Oncology Nursing Society (ONS). Access device guidelines: recommendations for nursing practice and education. Pittsburgh (PA): Oncology Nursing Society; 1996. 83 p. [326 references]

    2. Manual for bone marrow transplant nursing: recommendations for practice and education. (NGC-0912)
      • Oncology Nursing Society (ONS). Manual for bone marrow transplant nursing: recommendation for practice and education. Pittsburgh (PA): Oncology Nursing Society; 1994. 50 p. [159 references]

    3. Manual for radiation oncology nursing practice and education. (NGC-0913)
      • Oncology Nursing Society (ONS). Manual for radiation oncology nursing practice and education. Pittsburgh (PA): Oncology Nursing Society; 1998. 79 p. [27 references]

    4. Multicultural outcomes: guidelines for cultural competence. (NGC-2058)
      • Multicultural outcomes: Guidelines for cultural competence. Pittsburgh, PA: Oncology Nursing Society; 2000. 24 p. [29 references]

    5. Peripheral blood stem cell transplantation: recommendations for nursing education and practice. (NGC-0914)
      • Oncology Nursing Society (ONS). Peripheral blood stem cell transplantation. Recommendations for nursing education and practice. Pittsburgh (PA): Oncology Nursing Society; 1997. 44 p. [141 references]

    For more information, please refer to the Oncology Nursing Society Web site.

    Optimed Medical Systems Clinical Development Group

    1. Cholecystectomy. (NGC-1489)
      • Cholecystectomy. Version 6.6 [software]. Lexington (MA): Optimed Medical Systems; 2000.

    2. Hysterectomy. (NGC-1350)
      • Optimed Medical Systems, Inc. Clinical standard hysterectomy. Version 6.1 [software]. Lexington, MD: Optimed Medical Systems, Inc.; 1997. 94 p. [72 references]

    PinnacleHealth

    1. Management of decision-making incapacity in nursing homes. (NGC-0459)
      • MacLean DS. Management of decision-making incapacity in nursing homes. Nurs Home Med 1996 Mar;4(3):78-92. [22 references]

    For more information, please refer to the PinnacleHealth Web site.

    Practice Guidelines Initiative

    1. Drug therapy for chronic myeloid leukemia. (NGC-2231)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Drug therapy for chronic myeloid leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 6-3). [4 references]


      • Cancer Care Ontario Practice Guidelines Initiative. Drug therapy for chronic myeloid leukemia. Curr Oncol 2000;7(4):229-41. [28 references]

    For more information, please refer to the Practice Guidelines Initiative Web site.

    Royal College of Obstetricians and Gynaecologists

    1. Male and female sterilisation. (NGC-1783)
      • Royal College of Obstetricians and Gynaecologists (RCOG). Male and female sterilisation. London: RCOG Press; 1999 Apr. 86 p. (Evidence-based clinical guidelines; no. 4). [275 references]

    2. The care of women requesting induced abortion. (NGC-1780)
      • Royal College of Obstetricians & Gynaecologists. The care of women requesting induced abortion. London: RCOG Press; 2000. 70 p. (Evidence-based clinical guidelines; no. 7). [176 references]

    3. The initial investigation and management of the infertile couple. (NGC-1779)
      • Royal College of Obstetricians and Gynaecologists. The initial investigation and management of the infertile couple. London: RCOG Press; 1998 Feb. 82 p. (Evidence-based clinical guidelines; no. 2). [390 references]

    4. The initial management of menorrhagia. (NGC-1777)
      • Royal College of Obstetricians and Gynaecologists. The initial management of menorrhagia. London: RCOG Press; 1998 Feb. 43 p. (Evidence-based clinical guidelines; no. 1). [129 references]

    5. The management of infertility in secondary care. (NGC-1778)
      • Royal College of Obstetricians and Gynaecologists. The management of infertility in secondary care. London: RCOG Press; 1998 Feb. 148 p. (Evidence-based clinical guidelines; no. 3). [677 references]

    6. The management of infertility in tertiary care. (NGC-1781)
      • Royal College of Obstetricians and Gynaecologists. The management of infertility in tertiary care. London: RCOG Press; 2000 Jan. 121 p. (Evidence-based clinical guidelines; no. 6). [543 references]

    For more information, please refer to the Royal College of Obstetricians and Gynaecologists Web site.

    Royal New Zealand College of General Practitioners

    1. Guidelines for primary care providers. Detection and management of young people at risk of suicide. (NGC-2281)
      • Royal New Zealand College of General Practitioners. Guidelines for primary care providers. Detection and management of young people at risk of suicide. Wellington (New Zealand): Royal New Zealand College of General Practitioners; 1999. Various p. [125 references]

    Scottish Intercollegiate Guidelines Network

    1. Breast cancer in women. A national clinical guideline. (NGC-1066)
      • Scottish Intercollegiate Guidelines Network (SIGN). Breast cancer in women. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN), Scottish Cancer Therapy Network; 1998 Oct. 64 p. (SIGN publication; no. 29). [216 references]

    2. British guideline on the management of asthma. (NGC-2882)
      • Scottish Intercollegiate Guidelines Network (SIGN), British Thoracic Society. British guideline on the management of asthma. Thorax 2003;58(Suppl 1):i1-i94. [517 references]

    3. Coronary revascularisation in the management of stable angina pectoris. A national clinical guideline. (NGC-2131)
      • Coronary revascularisation in the management of stable angina pectoris. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998. 42 p. (SIGN publication; no. 32). [170 references]

    4. Drug therapy for peripheral vascular disease. A national clinical guideline. (NGC-2128)
      • Drug therapy for peripheral vascular disease. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Jul. 23 p. (SIGN publication; no. 27). [111 references]

    5. Interventions in the management of behavioural and psychological aspects of dementia. A national clinical guideline. (NGC-2124)
      • Interventions in the management of behavioural and psychological aspects of dementia. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Feb. 26 p. (SIGN publication; no. 22). [76 references]

    6. Management of adult testicular germ cell tumours. A national clinical guideline. (NGC-2129)
      • Management of adult testicular germ cell tumours. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Sep. 39 p. (SIGN publication; no. 28). [87 references]

    7. Management of early rheumatoid arthritis. A national clinical guideline. (NGC-2140)
      • Management of early rheumatoid arthritis. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000. 44 p. (SIGN publication; no. 48). [202 references]

    8. Management of lung cancer. A national clinical guideline. (NGC-2125)
      • Management of lung cancer. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Feb. 53 p. (SIGN publication; no. 23). [134 references]

    9. Management of patients with stroke. I: assessment, investigation, immediate management and secondary prevention. A national clinical guideline. (NGC-2122)
      • Management of patients with stroke. I: assessment, investigation, immediate management and secondary prevention. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1997 May. 27 p. (SIGN publication; no. 13). [46 references]

    10. Management of patients with stroke. II: management of carotid stenosis and carotid endarterectomy. A national clinical guideline. (NGC-2123)
      • Management of patients with stroke. II: management of carotid stenosis and carotid endarterectomy. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1997 May. 37 p. (SIGN publication; no. 14). [38 references]

    11. Psychosocial interventions in the management of schizophrenia. A national clinical guideline. (NGC-2130)
      • Psychosocial interventions for the management of schizophrenia. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Oct. 14 p. (SIGN publication; no. 30). [43 references]

    12. Safe sedation of children undergoing diagnostic and therapeutic procedures. A national clinical guideline. (NGC-2412)
      • Scottish Intercollegiate Guidelines Network (SIGN). Safe sedation of children undergoing diagnostic and therapeutic procedures. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Feb. 28 p. (SIGN publication; no. 58). [175 references]

    13. The care of patients with chronic leg ulcer. A national clinical guideline. (NGC-2127)
      • The care of patients with chronic leg ulcer. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Jul. 21 p. (SIGN publication; no. 26). [72 references]

    For more information, please refer to the Scottish Intercollegiate Guidelines Network Web site.

    Society of American Gastrointestinal Endoscopic Surgeons

    1. Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery. (NGC-1084)
      • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery.SAGES position statement. Surg Endosc 1999 Feb;13(2):200. [6 references] PubMed

    2. Guidelines for office endoscopic services. (NGC-1082)
      • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for office endoscopic services. Surg Endosc 1998 Feb;12(2):191-2. [2 references] PubMed

    For more information, please refer to the Society of American Gastrointestinal Endoscopic Surgeons Web site.

    Society of Critical Care Medicine

    1. Practice guidelines for evaluating new fever in critically ill adult patients. (NGC-0698)
      • Practice guidelines for evaluating new fever in critically ill adult patients. Clin Infect Dis 1998 May;26:1042-59. [106 references]


      • Practice guidelines for evaluating new fever in critically ill adult patients. Crit Care Med 1998 Feb;26(2):392-408. [105 references]

    For more information, please refer to the Society of Critical Care Medicine Web site.

    Society of Interventional Radiology

    1. Angioplasty standard of practice. (NGC-1135)
      • Angioplasty standard of practice. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1992 May;3(2):269-71. [15 references] PubMed

    2. Diagnostic arteriography in adults. (NGC-1136)
      • Standard for diagnostic arteriography in adults. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1993 May-Jun;4(3):385-95. [34 references] PubMed

    3. Guidelines for percutaneous transluminal angioplasty. (NGC-1134)
      • Guidelines for percutaneous transluminal angioplasty. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology [editorial]. Radiology 1990 Dec;177(3):619-26. PubMed

    4. Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. (NGC-1146)
      • Hansen ME, SCVIR Technology Assessment Committee, Bakal CW, Dixon GD, Eschelman DJ, Horton KM, Katz M, Olcott EW, Sacks D. Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. J Vasc Interv Radiol 1997 Jul-Aug;8(4):667-76. [60 references] PubMed

    For more information, please refer to the Society of Interventional Radiology Web site.

    Society of Nuclear Medicine, Inc

    1. Procedure guideline for bone pain treatment. (NGC-0620)
      • Society of Nuclear Medicine. Procedure guideline for bone pain treatment, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 26 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0). [5 references]

    2. Procedure guideline for bone scintigraphy. (NGC-0601)
      • Society of Nuclear Medicine. Procedure guideline for bone scintigraphy, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 25 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0). [5 references]

    3. Procedure guideline for diagnosis of renovascular hypertension. (NGC-0617)
      • Society of Nuclear Medicine. Procedure guideline for diagnosis of renovascular hypertension, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 21 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    4. Procedure guideline for gated equilibrium radionuclide ventriculography. (NGC-0619)
      • Society of Nuclear Medicine. Procedure guideline for gated equilibrium radionuclide ventriculography, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 20 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    5. Procedure guideline for hepatic and splenic imaging. (NGC-0605)
      • Society of Nuclear Medicine. Procedure guideline for hepatic and splenic imaging, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 16 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    6. Procedure guideline for myocardial perfusion imaging. (NGC-0611)
      • Society of Nuclear Medicine. Procedure guideline for myocardial perfusion imaging. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 26 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    7. Procedure guideline for pediatric sedation in nuclear medicine. (NGC-0616)
      • Society of Nuclear Medicine. Procedure guideline for pediatric sedation in nuclear medicine, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 15 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    8. Procedure guideline for radionuclide cystography in children. (NGC-0614)
      • Society of Nuclear Medicine. Procedure guideline for radionuclide cystography in children, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 18 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    9. Procedure guideline for renal cortical scintigraphy in children. (NGC-0613)
      • Society of Nuclear Medicine. Procedure guideline for renal cortical scintigraphy in children, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 16 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    For more information, please refer to the Society of Nuclear Medicine, Inc Web site.

    Substance Abuse and Mental Health Services Administration (U.S.)

    1. A guide to substance abuse services for primary care clinicians. (NGC-0787)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). A guide to substance abuse services for primary care clinicians. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1997. 187 p. (Treatment improvement protocol (TIP) series; no. 24). [210 references]

    2. Comprehensive case management for substance abuse treatment. (NGC-0790)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Comprehensive case management for substance abuse treatment. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1998. 122 p. (Treatment improvement protocol (TIP) series; no. 27). [180 references]

    3. Continuity of offender treatment for substance use disorders from institution to community. (NGC-1041)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Continuity of offender treatment for substance use disorders from institution to community. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1998. 124 p. (Treatment improvement protocol (TIP); no. 30). [132 references]

    4. Naltrexone and alcoholism treatment. (NGC-0791)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Naltrexone and alcoholism treatment. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1998. 94 p. (Treatment improvement protocol (TIP) series; no. 28). [225 references]

    5. Substance abuse among older adults. (NGC-0789)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Substance abuse among older adults. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1998. 173 p. (Treatment improvement protocol (TIP) series; no. 26). [396 references]

    6. Substance abuse treatment and domestic violence. (NGC-0788)
      • Substance abuse treatment and domestic violence. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1997. 102 p. (Treatment improvement protocol (TIP) series; no. 25). [201 references]

    7. Substance use disorder treatment for people with physical and cognitive disabilities. (NGC-1040)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Substance use disorder treatment for people with physical and cognitive disabilities. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1998. 171 p. (Treatment improvement protocol (TIP) series; no. 29). [101 references]

    8. Treatment drug courts: integrating substance abuse treatment with legal case processing. (NGC-0786)
      • Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment drug courts: integrating substance abuse treatment with legal case processing. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1996. 66 p. (Treatment improvement protocol (TIP) series; no. 23). [60 references]

    For more information, please refer to the Substance Abuse and Mental Health Services Administration (U.S.) Web site.

    The North American Menopause Society

    1. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. (NGC-1791)
      • A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause 2000 Mar-Apr;7(2):76-86. [53 references]

    2. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society. (NGC-1792)
      • Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society. Menopause 2000 Mar-Apr;7(2):87-95. [87 references]

    For more information, please refer to the The North American Menopause Society Web site.

    United States Preventive Services Task Force

    1. Adult immunizations - including chemoprophylaxis against influenza A. (NGC-0210)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 66, Adult immunizations - including chemoprophylaxis against influenza A. p. 791-814. [202 references]

    2. Aspirin prophylaxis in pregnancy. (NGC-0214)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 70, Aspirin prophylaxis in pregnancy. p. 853-59. [31 references]

    3. Childhood immunization. (NGC-0209)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 65, Childhood immunizations. p. 767-90. [216 references]

    4. Counseling to prevent gynecologic cancers. (NGC-0208)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 64, Counseling to prevent gynecologic cancers. p. 755-64. [103 references]

    5. Counseling to prevent HIV infection and other sexually transmitted diseases. (NGC-0206)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 62, Counseling to prevent HIV infection and other sexually transmitted diseases. p. 723-37. [111 references]

    6. Counseling to prevent household and recreational injuries (NGC-0202)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 58, Counseling to prevent household and recreational injuries. p. 659-86. [201 references]

    7. Counseling to prevent motor vehicle injuries (NGC-0201)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 57, Counseling to prevent motor vehicle injuries. p. 643-58. [201 references]

    8. Counseling to prevent unintended pregnancy (NGC-0207)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 63, Counseling to prevent unintended pregnancy. p. 739-54. [94 references]

    9. Counseling to prevent youth violence (NGC-0203)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 59, Counseling to prevent youth violence. p. 687-98. [90 references]

    10. Home uterine activity monitoring. (NGC-0184)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 40, Home uterine activity monitoring. p. 443-7. [28 references]

    11. Intrapartum electronic fetal monitoring. (NGC-0183)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 39, Intrapartum electronic fetal monitoring. p. 433-42. [46 references]

    12. Postexposure prophylaxis for selected infectious diseases. (NGC-0211)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 67, Postexposure prophylaxis for selected infectious diseases. p. 815-27. [111 references]

    13. Screening for abdominal aortic aneurysm. (NGC-0150)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 6, Screening for abdominal aortic aneurysm. p. 67-72. [25 references]

    14. Screening for asymptomatic carotid artery stenosis. (NGC-0149)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 4, Screening for asymptomatic carotid artery stenosis. p. 53-61. [58 references]

    15. Screening for congenital hypothyroidism (NGC-0189)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 45, Screening for congenital hypothyroidism. p. 503-507. [39 references]

    16. Screening for Down syndrome. (NGC-0185)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 41, Screening for Down syndrome. p. 449-65. [123 references]

    17. Screening for drug abuse (NGC-0197)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 53, Screening for drug abuse. p. 583-95. [80 references]

    18. Screening for elevated lead levels in childhood and pregnancy. (NGC-0167)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 23, Screening for elevated lead levels in childhood and pregnancy. p. 247-67. [152 references]

    19. Screening for genital herpes simplex. (NGC-0174)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 30, Screening for genital herpes simplex. p. 335-46. [68 references]

    20. Screening for glaucoma. (NGC-0178)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 34, Screening for glaucoma. p. 383-92. [41 references]

    21. Screening for gonorrhea - including ocular prophylaxis in newborns. (NGC-0171)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 27, Screening for gonorrhea - including ocular prophylaxis in newborns. p. 293-302. [52 references]

    22. Screening for hearing impairment. (NGC-0179)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 35, Screening for hearing impairment. p. 393-406. [88 references]

    23. Screening for hemoglobinopathies. (NGC-0187)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 43, Screening for hemoglobinopathies. p. 485-94. [53 references]

    24. Screening for human immunodeficiency virus. (NGC-0172)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 28, Screening for human immunodeficiency virus infection. p. 303-24. [159 references]

    25. Screening for iron deficiency anemia - including iron prophylaxis. (NGC-0166)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 22, Screening for iron deficiency anemia--including iron prophylaxis. p. 231-46.

    26. Screening for neural tube defects - including folic acid/folate prophylaxis. (NGC-0186)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 42, Screening for neural tube defects - including folic acid/folate prophylaxis. p. 467-484. [111 references]

    27. Screening for peripheral arterial disease. (NGC-0393)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 5, Screening for peripheral arterial disease. p. 63-6. [16 references]

    28. Screening for phenylketonuria. (NGC-0188)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 44, Screening for phenylketonuria. p. 495-502. [56 references]

    29. Screening for preeclampsia. (NGC-0181)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 37, Screening for preeclampsia. p. 419-424. [32 references]

    30. Screening for rubella - including immunization of adolescents and adults. (NGC-0176)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 32, Screening for rubella - including immunization of adolescents and adults. p. 361-72. [97 references]

    31. Screening for thyroid cancer. (NGC-0162)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 18, Screening for thyroid cancer. p. 187-91. [25 references]

    32. Screening for tuberculosis infection: including Bacille Calmette-Guerin immunization. (NGC-0169)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 25, Screening for tuberculosis infection - including Bacille Calmette-Guerin immunization. p. 277-86. [55 references]

    33. Screening ultrasonography in pregnancy. (NGC-0180)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Washington (DC): Williams & Wilkins; 1996. Screening ultrasonography in pregnancy. p. 407-18. [60 references]

    For more information, please refer to the United States Preventive Services Task Force Web site.

    University HealthSystem Consortium

    1. Dementia identification and assessment: guidelines for primary care practitioners. (NGC-1203)
      • University HealthSystem Consortium (UHC), U.S. Department of Veterans Affairs. Dementia indentification and assessment: guidelines for primary care practitioners. Oak Brook (IL): UHC; 1997 Mar. 112 p. [120 references]

    For more information, please refer to the University HealthSystem Consortium Web site.

    University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core

    1. Acute confusion/delirium. (NGC-0536)
      • Iowa Veterans Affairs Consortium. Rapp CG. Acute confusion/delirium. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 41 p. [81 references]

    2. Alzheimer's disease and chronic dementing illnesses. (NGC-0546)
      • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Alzheimer's disease and chronic dementing illnesses. Iowa City (IA): University of Iowa; 1996. 65 p. (Research-based protocol; no. 1996). [24 references]

    3. Bathing persons with dementia. (NGC-0544)
      • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Bathing persons with dementia. Iowa City (IA): University of Iowa; 1998 Apr. 17 p. (Research-based protocol; no. 1998). [14 references]

    4. Detection of depression in the cognitively intact older adult. (NGC-0729)
      • Piven MLS. Detection of depression in the cognitively intact older adult evidence-based protocol. In: Titler MG, editor(s). Series on evidence-based practice for older adults. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. p. 25 . [92 references]

    5. Latex precautions. (NGC-0547)
      • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Latex precautions. Iowa City (IA): University of Iowa; 1998 Apr 29. 15 p. (Research-based protocols; no. 1998). [29 references]

    6. Management of constipation. (NGC-0543)
      • Hert M, Huseboe J. Management of constipation. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998 Jun. 49 p. [50 references]

    7. Music therapy programming for individuals with Alzheimer's disease and related disorders. (NGC-1785)
      • Gfeller K, Hanson N, editor(s). Music therapy programming for individuals with Alzheimer's disease and related disorders. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center Research Dissemination Core; 1995. 149 p. (Research-based protocol; no. 1995).

    8. Restraints. (NGC-0545)
      • Ledford L, Mentes J. Restraints research-based protocol. In: Titler MG, editor(s). Series on evidence-based practice for older adults. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1997 Sep. p. 83. [55 references]

    9. Split-thickness skin graft donor site care. (NGC-0538)
      • The UIHC STSG Donor Site Care RU Committee. Abbott L. Split-thickness skin graft donor site care. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 28 p. [37 references]

    For more information, please refer to the University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core Web site.

    University of Michigan Health System

    1. Heart failure - systolic dysfunction. (NGC-1508)
      • University of Michigan Health System. Heart failure - systolic dysfunction. Ann Arbor (MI): University of Michigan Health System; 1999 Aug. 12 p. [9 references]

    2. Venous thromboembolism (VTE). (NGC-1015)
      • University of Michigan Health System. Venous thromboembolism (VTE). Ann Arbor (MI): University of Michigan Health System; 1998. 10 p. [6 references]

    For more information, please refer to the University of Michigan Health System Web site.

    University of Pennsylvania

    1. Venous leg ulcer guideline. (NGC-1363)
      • University of Pennsylvania. Venous leg ulcer guideline. Philadelphia (PA): University of Pennsylvania; 1997. 45 p. [120 references]

    University of Texas Medical Branch Correctional Managed Care

    1. Acute and chronic asthma. (NGC-2700)
      • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Acute and chronic asthma. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Apr. 4 p. [1 reference]

    2. Hyperlipidemia. (NGC-2778)
      • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Hyperlipidemia. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Jul. 12 p. [1 reference]

    Veterans Health Administration

    1. The management of diabetes mellitus in the primary care setting. (NGC-1809)
      • Management of diabetes mellitus in the primary care setting. Washington (DC): Department of Veterans Affairs (U.S.); 1999 Dec. 147 p. [185 references]

    2. The pharmacologic management of chronic heart failure. (NGC-2253)
      • The pharmacologic management of chronic heart failure. Washington (DC): Department of Veterans Affairs (U.S.), Veterans Health Administration (VHA); 2001 Feb. 42 p. [159 references]

    For more information, please refer to the Veterans Health Administration Web site.

    UPDATED NGC SUMMARIES

    The list below identifies those NGC Summaries that have been withdrawn from the NGC Web site because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete and should no longer be used. In each case the withdrawn guideline has been replaced with a new/revised guideline.

    The National Guideline Clearinghouse™ currently contains 730 guidelines have been superceded.

    Academy of Ambulatory Foot and Ankle Surgery

    1. Hallux abductovalgus. (NGC-1563)
      • Academy of Ambulatory Foot and Ankle Surgery. Hallux abductovalgus. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 21 p. [50 references]

      CURRENT NGC SUMMARY: Hallux abductovalgus. (NGC-3240)

    2. Hallux limitus and hallux rigidus. (NGC-1567)
      • Academy of Ambulatory Foot and Ankle Surgery. Hallux limitus & hallux rigidus. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p. [3 references]

      CURRENT NGC SUMMARY: Hallux limitus and hallux rigidus. (NGC-3244)

    3. Hammertoe syndrome. (NGC-1565)
      • Academy of Ambulatory Foot and Ankle Surgery. Hammertoe syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 23 p. [31 references]

      CURRENT NGC SUMMARY: Hammertoe syndrome. (NGC-3242)

    4. Heel spur syndrome. (NGC-1568)
      • Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p. [14 references]

      CURRENT NGC SUMMARY: Heel spur syndrome. (NGC-3245)

    5. Ingrown toenails. (NGC-1564)
      • Academy of Ambulatory Foot and Ankle Surgery. Ingrown toenails. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 20 p. [30 references]

      CURRENT NGC SUMMARY: Ingrown toenails. (NGC-3241)

    6. Intermetatarsal neuroma. (NGC-1566)
      • Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 17 p. [15 references]

      CURRENT NGC SUMMARY: Intermetatarsal neuroma. (NGC-3243)

    7. Metatarsalgia/intractable plantar keratosis/Tailor's bunion. (NGC-1569)
      • Academy of Ambulatory Foot and Ankle Surgery. Metatarsalgia/intractable plantar keratosis/Tailor's bunion. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 13 p. [26 references]

      CURRENT NGC SUMMARY: Metatarsalgia/intractable plantar keratosis/Tailor's bunion. (NGC-3246)

    Agency for Healthcare Research and Quality

    1. Smoking cessation. (NGC-0094)
      • Agency for Health Care Policy and Research (AHCPR). Smoking cessation. Clinical practice guideline. Rockville (MD): U. S. Department of Health and Human Services, Public Health Service, AHCPR; 1996 Apr. 124 p. (Clinical practice guideline; no. 18). [145 references]

      CURRENT NGC SUMMARY: Treating tobacco use and dependence. A clinical practice guideline. (NGC-1586)

    Alzheimer's Association of Los Angeles, Riverside and San Bernardino Counties

    1. Guidelines for Alzheimer's disease management. (NGC-0846)
      • California Workgroup on Alzheimer's Disease Management Guidelines. Guidelines for alzheimer's disease management. Los Angeles (CA): Alzheimer's Association and Related Disorders Association, Inc; 1999 Jan 8. 23 p. [79 references]

      CURRENT NGC SUMMARY: Guidelines for Alzheimer's disease management. (NGC-2383)

    American Academy of Child and Adolescent Psychiatry

    1. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. (NGC-0321)
      • Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):177S-93S. [90 references]

      CURRENT NGC SUMMARY: Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. (NGC-2243)

    American Academy of Family Physicians

    1. Summary of policy recommendations for periodic health examinations. (NGC-2654)
      • American Academy of Family Physicians (AAFP). Summary of policy recommendations for periodic health examinations. Leawood (KS): American Academy of Family Physicians (AAFP); 2002 Aug . 15 p.

      CURRENT NGC SUMMARY: Summary of policy recommendations for periodic health examinations. (NGC-3208)

    American Academy of Neurology

    1. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome. (NGC-0452)
      • American Association of Electrodiagnostic Medicine (AAEM), American Academy of Neurology. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome. Summary statement [published erratum appears in Neurology 1994 Feb;44(2):367]. Neurology 1993 Nov;43(11):2404-5. [165 references]


      • Practice parameter for electrodiagnostic studies in carpal tunnel syndrome. Muscle Nerve 1993 Dec;16(12):1390-1. [165 references] PubMed

      CURRENT NGC SUMMARY: Practice parameter: electrodiagnostic studies in carpal tunnel syndrome. (NGC-2515)

    American Academy of Ophthalmology

    1. Age-related macular degeneration. (NGC-2314)
      • American Academy of Ophthalmology, Retina Panel. Age-related macular degeneration, limited revision. San Francisco (CA): American Academy of Ophthalmology (AAO); 2001. 31 p. [67 references]

      CURRENT NGC SUMMARY: Age-related macular degeneration. (NGC-3275)

    2. Amblyopia. (NGC-0398)
      • Amblyopia. San Francisco (CA): American Academy of Ophthalmology (AAO); 1997 Sep 16. 30 p. [85 references]

      CURRENT NGC SUMMARY: Amblyopia. (NGC-2772)

    3. Bacterial keratitis. (NGC-0399)
      • American Academy of Ophthalmology. Amercan Academy of Ophthalmology Quality of Care Committee Retinal Panel. Bacterial keratitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 1995 Sep 16. 21 p. [32 references]

      CURRENT NGC SUMMARY: Bacterial keratitis. (NGC-1882)

    4. Blepharitis. (NGC-0738)
      • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease Panel. Blepharitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 1998. 16 p. [27 references]

      CURRENT NGC SUMMARY: Blepharitis. (NGC-3279)

    5. Cataract in the adult eye. (NGC-0401)
      • American Academy of Ophthalmology (AAO). Cataract in the adult eye. San Francisco (CA): American Academy of Ophthalmology (AAO); 1996. 25 p. [73 references]

      CURRENT NGC SUMMARY: Cataract in the adult eye. (NGC-2313)

    6. Comprehensive adult eye evaluation. (NGC-0402)
      • Comprehensive adult eye examination. Preferred practice patterns. San Francisco (CA): American Academy of Ophthalmology (AAO); 1996. 13 p. (Preferred practice pattern; no. 1996). [30 references]

      CURRENT NGC SUMMARY: Comprehensive adult medical eye evaluation. (NGC-1884)

    7. Conjunctivitis. (NGC-0894)
      • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease. Conjunctivitis. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 24 p. [33 references]

      CURRENT NGC SUMMARY: Conjunctivitis. (NGC-3280)

    8. Corneal opacification (NGC-0404)
      • American Academy of Ophthalmology. American Academy of Ophthalmology Quality of Care Committee Retina Panel. Corneal opacification. San Francisco (CA): American Academy of Ophthalmology (AAO); 1995 Sep 16. 15 p. [12 references]

      CURRENT NGC SUMMARY: Corneal opacification and ectasia. (NGC-1883)

    9. Diabetic retinopathy. (NGC-0741)
      • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Retina Panel. Diabetic retinopathy. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 32 p. [60 references]

      CURRENT NGC SUMMARY: Diabetic retinopathy. (NGC-3276)

    10. Dry eye syndrome. (NGC-0739)
      • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease Panel. Dry eye syndrome. San Francisco (CA): American Academy of Ophthalmology (AAO); 1998. 18 p. [29 references]

      CURRENT NGC SUMMARY: Dry eye syndrome. (NGC-3281)

    11. Esotropia. (NGC-0405)
      • Esotropia. San Francisco (CA): American Academy of Ophthalmology (AAO); 1997 Sep. 23 p. [67 references]

      CURRENT NGC SUMMARY: Esotropia and exotropia. (NGC-2770)

    12. Management of posterior vitreous detachment, retinal breaks, and lattice degeneration. (NGC-0742)
      • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Retina Panel. Management of posterior vitreous detachment, retinal breaks, and lattice degeneration. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 24 p. [82 references]

      CURRENT NGC SUMMARY: Posterior vitreous detachment, retinal breaks, and lattice degeneration. (NGC-3277)

    13. Pediatric eye evaluations. (NGC-0406)
      • Pediatric eye evaluations. San Francisco (CA): American Academy of Ophthalmology (AAO); 1997. 17 p. [17 references]

      CURRENT NGC SUMMARY: Pediatric eye evaluations. (NGC-2769)

    14. Primary angle-closure glaucoma. (NGC-0407)
      • Primary angle-closure glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 1996. 15 p. [27 references]

      CURRENT NGC SUMMARY: Primary angle closure. (NGC-1774)

    15. Primary open-angle glaucoma suspect. (NGC-1776)
      • American Academy of Ophthalmology, Quality of Care Committe Retina Panel. Primary open angle glaucoma suspect. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000. 26 p. [76 references]

      CURRENT NGC SUMMARY: Primary open-angle glaucoma suspect. (NGC-2773)

    16. Primary open-angle glaucoma. (NGC-1775)
      • American Academy of Ophthalmology, Quality of Care Committee Retina Panel. Primary open-angle glaucoma. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000. 36 p. [148 references]

      CURRENT NGC SUMMARY: Primary open-angle glaucoma. Limited revision. (NGC-3282)

    17. Refractive errors. (NGC-0411)
      • Refractive errors. San Francisco (CA): American Academy of Ophthalmology (AAO); 1997 Sep. 41 p. [208 references]

      CURRENT NGC SUMMARY: Refractive errors. (NGC-2771)

    18. Rehabilitation: the management of adult patients with low vision. (NGC-0412)
      • American Academy of Ophthalmology. American Academy of Ophthalmology Quality of Care Committee Retina Panel. Rehabilitation: the management of adult patients with low vision. San Francisco (CA): American Academy of Ophthalmology (AAO); 1994 Feb 26. 20 p.

      CURRENT NGC SUMMARY: Vision rehabilitation for adults. (NGC-2119)

    American Academy of Orthopaedic Surgeons

    1. Clinical guideline on hip pain. (NGC-0936)
      • American Academy of Orthopaedic Surgeons. Clinical guideline on hip pain. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1999. 5 p. [4 references]

      CURRENT NGC SUMMARY: American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on sub-acute (non-traumatic) hip pain in adults (>50 years of age). (NGC-3671)

    2. Clinical guideline on knee pain. (NGC-0933)
      • American Academy of Orthopaedic Surgeons. Clinical guideline on knee pain. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1996. 12 p. [102 references]

      CURRENT NGC SUMMARY: AAOS clinical guideline on osteoarthritis of the knee. (NGC-3069)

    3. Clinical guideline on low back pain. (NGC-0932)
      • American Academy of Orthopaedic Surgeons. Clinical guideline on low back pain. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1999. 16 p. [128 references]

      CURRENT NGC SUMMARY: American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on low back pain/sciatica (acute) (phases I and II). (NGC-3672)

    4. Clinical guideline on wrist pain. (NGC-0934)
      • American Academy of Orthopaedic Surgeons. Clinical guideline on wrist pain. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1999. 6 p. [20 references]

      CURRENT NGC SUMMARY: American Academy of Orthopaedic Surgeons (AAOS) clinical guideline on wrist pain - phase I. (NGC-3673)

    American Academy of Pediatrics

    1. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. (NGC-0081)
      • American Academy of Pediatrics. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994 Oct;94(4 Pt 1):558-65. [31 references] PubMed

      CURRENT NGC SUMMARY: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (NGC-3716)

    2. Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. (NGC-1003)
      • American Academy of Pediatrics (AAP). Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. Committee on Injury and Poison Prevention. Pediatrics 1996 May;97(5):761-3. [11 references] PubMed

      CURRENT NGC SUMMARY: Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. (NGC-2408)

    American Academy of Periodontology

    1. Parameter on acute periodontal diseases. (NGC-0984)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on acute periodontal diseases. p. 33-40. [7 references]

      CURRENT NGC SUMMARY: Parameter on acute periodontal diseases. (NGC-1555)

    2. Parameter on adult periodontitis with advanced loss of periodontal support. (NGC-0980)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on adult periodontitis with advanced loss of periodontal support. p. 15-19. [19 references]

      CURRENT NGC SUMMARY: Parameter on chronic periodontitis with advanced loss of periodontal support. (NGC-1552)

    3. Parameter on adult periodontitis with slight to moderate loss of periodontal support. (NGC-0979)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on adult periodontitis with slight to moderate loss of periodontal support. p. 9-14. [21 references]

      CURRENT NGC SUMMARY: Parameter on chronic periodontitis with slight to moderate loss of periodontal support. (NGC-1551)

    4. Parameter on comprehensive periodontal examination. (NGC-0977)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on comprehensive periodontal examination. p. 2-5. [26 references]

      CURRENT NGC SUMMARY: Parameter on comprehensive periodontal examination. (NGC-1548)

    5. Parameter on early-onset periodontitis. (NGC-0985)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on early-onset periodontitis. p. 41-5. [29 references]

      CURRENT NGC SUMMARY: Parameter on aggressive periodontitis. (NGC-1556)

    6. Parameter on mucogingival conditions. (NGC-0983)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on mucogingival conditions. p. 29-32. [15 references]

      CURRENT NGC SUMMARY: Parameter on mucogingival conditions. (NGC-1554)

    7. Parameter on occlusal traumatism in patients with adult periodontitis. (NGC-0987)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on occlusal traumatism in patients with adult periodontitis. p. 51-5. [12 references]

      CURRENT NGC SUMMARY: Parameter on occlusal traumatism in patients with chronic periodontitis. (NGC-1558)

    8. Parameter on periodontitis associated with systemic conditions. (NGC-0988)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on periodontitis associated with systemic conditions. p. 56-62. [28 references]

      CURRENT NGC SUMMARY: Parameter on periodontitis associated with systemic conditions. (NGC-1559)

    9. Parameter on placement and management of the dental implant. (NGC-0986)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on placement and management of the dental implant. p. 46-50. [16 references]

      CURRENT NGC SUMMARY: Parameter on placement and management of the dental implant. (NGC-1557)

    10. Parameter on plaque-associated gingivitis. (NGC-0978)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter of plaque-associated gingivitis. p. 6-8. [11 references]

      CURRENT NGC SUMMARY: Parameter on plaque-induced gingivitis. (NGC-1550)

    11. Parameter on refractory periodontitis. (NGC-0982)
      • American Academy of Periodontology (AAP). Parameters of care. Chicago (IL): American Academy of Periodontology; 1996 Oct. Parameter on refractory periodontitis. p. 24-8. [23 references]

      CURRENT NGC SUMMARY: Parameter on "refractory" periodontitis. (NGC-1553)

    American Academy of Sleep Medicine

    1. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. (NGC-0899)
      • American Sleep Disorders Association. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep - Europe 1995 May;18(4):285-7.

      CURRENT NGC SUMMARY: Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. (NGC-3033)

    2. Practice parameters for the use of laser-assisted uvulopalatoplasty. (NGC-0897)
      • American Sleep Disorders Association. Practice parameters for the use of laser-assisted uvulopalatoplasty. Sleep - Europe 1994 Dec;17(8):744-8. [38 references] PubMed

      CURRENT NGC SUMMARY: Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. (NGC-2158)

    3. Practice parameters for the use of polysomnography in the evaluation of insomnia. (NGC-0898)
      • American Sleep Disorders Association. Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep - Europe 1995 Jan;18(1):55-7. [2 references] PubMed

      CURRENT NGC SUMMARY: Practice parameters for using polysomnography to evaluate insomnia: an update. (NGC-3292)

    4. Practice parameters for the use of stimulants in the treatment of narcolepsy. (NGC-1162)
      • American Sleep Disorders Association. Practice parameters for the use of stimulants in the treatment of narcolepsy [published erratum appears in Sleep 1994 Dec;17(8):748]. Sleep - Europe 1994 Jun;17(4):348-51. [3 references] PubMed

      CURRENT NGC SUMMARY: Practice parameters for the treatment of narcolepsy: an update for 2000. (NGC-2159)

    American Association for Respiratory Care

    1. Bland aerosol administration. (NGC-0359)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Bland aerosol administration. Respir Care 1993 Nov;38(11):1196-200. [20 references]

      CURRENT NGC SUMMARY: Bland aerosol administration: 2003 revision and update. (NGC-2978)

    2. Body plethysmography. (NGC-0370)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Body plethysmography. Respir Care 1994 Dec;39(12):1184-90. [40 references]

      CURRENT NGC SUMMARY: Body plethysmography: 2001 revision and update. (NGC-2069)

    3. Bronchial provocation. (NGC-0350)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Bronchial provocation. Respir Care 1992 Aug;37(8):902-6. [23 references]

      CURRENT NGC SUMMARY: Methacholine challenge testing: 2001 revision and update. (NGC-2071)

    4. Capnography/capnometry during mechanical ventilation. (NGC-0378)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capnography/capnometry during mechanical ventilation. Respir Care 1995 Dec;40(12):1321-4. [41 references]

      CURRENT NGC SUMMARY: Capnography/capnometry during mechanical ventilation: 2003 revision and update. (NGC-2980)

    5. Exercise testing for evaluation of hypoxemia and/or desaturation. (NGC-0355)
      • American Association for Repiratory Care (AARC). AARC clinical practice guideline. Exercise testing for evaluation of hypoxemia and/or desaturation. Respir Care 1992 Aug;37(8):907-12. [41 references]

      CURRENT NGC SUMMARY: Exercise testing for evaluation of hypoxemia and/or desaturation: 2001 revision and update. (NGC-2070)

    6. Intermittent positive pressure breathing. (NGC-0361)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Intermittent positive pressure breathing. Respir Care 1993 Dec;38(12):1189-95. [66 references]

      CURRENT NGC SUMMARY: Intermittent positive pressure breathing: 2003 revision and update. (NGC-2979)

    7. Oxygen therapy in the acute care hospital. (NGC-0340)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Oxygen therapy in the acute care hospital. Respir Care 1991 Dec;36(12):1410-3. [30 references]

      CURRENT NGC SUMMARY: Oxygen therapy for adults in the acute care facility: 2002 revision and update. (NGC-2474)

    8. Sampling for arterial blood gas analysis (NGC-0346)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Sampling for arterial blood gas analysis. Respir Care 1992 Aug;37(8):913-7. [20 references]

      CURRENT NGC SUMMARY: Blood gas analysis and hemoximetry: 2001 revision and update. (NGC-2068)

    9. Selection of an oxygen delivery device for neonatal and pediatric patients (NGC-0381)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Selection of an oxygen delivery device for neonatal and pediatric patients. Respir Care 1996 Jul;41(7):637-46. [83 references]

      CURRENT NGC SUMMARY: Selection of an oxygen delivery device for neonatal and pediatric patients: 2002 revision and update. (NGC-2475)

    10. Single-breath carbon monoxide diffusing capacity. (NGC-0353)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Single-breath carbon monoxide diffusing capacity. Respir Care 1993 May;38(5):511-5. [27 references]

      CURRENT NGC SUMMARY: Single-breath carbon monoxide diffusing capacity, 1999 update. (NGC-0993)

    11. Static lung volumes. (NGC-0365)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Static lung volumes. Respir Care 1994 Aug;39(8):830-6. [30 references]

      CURRENT NGC SUMMARY: Static lung volumes: 2001 revision and update. (NGC-2072)

    12. Transport of the mechanically ventilated patient. (NGC-0357)
      • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Transport of the mechanically ventilated patient. Respir Care 1993 Dec;38(12):1169-72. [26 references]

      CURRENT NGC SUMMARY: In-hospital transport of the mechanically ventilated patient: 2002 revision and update. (NGC-2473)

    American Association for the Study of Liver Diseases

    1. Chronic hepatitis B. (NGC-2672)
      • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001 Dec;34(6):1225-41. [228 references] PubMed

      CURRENT NGC SUMMARY: Chronic hepatitis B. (NGC-3589)

    2. Management of adult patients with ascites caused by cirrhosis. (NGC-2676)
      • Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998 Jan;27(1):264-72. [78 references] PubMed

      CURRENT NGC SUMMARY: Management of adult patients with ascites due to cirrhosis. (NGC-3590)

    American Association of Clinical Endocrinologists

    1. AACE clinical practice guidelines for growth hormone use in adults and children. (NGC-0455)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for growth hormone use in adults and children. Endocr Pract 1998 May-Jun;4(3):165-73. [12 references]


      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for growth hormone use in adults and children. Jacksonville (FL): AACE; 1998. 17 p. [12 references]

      CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. (NGC-2952)

    2. AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. (NGC-0453)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Jacksonville (FL): AACE; 1996. 24 p. (AACE clinical guidelines; no. 1996).

      CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. (NGC-2751)

    3. AACE clinical practice guidelines for the evaluation and treatment of hypogonadism in adult male patients. (NGC-0454)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the evaluation and treatment of hypogonadism in adult male patients. Jacksonville (FL): AACE; 1996. 28 p. (AACE clinical guidelines; no. 1996). [69 references]

      CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. (NGC-2750)

    4. AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction. (NGC-0554)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology. AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction. Endocr Pract 1998 Jul-Aug;4(4):219-35. [69 references]

      CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update. (NGC-2951)

    5. AACE clinical practice guidelines for the management of thyroid carcinoma. (NGC-0456)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the management of thyroid carcinoma. Jacksonville (FL): AACE; 1997. 24 p. (AACE clinical guidelines; no. 1997). [33 references]

      CURRENT NGC SUMMARY: AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. (NGC-2074)

    6. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. (NGC-0457)
      • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Jacksonville (FL): AACE; 1996. 26 p. (AACE clinical guidelines; no. 1996). [33 references]


      • American Association of Clinical Endocrinologists (AACE). AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 1996 Mar-Apr;2(2):155-71. [33 references]

      CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. (NGC-3185)

    7. The AACE medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management. 2000 update. (NGC-1380)
      • American Association of Clinical Endocrinologists, American College of Endocrinology. AACE medical guidelines for the management of diabetes mellitus--1999 update. Endocr Pract 2000 Jan-Feb;6(1):42-84. [96 references]

      CURRENT NGC SUMMARY: The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management--2002 update. (NGC-2398)

    American Cancer Society

    1. ACS guidelines for the early detection of breast cancer: update 1997. (NGC-0922)
      • Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, Smith RA. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997 May-Jun;47(3):150-3. PubMed

      CURRENT NGC SUMMARY: ACS guidelines for breast cancer screening: update 2003. (NGC-2971)

    2. ACS prostate cancer screening guideline: update 1997. (NGC-0923)
      • von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin 1997 Sep-Oct;47(5):261-4. PubMed

      CURRENT NGC SUMMARY: Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Detection, May 4-6, 2000 and ACS guideline on testing for early prostate cancer detection: update 2001. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1973)

    3. American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and cancer-update 2001. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1974)
      • American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and colorectal cancer-update 2001. CA Cancer J Clin 2001 Jan-Feb;51(1):44-54. [181 references]


      • Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002 Jan-Feb;52(1):8-22. [61 references] PubMed

      CURRENT NGC SUMMARY: American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and colorectal cancer-update 2003. In: American Cancer Society guidelines for the early detection of cancer, 2003. (NGC-3135)

    American College of Cardiology Foundation

    1. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). (NGC-0033)
      • Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, Marwick TH, McCallister BD, Thompson PD Jr, Winters WL, Yanowitz FG, Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Lewis RP, O'Rourke RA, Ryan TJ. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997 Jul;30(1):260-311. [343 references] PubMed

      CURRENT NGC SUMMARY: ACC/AHA 2002 guideline update for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). (NGC-2653)

    2. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). (NGC-0495)
      • Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ, Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner TJ, Lewis RP, O'Rourke RA, Ryan TJ, Garson A Jr. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998 Apr;31(5):1175-209. [333 references] PubMed

      CURRENT NGC SUMMARY: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (NGC-2665)

    3. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (NGC-0020)
      • American College of Cardiology, American Heart Association Task Force on Practice Guidelines. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996 Nov 1;28(5):1328-1428. [787 references]

      CURRENT NGC SUMMARY: 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). (NGC-1232)

    4. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (NGC-1800)
      • Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3d, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2000 Sep;36(3):970-1062. [515 references] PubMed

      CURRENT NGC SUMMARY: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (NGC-2416)

    5. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). (NGC-0215)
      • Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH 3d, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the ACC/AHA Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 1996 Mar 15;93(6):1278-317. [229 references] PubMed


      • Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan TJ, Schlant RC, Spencer WH, et al. ACC/AHA Task Force Report - special report - guidelines for perioperative cardiovascular evaluation for noncardiac surgery. J Cardiothorac Vasc Anesth 1996 Jun;10(4):540-52. [229 references]


      • Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac . J Am Coll Cardiol 1996 Jun;27(4):910-48. [229 references]

      CURRENT NGC SUMMARY: ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). (NGC-2375)

    6. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). (NGC-0056)
      • Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995 Nov 1;92(9):2764-84. [112 references]


      • Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995 Nov 1;26(5):1376-98. [112 references]

      CURRENT NGC SUMMARY: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). (NGC-2340)

    7. Guidelines for the management of patients with chronic stable angina. (NGC-1192)
      • Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1999 Jun;33(7):2092-197. [891 references] PubMed

      CURRENT NGC SUMMARY: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina). (NGC-2814)

    American College of Chest Physicians

    1. Fifth ACCP consensus conference on antithrombotic therapy. (NGC-1230)
      • American College of Chest Physicians. Proceedings of the American College of Chest Physicians 5th Consensus on Antithrombotic Therapy. 1998. Chest 1998 Nov;114(5 Suppl):439S-769S. [3207 references] PubMed

      CURRENT NGC SUMMARY: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1946)

    American College of Foot and Ankle Surgeons

    1. Hammer toe syndrome. (NGC-0851)
      • American College of Foot and Ankle Surgeons. Hammer toe syndrome. Park Ridge (IL): American College of Foot and Ankle Surgeons; 1992. 27 p. (Preferred practice guideline; no. 1/92). [87 references]

      CURRENT NGC SUMMARY: Hammer toe syndrome. (NGC-2117)

    American College of Preventive Medicine

    1. Childhood immunizations. (NGC-0560)
      • Patel R, Kinsinger L. Childhood immunizations: American College of Preventive Medicine practice policy. Am J Prev Med 1997 Mar-Apr;13(2):74-7. [21 references] PubMed

      CURRENT NGC SUMMARY: Childhood immunizations. (NGC-3164)

    American College of Radiology

    1. ACR Appropriateness Criteria™ for acute chest pain--no ECG evidence of myocardial ischemia/infarction. (NGC-1617)
      • Stanford W, Levin DC, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Hessel SJ, Higgins CB, Kelley MJ, Needleman L, Polak JF, Wexler L, Abbott W, Port S. Acute chest pain--no ECG evidence of myocardial ischemia/infarction. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):79-84. [44 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute chest pain--no ECG evidence of myocardial ischemia/infarction. (NGC-2480)

    2. ACR Appropriateness Criteria™ for acute hand and wrist trauma. (NGC-1658)
      • Newberg A, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Acute hand and wrist trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):375-8.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute hand and wrist trauma. (NGC-2488)

    3. ACR Appropriateness Criteria™ for acute pancreatitis. (NGC-1635)
      • Megibow AJ, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Kidd R, Levine MS, Mezwa DG, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Acute pancreatitis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):203-7. [18 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute pancreatitis. (NGC-2483)

    4. ACR Appropriateness Criteria™ for acute trauma to the knee. (NGC-1657)
      • Pavlov H, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Schweitzer ME, Haralson RH, McCabe JB. Acute trauma to the knee. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):365-73.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute trauma to the knee. (NGC-2487)

    5. ACR Appropriateness Criteria™ for bone metastases. (NGC-0839)
      • American College of Radiology (ACR), Expert Panel on Radiation Oncology. Bone metastases. Reston (VA): American College of Radiology (ACR); 1996 Sep. 31 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/96). [22 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for bone metastases. (NGC-1795)

    6. ACR Appropriateness Criteria™ for cervical spine trauma. (NGC-1641)
      • Keats TE, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Cervical spine trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):243-6. [17 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for suspected cervical spine trauma. (NGC-2790)

    7. ACR Appropriateness Criteria™ for chronic ankle pain. (NGC-1652)
      • DeSmet AA, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Chronic ankle pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):321-32.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for chronic ankle pain. (NGC-2780)

    8. ACR Appropriateness Criteria™ for chronic elbow pain. (NGC-1654)
      • Goergen T, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Keats TE, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Chronic elbow pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):339-43.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for chronic elbow pain. (NGC-2486)

    9. ACR Appropriateness Criteria™ for chronic foot pain. (NGC-1656)
      • el-Khoury GY, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Chronic foot pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):357-63.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for chronic foot pain. (NGC-2781)

    10. ACR Appropriateness Criteria™ for follow-up examinations for bone tumors, soft tissue tumors and suspected metastasis post therapy. (NGC-1659)
      • Manaster BJ, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Follow-up examinations for bone tumors, soft tissue tumors, and suspected metastasis post therapy. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):379-87.

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for follow-up examinations for bone tumors, soft-tissue tumors, and suspected metastasis post therapy. (NGC-2782)

    11. ACR Appropriateness Criteria™ for hematemesis. (NGC-1623)
      • Gomes AS, Levin DC, Bettmann MA, Grollman J, Henkin RE, Hessel SJ, Higgins CB, Kelley MJ, Needleman L, Polak JF, Stanford W, Wexler L, Abbott W, Port S. Hematemesis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):113-9. [35 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for hematemesis. (NGC-2783)

    12. ACR Appropriateness Criteria™ for imaging evaluation of patients with acute abdominal pain and fever. (NGC-1636)
      • Shuman WP, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Kidd R, Levine MS, Megibow AJ, Mezwa DG, Saini S, Greene FL, Laine LA, Lillemoe K. Imaging evaluation of patients with acute abdominal pain and fever. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):209-12. [21 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for imaging evaluation of patients with acute abdominal pain and fever. (NGC-2484)

    13. ACR Appropriateness Criteria™ for imaging evaluation of the palpable abdominal mass. (NGC-1634)
      • DiSantis DJ, Ralls PW, Balfe DM, Bree RL, Glick SN, Kidd R, Levine MS, Megibow AJ, Mezwa DG, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Imaging evaluation of the palpable abdominal mass. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):201-2. [8 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for imaging evaluation of the palpable abdominal mass. (NGC-2482)

    14. ACR Appropriateness Criteria™ for imaging recommendations for patients with dysphagia. (NGC-1638)
      • Levine MS, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Kidd R, Megibow AJ, Mezwa DG, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Imaging recommendations for patients with dysphagia. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):225-30. [26 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for imaging recommendations for patients with dysphagia. (NGC-2485)

    15. ACR Appropriateness Criteria™ for imaging recommendations for patients with newly suspected Crohn's disease, and in patients with known Crohn's disease and acute exacerbation or suspected complications. (NGC-1632)
      • Kidd R, Mezwa DG, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Imaging recommendations for patients with newly suspected Crohn's disease, and in patients with known Crohn's disease and acute exacerbation or suspected complications. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):181-92. [32 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for imaging recommendations for patients with Crohn's disease. (NGC-2481)

    16. ACR Appropriateness Criteria™ for imaging work-up for stage I breast carcinoma. (NGC-1721)
      • Bassett L, Mendelson E, Bohm-Velez M, Cardenosa G, D'Orsi C, Evans WP 3d, Monsees B, Thurmond A, Goldstein S. Imaging work-up for stage I breast carcinoma. American College of Radiology (ACR). ACR Appropriateness Criteria. Radiology 2000 Jun;215 Suppl:955-9. [29 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for imaging work-up for stage I breast carcinoma. (NGC-2788)

    17. ACR Appropriateness Criteria™ for liver lesion characterization. (NGC-1633)
      • Saini S, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Kidd R, Levine MS, Megibow AJ, Mezwa DG, Shuman WP, Greene FL, Laine LA, Lillemoe K. Liver lesion characterization. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):193-9. [15 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for liver lesion characterization. (NGC-2784)

    18. ACR Appropriateness Criteria™ for recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. (NGC-1620)
      • Grollman J, Levin DC, Bettmann MA, Gomes AS, Henkin RE, Hessel SJ, Higgins CB, Kelley MJ, Needleman L, Polak JF, Stanford W, Wexler L, Abbott W, Port S. Recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):95-9. [29 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. (NGC-2787)

    19. ACR Appropriateness Criteria™ for renal trauma. (NGC-0835)
      • American College of Radiology (ACR), Expert Panel on Urologic Imaging - Second Series. Renal trauma. Reston (VA): American College of Radiology (ACR); 1996 Sep. 8 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/96). [17 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for diagnostic approach to renal trauma. (NGC-1699)

    20. ACR Appropriateness Criteria™ for sinusitis in the pediatric population. (NGC-0833)
      • American College of Radiology (ACR), Expert Panel on Pediatric Imaging. Possible acute or chronic sinusitis. Reston (VA): American College of Radiology (ACR); 1995 Sep. 14 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/95). [44 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for sinusitis in the pediatric population. (NGC-1711)

    21. ACR Appropriateness Criteria™ for suspected congenital heart disease in the adult. (NGC-1615)
      • Kelley MJ, Levin DC, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Hessel SJ, Higgins CB, Needleman L, Polak JF, Stanford W, Wexler L, Abbott W, Port S. Suspected congenital heart disease in the adult. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):67-72. [24 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for suspected congenital heart disease in the adult. (NGC-2789)

    22. ACR Appropriateness Criteria™ for suspected small bowel obstruction. (NGC-0840)
      • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Suspected small bowel obstruction. Reston (VA): American College of Radiology (ACR); 1996 Sep. 6 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/96). [22 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for patient with suspected small bowel obstruction: imaging strategies. (NGC-1624)

    23. ACR Appropriateness Criteria™ for uncomplicated low back pain. (NGC-0838)
      • American College of Radiology (ACR), Expert Panel on Neuro Imaging. Uncomplicated low back pain. Reston (VA): American College of Radiolgoy (ACR); 1996 Sep. 11 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/96). [15 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute low back pain--radiculopathy. (NGC-1667)

    24. ACR Appropriateness Criteria™ for work-up of the solitary pulmonary nodule (SPN). (NGC-0834)
      • American College of Radiology (ACR), Expert Panel on Thoracic Imaging. Work-up of the solitary pulmonary nodule (SPN). Reston (VA): American College of Radiology (ACR); 1995 Sep. 5 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/95). [18 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for work-up of the solitary pulmonary nodule (SPN). (NGC-1796)

    25. Appropriateness criteria™ for acute chest pain, suspected myocardial ischemia. (NGC-0831)
      • American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Acute chest pain, suspected myocardial ischemia. Reston (VA): American College of Radiology (ACR); 1995 Sep. 8 p. (Appropriateness criteria for imaging and treatment decisions; no. 9/95). [41 references]

      CURRENT NGC SUMMARY: ACR Appropriateness Criteria™ for acute chest pain--suspected myocardial ischemia. (NGC-1606)

    26. Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. (NGC-0331)
      • American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology, Winchester DP, Strom EA. Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. CA Cancer J Clin 1998 Mar/Apr;48(2):108-28. [53 references]

      CURRENT NGC SUMMARY: Standards for the management of ductal carcinoma in situ of the breast (DCIS). (NGC-2518)

    27. Standards for diagnosis and management of invasive breast carcinoma. (NGC-0327)
      • American College of Radiology, American College of Surgeons, College of American Pathologists, Society of Surgical Oncology, Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin 1998 Mar-Apr;48(2):83-107. [46 references]

      CURRENT NGC SUMMARY: Standards for breast conservation therapy in the management of invasive breast carcinoma. (NGC-2517)

    American Diabetes Association

    1. Care of children with diabetes in the school and day care setting. (NGC-2812)
      • Klingensmith G, Kaufman F, Schatz D, Clarke W. Care of children with diabetes in the school and day care setting. Diabetes Care 2003 Jan;26 Suppl 1:S131-5. [21 references] PubMed

      CURRENT NGC SUMMARY: Diabetes care in the school and day care setting. (NGC-3432)

    2. Diabetic nephropathy. (NGC-2804)
      • Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH. Diabetic nephropathy. Diabetes Care 2003 Jan;26(Suppl 1):S94-8. [15 references] PubMed

      CURRENT NGC SUMMARY: Nephropathy in diabetes. (NGC-3424)

    3. Diabetic retinopathy. (NGC-2805)
      • Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2003 Jan;26(Suppl 1):S99-102. [10 references] PubMed

      CURRENT NGC SUMMARY: Retinopathy in diabetes. (NGC-3425)

    4. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. (NGC-2794)
      • Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ, Wheeler M. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003 Jan;26 Suppl 1:S51-61. [7 references] PubMed

      CURRENT NGC SUMMARY: Nutrition principles and recommendations in diabetes. (NGC-3414)

    5. Gestational diabetes mellitus. (NGC-2806)
      • Gestational diabetes mellitus. Diabetes Care 2003 Jan;26 Suppl 1:S103-5. [5 references] PubMed

      CURRENT NGC SUMMARY: Gestational diabetes mellitus. (NGC-3426)

    6. Hyperglycemic crises in patients with diabetes mellitus. (NGC-2808)
      • Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM. Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 2003 Jan;26 Suppl 1:S109-17. [38 references] PubMed

      CURRENT NGC SUMMARY: Hyperglycemic crises in diabetes. (NGC-3428)

    7. Management of diabetes in correctional institutions. (NGC-2811)
      • Management of diabetes in correctional institutions. Diabetes Care 2003 Jan;26 Suppl 1:S129-30. [4 references] PubMed

      CURRENT NGC SUMMARY: Diabetes management in correctional institutions. (NGC-3431)

    8. Management of dyslipidemia in adults with diabetes. (NGC-2800)
      • Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S83-6. [12 references] PubMed

      CURRENT NGC SUMMARY: Dyslipidemia management in adults with diabetes. (NGC-3420)

    9. Pancreas transplantation for patients with type 1 diabetes. (NGC-2809)
      • Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S120. [1 reference] PubMed

      CURRENT NGC SUMMARY: Pancreas transplantation in type 1 diabetes. (NGC-3429)

    10. Physical activity/exercise and diabetes mellitus. (NGC-2797)
      • Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH. Physical activity/exercise and diabetes mellitus. Diabetes Care 2003 Jan;26 Suppl 1:S73-7. [9 references] PubMed

      CURRENT NGC SUMMARY: Physical activity/exercise and diabetes. (NGC-3417)

    11. Preconception care of women with diabetes. (NGC-2803)
      • Preconception care of women with diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S91-3. [2 references] PubMed

      CURRENT NGC SUMMARY: Preconception care of women with diabetes. (NGC-3423)

    12. Screening for type 2 diabetes. (NGC-2792)
      • Screening for type 2 diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S21-4. [20 references] PubMed

      CURRENT NGC SUMMARY: Screening for type 2 diabetes. (NGC-3412)

    13. Smoking and diabetes. (NGC-2802)
      • Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 2003 Jan;26(Suppl 1):S89-90. [4 references] PubMed

      CURRENT NGC SUMMARY: Smoking and diabetes. (NGC-3422)

    14. Standards of medical care for patients with diabetes mellitus. (NGC-2793)
      • Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003 Jan;26(Suppl 1):S33-50. [106 references] PubMed

      CURRENT NGC SUMMARY: Standards of medical care in diabetes. (NGC-3413)

    15. Tests of glycemia in diabetes. (NGC-2807)
      • Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM. Tests of glycemia in diabetes. Diabetes Care 2003 Jan;26(Suppl 1):S106-8. [4 references] PubMed

      CURRENT NGC SUMMARY: Tests of glycemia in diabetes. (NGC-3427)

    16. The prevention or delay of type 2 diabetes. (NGC-2795)
      • Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg HN, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B. The prevention or delay of type 2 diabetes. Diabetes Care 2003 Jan;26(Suppl 1):S62-9. [60 references] PubMed

      CURRENT NGC SUMMARY: Prevention or delay of type 2 diabetes. (NGC-3415)

    17. Translation of the diabetes nutrition recommendations for health care institutions. (NGC-2796)
      • Schafer RG, Bohannon B, Franz MJ, Freeman J, Holmes A, McLaughlin S, Haas LB, Kruger DF, Lorenz RA, McMahon MM. Translation of the diabetes nutrition recommendations for health care institutions. Diabetes Care 2003 Jan;26(Suppl 1):S70-2. [6 references] PubMed

      CURRENT NGC SUMMARY: Diabetes nutrition recommendations for health care institutions. (NGC-3416)

    American Gastroenterological Association

    1. Colorectal cancer screening: clinical guidelines and rationale. (NGC-0045)
      • Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ. Colorectal cancer screening: clinical guidelines and rationale [published errata appear in Gastroenterology 1997 Mar;112(3):1060 and 1998 Mar;114(3):625]. Gastroenterology 1997 Feb;112(2):594-642. [220 references] PubMed

      CURRENT NGC SUMMARY: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. (NGC-2912)

    2. Medical position statement: irritable bowel syndrome. (NGC-0530)
      • American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 1997 Jun;112(6):2118-9. [190 references] PubMed

      CURRENT NGC SUMMARY: American Gastroenterological Association medical position statement: irritable bowel syndrome. (NGC-2911)

    American Geriatrics Society

    1. The management of chronic pain in older persons. (NGC-1113)
      • Amercian Geriatrics Society (AGS). AGS clinical practice guidelines: the management of chronic pain in older persons. Geriatrics 1998 Oct;53(Suppl 3):S8-24. [116 references] PubMed


      • American Geriatric Society (AGS). The management of chronic pain in older persons. AGS Panel on Chronic Pain in Older Persons . J Am Geriatr Soc 1998 May;46(5):635-51. [116 references] PubMed

      CURRENT NGC SUMMARY: The management of persistent pain in older persons. (NGC-2591)

    American Healthways, Inc

    1. Inpatient management guidelines for people with diabetes. (NGC-0929)
      • Diabetes Treatment Centers of America (DTCA). Inpatient management guidelines for people with diabetes. Nashville (TN): Diabetes Treatment Centers of America (DTCA); 1999. 18 p. [38 references]

      CURRENT NGC SUMMARY: Inpatient management guidelines for people with diabetes. (NGC-2443)

    2. Specialty referral guidelines for people with diabetes. (NGC-0448)
      • Diabetes Treatment Centers of America. Specialty referral guidelines for people with diabetes. Nashville (TN): Diabetes Treatment Centers of America; 1998. 18 p. [14 references]

      CURRENT NGC SUMMARY: Specialty referral guidelines for people with diabetes. (NGC-1231)

    American Medical Directors Association

    1. Depression. (NGC-1032)
      • American Medical Directors Association (AMDA). Depression. Columbia (MD): American Medical Directors Association (AMDA); 1996. 20 p. [38 references]

      CURRENT NGC SUMMARY: Depression. (NGC-3520)

    2. Falls and fall risk. (NGC-1034)
      • American Medical Directors Association (AMDA). Falls and fall risk. Columbia (MD): American Medical Directors Association (AMDA); 1998. 16 p. [23 references]

      CURRENT NGC SUMMARY: Falls and fall risk. (NGC-3521)

    3. Heart failure. (NGC-1035)
      • American Medical Directors Association (AMDA). Heart failure. Columbia (MD): The American Medical Directors Association (AMDA); 1996. 12 p. [15 references]

      CURRENT NGC SUMMARY: Heart failure. (NGC-2529)

    4. Osteoporosis. (NGC-1036)
      • American Medical Directors Association (AMDA). Osteoporosis. Columbia (MD): American Medical Directors Association (AMDA); 1998. 16 p. [16 references]

      CURRENT NGC SUMMARY: Osteoporosis. (NGC-3523)

    American Optometric Association

    1. Care of the patient with conjunctivitis. (NGC-1220)
      • American Optometric Association. Care of the patient with conjunctivitis. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 54 p. (Optometric clinical practice guideline; no. 11). [54 references]

      CURRENT NGC SUMMARY: Care of the patient with conjunctivitis. 2nd edition. (NGC-3384)

    2. Care of the patient with diabetes mellitus. 2nd edition. (NGC-1212)
      • American Optometric Association. Care of the patient with diabetes mellitus. 2nd ed. St. Louis (MO): American Optometric Association; 1998. 69 p. (Optometric clinical practice guideline; no. 3). [98 references]

      CURRENT NGC SUMMARY: Care of the patient with diabetes mellitus. 3rd edition. (NGC-3386)

    3. Care of the patient with ocular surface disease. (NGC-1219)
      • American Optometric Association. Care of the patient with ocular surface disease. 2nd ed. St. Louis (MO): American Optometric Association; 1995. 58 p. (Optometric clinical practice guideline; no. 10). [88 references]

      CURRENT NGC SUMMARY: Care of the patient with ocular surface disorders. (NGC-2775)

    4. Care of the patient with open angle glaucoma. (NGC-1218)
      • American Optometric Association. Care of the patient with open angle glaucoma. St. Louis (MO): American Optometric Association; 1995. 90 p. (Optometric clinical practice guideline; no. 9). [285 references]

      CURRENT NGC SUMMARY: Care of the patient with open angle glaucoma. 2nd edition. (NGC-3385)

    5. Pediatric eye and vision examination. (NGC-1211)
      • American Optometric Association. Pediatric eye and vision examination. 2nd ed. St. Louis (MO): American Optometric Association; 1994. 27 p. (Optometric clinical practice guideline; no. 2). [95 references]

      CURRENT NGC SUMMARY: Pediatric eye and vision examination. (NGC-2774)

    American Psychiatric Association

    1. Practice guideline for eating disorders. (NGC-0661)
      • American Psychiatric Association (APA). Practice guideline for eating disorders. Am J Psychiatry 1993 Feb;150(2):212-28. [182 references]


      • American Psychiatric Association (APA). Practice guideline for eating disorders. Washington (DC): American Psychiatric Press, Inc; 1993. 38 p. (APA practice guidelines; no. 1993). [182 references]

      CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with eating disorders. (NGC-1420)

    2. Practice guideline for major depressive disorder in adults. (NGC-0662)
      • American Psychiatric Association (APA). Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993 Apr;150(4 Suppl):1-26. [169 references]


      • American Psychiatric Association (APA). Practice guideline for major depressive disorder in adults. Washington (DC): American Psychiatric Press, Inc; 1993. 51 p. (APA practice guidelines; no. 1993). [169 references]

      CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with major depressive disorder. (NGC-1831)

    3. Practice guideline for the treatment of patients with schizophrenia. (NGC-0667)
      • American Psychiatric Association (APA). Practice guideline for the treatment of patients with schizophrenia. Washington (DC): American Psychiatric Press, Inc; 1997. 146 p. [581 references]


      • Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association (APA). Am J Psychiatry 1997 Apr;154(4 Suppl):1-63. [581 references] PubMed

      CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with schizophrenia. Second edition. (NGC-3572)

    4. Practice guideline for treatment of patients with bipolar disorder. (NGC-0663)
      • American Psychiatric Association (APA). Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994 Dec;151(12 Suppl):1-36. [258 references] PubMed


      • American Psychiatric Association (APA). Practice guideline for treatment of patients with bipolar disorder. Washington (DC): American Psychiatric Press, Inc; 1995. 74 p. [258 references]

      CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with bipolar disorder (revision). (NGC-2528)

    American Society for Colposcopy and Cervical Pathology

    1. Endocervical curettage. (NGC-1189)
      • American Society of Colposcopy and Cervical Pathology (ASCCP), Cox JT. ASCCP practice guidelines: endocervical curettage. J Lower Genital Tract Disease 1997;1(4):251-6. [22 references]

      CURRENT NGC SUMMARY: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (NGC-2512)

    2. Management guidelines for follow-up of atypical squamous cells of undetermined significance (ASCUS). (NGC-1187)
      • American Society of Colpsocopy and Cervical Pathology (ASCCP). ASCCP practice guideline. Management guidelines for follow-up of atypical squamous cells of undetermined significance (ASCUS). Colposcopist 1996 Winter;27(1):1-9. [31 references]

      CURRENT NGC SUMMARY: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (NGC-2512)

    3. Management issues related to quality of the smear. (NGC-1190)
      • Cox JT. ASCCP practice guidelines: management issues related to quality of the smear. J Lower Genital Tract Disease 1997;1(2):100-6. [31 references]

      CURRENT NGC SUMMARY: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (NGC-2512)

    4. Management of glandular abnormalities in the cervical smear. (NGC-1191)
      • Cox JT. ASCCP practice guidelines: management of glandular abnormalities in the cervical smear. J Lower Genital Tract Disease 1997;1(1):41-5. [25 references]

      CURRENT NGC SUMMARY: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (NGC-2512)

    American Society of Clinical Oncology

    1. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. (NGC-0656)
      • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997 Aug;15(8):2996-3018. [256 references] PubMed

      CURRENT NGC SUMMARY: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. (NGC-3361)

    2. Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. (NGC-1376)
      • American Society of Clinical Oncology. Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999 Oct;17(10):3333-3355. [113 references]

      CURRENT NGC SUMMARY: 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-2574)

    3. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. (NGC-0142)
      • 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1998 Feb;16(2):793-5. [256 references] PubMed

      CURRENT NGC SUMMARY: 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-1972)

    4. Guideline on the role of bisphosphonates in breast cancer. (NGC-1588)
      • American Society of Clinical Oncology. Guideline on the role of bisphosphonates in breast cancer. J Clin Oncol 2000 Mar;18(6):1378-91. [68 references]

      CURRENT NGC SUMMARY: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (NGC-3355)

    American Society of Colon and Rectal Surgeons

    1. Practice parameters for ambulatory anorectal surgery. (NGC-1351)
      • American Society of Colon and Rectal Surgeons. Practice parameters for ambulatory anorectal surgery. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 3 p. [0 references]

      CURRENT NGC SUMMARY: Practice parameters for ambulatory anorectal surgery. (NGC-3797)

    Brain Trauma Foundation

    1. Part I. Guidelines for the management of severe traumatic brain injury. In: Management and prognosis of severe traumatic brain injury. (NGC-2347)
      • Brain Trauma Foundation, Inc, American Association of Neurological Surgeons. Part 1: guidelines for the management of severe traumatic brain injury. New York (NY): Brain Trauma Foundation, Inc.; 2000. 165 p. [299 references]

      CURRENT NGC SUMMARY: (1) Part I. Guidelines for the management of severe traumatic brain injury. In: Management and prognosis of severe traumatic brain injury. (2) Update notice. Guidelines for the management of severe traumatic brain injury: cerebral perfusion pressure. (NGC-3020)

    Brigham and Women's Hospital (Boston)

    1. Osteoporosis. Guide to prevention, diagnosis, and treatment. (NGC-1361)
      • LeBoff MS, Bermas B, Dunaif A, Gharib S, Fairchild DG, Ginsburg E, Johnson PA, Soloman CG. Osteoporosis: guide to prevention, diagnosis, and treatment. Boston (MA): Brigham and Women's Hospital; 1999. 9 p. [6 references]

      CURRENT NGC SUMMARY: Osteoporosis. Guide to prevention, diagnosis, and treatment. (NGC-2656)

    British Association of Sexual Health and HIV

    1. 2002 national guideline on the management of the viral hepatitides A, B, and C. (NGC-2270)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of the viral hepatitides A, B & C. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [200 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of the viral hepatitides A, B, and C. (NGC-2680)

    2. National guideline for the management of Phthirus pubis infestation. (NGC-1448)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of Phthirus pubis infestation. Sex Transm Infect 1999 Aug;75 (Suppl 1):S78-9. [4 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of Phthirus pubis infestation. (NGC-2274)

    3. National guideline for the management of adult victims of sexual assault. (NGC-1450)
      • Association of Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of adult victims of sexual assault. Sex Transm Infect 1999 Aug;75 (Suppl 1):S82-4. [17 references]

      CURRENT NGC SUMMARY: 2002 national guidelines on the management of adult victims of sexual assault. (NGC-2276)

    4. National guideline for the management of anogenital warts. (NGC-1446)
      • Association for Genitourinary Medicine (AGUM), Association for Genitourinary Medicine (AGUM). National guideline for the management of anogenital warts. Sex Transm Infect 1999 Aug;75 (Suppl 1):S71-5. [34 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of anogenital warts. (NGC-2272)

    5. National guideline for the management of bacterial vaginosis. (NGC-1432)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of bacterial vaginosis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S16-8. [23 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of bacterial vaginosis. (NGC-2258)

    6. National guideline for the management of balanitis. (NGC-1451)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of balanitis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S85-8. [17 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of balanitis. (NGC-2277)

    7. National guideline for the management of chancroid. (NGC-1440)
      • Association for Genitourinary Medicine (AGUM), Association for Genitourinary Medicine (AGUM). National guideline for the management of chancroid. Sex Transm Infect 1999 Aug;75 (Suppl 1):S43-5. [30 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of chancroid. (NGC-2266)

    8. National guideline for the management of chlamydia trachomatis genital tract infection. (NGC-1429)
      • Association of Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of Chlamydia trachomatis genital tract infection. Sex Transm Infect 1999 Aug;75(Suppl 1):S4-8. [38 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of Chlamydia trachomatis genital tract infection. (NGC-2255)

    9. National guideline for the management of donovanosis (granuloma inguinale). (NGC-1438)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of donovanosis (granuloma inguinale). Sex Transm Infect 1999 Aug;75 (Suppl 1):S38-9. [12 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of donovanosis (granuloma inguinale). (NGC-2264)

    10. National guideline for the management of early syphilis. (NGC-1436)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of early syphilis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S29-33. [78 references]

      CURRENT NGC SUMMARY: 2002 national guidelines on the management of early syphilis. (NGC-2262)

    11. National guideline for the management of epididymo-orchitis. (NGC-1442)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of epididymo-orchitis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S51-3. [41 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of epididymo-orchitis. (NGC-2268)

    12. National guideline for the management of genital herpes. (NGC-1435)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of genital herpes. Sex Transm Infect 1999 Aug;75 (Suppl 1):S24-8. [24 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of genital herpes. (NGC-2261)

    13. National guideline for the management of gonorrhoea in adults. (NGC-1431)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of gonorrhoea in adults. Sex Transm Infect 1999 Aug;75 (Suppl 1):S13-5. [17 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of gonorrhoea in adults. (NGC-2257)

    14. National guideline for the management of late syphilis. (NGC-1437)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of late syphilis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S34-7. [16 references]

      CURRENT NGC SUMMARY: 2002 national guidelines for the management of late syphilis. (NGC-2263)

    15. National guideline for the management of lymphogranuloma venereum. (NGC-1439)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of lymphogranuloma venereum. Sex Transm Infect 1999 Aug;75 (Suppl 1):S40-2. [19 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of lymphogranuloma venereum. (NGC-2265)

    16. National guideline for the management of molluscum contagiosum. (NGC-1449)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of molluscum contagiosum. Sex Transm Infect 1999 Aug;75 (Suppl 1):S80-1. [17 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of molluscum contagiosum. (NGC-2275)

    17. National guideline for the management of non-gonococcal urethritis. (NGC-1430)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of non-gonococcal urethritis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S9-12. [23 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of non-gonococcal urethritis. (NGC-2256)

    18. National guideline for the management of pelvic infection and perihepatitis. (NGC-1443)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of pelvic infection and perihepatitis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S54-6. [14 references]

      CURRENT NGC SUMMARY: 2002 guidelines for the management of pelvic infection and perihepatitis. (NGC-2269)

    19. National guideline for the management of prostatitis. (NGC-1441)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of prostatitis. Sex Transm Infect 1999 Aug;75(Suppl 1):S46-50. [87 references]

      CURRENT NGC SUMMARY: 2002 national guideline for the management of prostatitis. (NGC-2267)

    20. National guideline for the management of scabies. (NGC-1447)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of scabies. Sex Transm Infect 1999 Aug;75 (Suppl 1):S76-7. [6 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of scabies. (NGC-2273)

    21. National guideline for the management of sexually acquired reactive arthritis. (NGC-1445)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of sexually acquired reactive arthritis. Sex Transm Infect 1999 Aug;75 (Suppl 1):S65-70. [57 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of sexually acquired reactive arthritis. (NGC-2271)

    22. National guideline for the management of trichomonas vaginalis. (NGC-1434)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of Trichomonas vaginalis. Sex Transm Infect 1999 Aug;75(Suppl 1):S21-3. [15 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of trichomonas vaginalis. (NGC-2260)

    23. National guideline for the management of vulvovaginal candidiasis. (NGC-1433)
      • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Diseases (MSSVD). National guideline for the management of vulvovaginal candidiasis. Sex Transm Infect 1999 Aug;75(Suppl 1):S19-20. [8 references]

      CURRENT NGC SUMMARY: 2002 national guideline on the management of vulvovaginal candidiasis. (NGC-2259)

    Canadian Task Force on Preventive Health Care

    1. Breast feeding. (NGC-1254)
      • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Breast feeding. p. 232-42. [33 references]

      CURRENT NGC SUMMARY: Interventions to promote breast-feeding: applying the evidence in clinical practice. (NGC-3651)

    2. Prevention of oral cancer. (NGC-1301)
      • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of oral cancer. p. 826-36. [43 references]

      CURRENT NGC SUMMARY: Preventive health care, 1999 update: prevention of oral cancer mortality. (NGC-1932)

    3. Primary prevention of child maltreatment. (NGC-1261)
      • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary prevention of child maltreatment. p. 320-32. [29 references]

      CURRENT NGC SUMMARY: Preventive health care, 2000 update: prevention of child maltreatment. (NGC-1927)

    4. Screening for cognitive impairment in the elderly. (NGC-1307)
      • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Screening for cognitive impairment in the elderly. p. 902-9. [27 references]

      CURRENT NGC SUMMARY: Screening for cognitive impairment and dementia in the elderly. (NGC-2035)

    5. Screening for colorectal cancer. (NGC-1298)
      • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. CMAJ 1994 Jun 15;150(12):1961-70. [65 references] PubMed

      CURRENT NGC SUMMARY: Preventive health care, 2001 update: colorectal cancer screening. (NGC-2120)

    Center for Biosecurity

    1. Anthrax as a biological weapon. Medical and public health management. (NGC-2204)
      • Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999 May 12;281(18):1735-45. [73 references] PubMed

      CURRENT NGC SUMMARY: Anthrax as a biological weapon, 2002: updated recommendations for management. (NGC-2446)

    2. Botulinum toxin as a biological weapon. Medical and public health management. (NGC-2206)
      • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001 Feb 28;285(8):1059-70. [106 references]

      CURRENT NGC SUMMARY: (1) Botulinum toxin as a biological weapon: medical and public health management. (2) Botulinum toxin as a biological weapon. (Addendum) (NGC-2845)

    3. Smallpox as a biological weapon. Medical and public health management. (NGC-2208)
      • Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999 Jun 9;281(22):2127-37. [51 references] PubMed

      CURRENT NGC SUMMARY: (1) Smallpox as a biological weapon: medical and public health management. (2) Smallpox as a biological weapon. (Addendum) (NGC-2838)

    Centers for Disease Control and Prevention

    1. (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
      (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (NGC-0060)
      • Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR Recomm Rep 1997 Mar 28;46(RR-7):1-25. [50 references]


      • Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000 Nov 17;49(RR13):1-8. [17 references]

      CURRENT NGC SUMMARY: (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
      (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (Addendum)
      (NGC-3288)

    2. (1) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2) Interim influenza vaccination recommendations — 2004–05 influenza season. (NGC-3890)
      • Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004 May 28;53(RR-6):1-40. [336 references] PubMed


      • Interim influenza vaccination recommendations--2004-05 influenza season. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2004 Oct 5. 2 p.

      CURRENT NGC SUMMARY: (1) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2) Interim influenza vaccination recommendations — 2004–05 influenza season. (3) Influenza antiviral medications: 2004-05 interim chemoprophylaxis and treatment guidelines. (NGC-3923)

    3. (1) Prevention and treatment of tuberculosis among patients with infected human immunodeficiency virus: Principles of therapy and revised recommendations.
      (2) Notice to readers: updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. (NGC-1383)
      • Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Recomm Rep 1998 Oct 30;47(RR-20):1-58. [162 references] PubMed

      CURRENT NGC SUMMARY: (1) Prevention and treatment of tuberculosis among patients with infected human immunodeficiency virus: Principles of therapy and revised recommendations.
      (2) Notice to readers: updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
      (3) Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patient
      (NGC-3404)

    4. (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
      (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001. (NGC-1528)
      • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000 Jun;49(RR-6):1-54. [169 references]


      • Update: fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States 2001. MMWR Recomm Rep 2001 Aug 31;50(34):733-5.

      CURRENT NGC SUMMARY: (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
      (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
      (3) Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.
      (NGC-3134)

    5. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. (NGC-1813)
      • 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep 1999 Aug 20;48(RR-10):1-59, 61-6. [89 references] PubMed


      • Centers for Disease Control and Prevention (CDC), US Public Health Service (USPHS), Infectious Diseases Society of America (IDSA). 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. MMWR Recomm Rep 1999 Aug 20;48(RR-10):1-66.

      CURRENT NGC SUMMARY: 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. (NGC-2306)

    6. Diagnosis and management of foodborne illnesses: a primer for physicians. (NGC-1933)
      • Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR Recomm Rep 2001 Jan 26;50 (RR-2):1-69. [95 references]

      CURRENT NGC SUMMARY: Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. (NGC-3593)

    7. Epidemic/epizootic West Nile virus in the United States: Revised guidelines for surveillance, prevention, and control. (NGC-2011)
      • Epidemic/epizootic West Nile Virus in the United States: revised guidelines for surveillance, prevention, and control. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2001 Apr. 104 p. [55 references]

      CURRENT NGC SUMMARY: Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. (NGC-3165)

    8. Guidelines for prevention of intravascular device-related infections. (NGC-0843)
      • Centers for Disease Control and Prevention, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular device-related infections. Part II. Recommendations for the prevention of nosocomial intravascular device-related infections. Am J Infect Control 1996 Aug;24(4):277-93. [434 references] PubMed


      • Centers for Disease Control and Prevention. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. Am J Infect Control 1996 Aug;24(4):262-77. [434 references] PubMed

      CURRENT NGC SUMMARY: Guidelines for the prevention of intravascular catheter-related infections. (NGC-2613)

    9. Guidelines for prevention of nosocomial pneumonia. (NGC-0841)
      • Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Recomm Rep 1997 Jan 3;46(RR-1):1-79. [140 references] PubMed

      CURRENT NGC SUMMARY: Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. (NGC-3506)

    10. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. (NGC-3503)
      • Department of Health and Human Services, Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Bethesda (MD): Department of Health and Human Services, Henry J. Kaiser Family Foundation; 2004 Mar 23. 97 p. [355 references]

      CURRENT NGC SUMMARY: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. (NGC-3926)

    11. Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-3299)
      • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): U.S. Department of Health and Human Services; 2003 Nov 26. 77 p. [203 references]

      CURRENT NGC SUMMARY: Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-3400)

    12. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0065)
      • Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 Dec 27;45(RR-15):1-30. [159 references]

      CURRENT NGC SUMMARY: Prevention of Hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1365)

    13. Prevention of perinatal group B streptococcal disease: a public health perspective. (NGC-0893)
      • Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. [published erratum appears in MMWR Morb Mortal Wkly Rep 1996 Aug 9;45(31):679]. MMWR Recomm Rep 1996 May 31;45(RR-7):1-24. [87 references] PubMed

      CURRENT NGC SUMMARY: Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (NGC-2629)

    14. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0037)
      • Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 Jul 12;45(RR-11):1-36. [118 references]

      CURRENT NGC SUMMARY: Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1206)

    15. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. (NGC-0905)
      • Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998 May 15;47(RR-7):1-33. [104 references] PubMed

      CURRENT NGC SUMMARY: Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. (NGC-2088)

    16. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. (NGC-3300)
      • Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville (MD): U.S. Department of Health and Human Services; 2003 Nov 26. 46 p. [208 references]

      CURRENT NGC SUMMARY: Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. (NGC-3642)

    17. Recommended childhood and adolescent immunization schedule-United States, January-June 2004. (NGC-3444)
      • Recommended childhood and adolescent immunization schedule--United States, January-June 2004. MMWR Morb Mortal Wkly Rep 2004 Jan 16;53(1):Q1-4. [4 references] PubMed

      CURRENT NGC SUMMARY: Recommended childhood and adolescent immunization schedule - United States, July-December 2004. (NGC-3536)

    18. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. (NGC-0064)
      • U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep 1995 Jul 7;44(RR-7):1-15. [73 references]

      CURRENT NGC SUMMARY: Revised recommendations for HIV screening of pregnant women. (NGC-2279)

    19. Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. (NGC-3476)
      • Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep 2004 Mar 5;53(8):177-8. [5 references] PubMed

      CURRENT NGC SUMMARY: Updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose. (NGC-3735)

    Cincinnati Children's Hospital Medical Center

    1. Evidence based clinical practice guideline for managing an acute exacerbation of asthma. (NGC-1197)
      • Cincinnati Children's Hospital Medical Center. 1998-1999 evidence-based clinical practice guideline for managing an acute exacerbation of asthma. Cincinnati (OH): Children's Hospital Medical Center (CHMC); 1999. 12 p.

      CURRENT NGC SUMMARY: Evidence based clinical practice guideline for managing an acute exacerbation of asthma. (NGC-2670)

    2. Evidence based clinical practice guideline for medical management of first unprovoked seizure in children 2 to 18 years of age. (NGC-1195)
      • Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline for medical management of first unprovoked seizure in children 2 to 18 years of age. Cincinnati (OH): Children's Hospital Medical Center (CHMC); 1999 Jun 28. 13 p.

      CURRENT NGC SUMMARY: Evidence based clinical practice guideline for medical management of first unprovoked seizure in children 2 to 18 years of age. (NGC-2752)

    3. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. (NGC-0659)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1998. 32 p. [51 references]

      CURRENT NGC SUMMARY: Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. (NGC-3166)

    4. Evidence based guidelines and recommendations for the community evaluation and medical management of children with acute gastroenteritis. (NGC-0657)
      • Cincinnati Children's Hospital Medical Center. 1997-1998 Evidence based guidelines and recommendations for the community evaluation and medical management of children with acute gastroenteritis. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1997. 46 p. [107 references]

      CURRENT NGC SUMMARY: Evidence based clinical practice guideline for children with acute gastroenteritis (AGE). (NGC-2343)

    5. Evidence based guidelines for the medical management of infants one year of age or less with a first time episode of bronchiolitis. (NGC-0658)
      • Cincinnati Children's Hospital Medical Center. 1998-1999 Evidence based guidelines for the medical management of infants one year of age or less with a first time episode of bronchiolitis. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1998. 16 p. [31 references]

      CURRENT NGC SUMMARY: Evidence based clinical practice guidelines for the infant with bronchiolitis. (NGC-2339)

    Consortium for Spinal Cord Medicine

    1. Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. (NGC-0396)
      • Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. J Spinal Cord Med 1997 Jul;20(3):284-308. [88 references]

      CURRENT NGC SUMMARY: Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. (NGC-2190)

    2. Prevention of thromboembolism in spinal cord injury. (NGC-0395)
      • Prevention of thromboembolism in spinal cord injury. J Spinal Cord Med 1997 Jul;20(3):259-83. [60 references]

      CURRENT NGC SUMMARY: Prevention of thromboembolism in spinal cord injury. (NGC-2191)

    Council on Chiropractic Practice

    1. Vertebral subluxation in chiropractic practice. (NGC-0677)
      • Council on Chiropractic Practice. Vertebral subluxation in chiropractic practice. Chandler (AZ): Council on Chiropractic Practice; 1998. 120 p. (Clinical practice guideline; no. 1). [939 references]

      CURRENT NGC SUMMARY: Vertebral subluxation in chiropractic practice. (NGC-3438)

    Daniel Freeman Memorial Hospital

    1. Tissue plasminogen activator (t-PA) for acute ischemic stroke. (NGC-0472)
      • Daniel Freeman Memorial Hospital, Inc. Tissue plasminogen activator (t-PA) for acute ischemic stroke. Inglewood (CA): Daniel Freeman Hospitals, Inc; 1997. 10 p. [3 references]

      CURRENT NGC SUMMARY: Tissue plasminogen activator (t-PA) for acute ischemic stroke. (NGC-2648)

    Diabetes Prevention and Control Program

    1. Basic guidelines for diabetes care. (NGC-2640)
      • California Department of Health Services, Diabetes Control Program. Basic guidelines for diabetes care. Sacramento (CA): California Department of Health Services, Diabetes Control Program; 2002 Jan. Various p.

      CURRENT NGC SUMMARY: Basic guidelines for diabetes care. (NGC-3369)

    Eastern Association for the Surgery of Trauma

    1. Practice management guidelines for identifying cervical spine injuries following trauma. (NGC-0925)
      • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for Cervical Spine Clearance. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for identifying cervical spine injuries following trauma. p. 33-49. [62 references]

      CURRENT NGC SUMMARY: Determination of cervical spine stability in trauma patients (update of the 1997 EAST cervical spine clearance document). (NGC-1849)

    2. Practice management guidelines for the management of venous thromboembolism in trauma patients. (NGC-0927)
      • Eastern Association for the Surgery of Trauma (EAST), Practice Parameter Workgroup for DVT Prophylaxis. EAST practice management guidelines for trauma. Allentown (PA): Eastern Association for the Surgery of Trauma; 1998 Jan 23. Practice management guidelines for the management of venous thromboembolism in trauma patients. p. 66-162. [12 references]

      CURRENT NGC SUMMARY: Practice management guidelines for the management of venous thromboembolism in trauma patients. (NGC-2415)

    European Society of Cardiology

    1. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. (NGC-1817)
      • Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000 Sep;21(17):1406-32. [190 references]

      CURRENT NGC SUMMARY: Management of acute coronary syndromes in patients presenting without persistent ST- segment elevation. (NGC-2744)

    Finnish Medical Society Duodecim

    1. Acne. (NGC-2615)
      • Finnish Medical Society Duodecim. Acne. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Apr 30. Various p.

      CURRENT NGC SUMMARY: Acne. (NGC-3326)

    2. Angina pectoris and coronary artery disease (CAD). (NGC-2607)
      • Finnish Medical Society Duodecim. Angina pectoris and coronary artery disease (CAD). Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Dec 30. Various p.

      CURRENT NGC SUMMARY: Angina pectoris and coronary artery disease (CAD). (NGC-3294)

    3. Atrial fibrillation: drug treatment and electric cardioversion. (NGC-2603)
      • Finnish Medical Society Duodecim. Atrial fibrillation: drug treatment and electric cardioversion. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Mar 4. Various p.

      CURRENT NGC SUMMARY: Atrial fibrillation: drug treatment and electric cardioversion. (NGC-3327)

    4. Benign prostatic hyperplasia. (NGC-3037)
      • Finnish Medical Society Duodecim. Benign prostatic hyperplasia. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Mar 22. Various p. [9 references]

      CURRENT NGC SUMMARY: Benign prostatic hyperplasia. (NGC-3603)

    5. Chlamydial urethritis and cervicitis. (NGC-2627)
      • Finnish Medical Society Duodecim. Chlamydial urethritis and cervicitis. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Jun 5. Various p.

      CURRENT NGC SUMMARY: Chlamydial urethritis and cervicitis. (NGC-3803)

    6. Coronary angiography and indications for coronary artery bypass graft (CABG) or angioplasty. (NGC-1841)
      • EBM (evidence-based medicine) guidelines. Helsinki, Finland: Duodecim Medical Publications Ltd; 2001 Apr 30. Coronary angiography and indications for CABG or angioplasty. p. 1-3. [17 references]

      CURRENT NGC SUMMARY: Coronary angiography and indications for CABG or angioplasty. (NGC-2608)

    7. Deep venous thrombosis. (NGC-2610)
      • Finnish Medical Society Duodecim. Deep venous thrombosis. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Apr 20. Various p.

      CURRENT NGC SUMMARY: Deep venous thrombosis. (NGC-3562)

    8. Differential diagnosis of chest pain. (NGC-2078)
      • Differential diagnosis of chest pain. Helsinki, Finland: Duodecim Medical Publications Ltd; 2001 May 4. 6 p. [2 references]

      CURRENT NGC SUMMARY: Differential diagnosis of chest pain. (NGC-3329)

    9. Drug treatment for hyperlipidaemias. (NGC-3283)
      • Finnish Medical Society Duodecim. Drug treatment for hyperlipidaemias. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2003 Oct 5 [Various]. [18 references]

      CURRENT NGC SUMMARY: Drug treatment for hyperlipidaemias. (NGC-3604)

    10. Gynaecologic ultrasound examination. (NGC-3043)
      • Finnish Medical Society Duodecim. Gynaecologic ultrasound examination. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Mar 21. Various p. [2 references]

      CURRENT NGC SUMMARY: Gynaecological ultrasound examination. (NGC-3605)

    11. Indications for and techniques of red cell transfusion. (NGC-2628)
      • Finnish Medical Society Duodecim. Indications for and techniques of red cell transfusion. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2000 Mar 30. Various p.

      CURRENT NGC SUMMARY: Indications for and techniques of red cell transfusion. (NGC-3606)

    12. Long-term management of asthma. (NGC-2601)
      • Finnish Medical Society Duodecim. Long-term management of asthma. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Dec 30. Various p.

      CURRENT NGC SUMMARY: Long-term management of asthma. (NGC-3561)

    13. Myocardial infarction. (NGC-2604)
      • Finnish Medical Society Duodecim. Myocardial infarction. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Mar 30. Various p.

      CURRENT NGC SUMMARY: Myocardial infarction. (NGC-3295)

    14. Palliative treatment of cancer. (NGC-2621)
      • Finnish Medical Society Duodecim. Palliative treatment of cancer. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Dec 27. Various p.

      CURRENT NGC SUMMARY: Palliative treatment of cancer. (NGC-3296)

    15. Physical activity in the prevention, treatment and rehabilitation of diseases. (NGC-2624)
      • Finnish Medical Society Duodecim. Physical activity in the prevention, treatment and rehabilitation of diseases. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 May 7. Various p.

      CURRENT NGC SUMMARY: Physical activity in the prevention, treatment and rehabilitation of diseases. (NGC-3560)

    16. Prevention and screening of colorectal cancer. (NGC-2623)
      • Finnish Medical Society Duodecim. Prevention and screening of colorectal cancer. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Apr 27. Various p.

      CURRENT NGC SUMMARY: Prevention and screening of colorectal cancer. (NGC-3607)

    17. Prolonged cough in children. (NGC-1833)
      • EBM (evidence-based medicine) guidelines. Helsinki, Finland: Duodecim Medical Publications Ltd; 2000 Apr 17. Prolonged cough in children. p. 1-2. [1 reference]

      CURRENT NGC SUMMARY: Prolonged cough in children. (NGC-2602)

    18. Seborrhoeic dermatitis. (NGC-2618)
      • Finnish Medical Society Duodecim. Seborrhoeic dermatitis. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Apr 21. Various p.

      CURRENT NGC SUMMARY: Seborrhoeic dermatitis. (NGC-3594)

    19. Sore throat and tonsillitis. (NGC-3297)
      • Finnish Medical Society Duodecim. Sore throat and tonsillitis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2003 Jul 17 [Various]. [5 references]

      CURRENT NGC SUMMARY: Sore throat and tonsillitis. (NGC-3811)

    20. Thrombocytopenia. (NGC-2619)
      • Finnish Medical Society Duodecim. Thrombocytopenia. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Apr 30. Various p.

      CURRENT NGC SUMMARY: Thrombocytopenia. (NGC-3332)

    21. Treatment of hyperlipidaemia: aims and selection. (NGC-2606)
      • Finnish Medical Society Duodecim. Treatment of hyperlipidaemia: aims and selection. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Nov 4. Various p.

      CURRENT NGC SUMMARY: Treatment of hyperlipidaemia: aims and selection. (NGC-3596)

    22. Ultrasonographic examinations: indications and preparation of the patient. (NGC-2611)
      • Finnish Medical Society Duodecim. Ultrasonographic examinations: indications and preparation of the patient. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Oct 24. Various p.

      CURRENT NGC SUMMARY: Ultrasonographic examinations: indications and preparation of the patient. (NGC-3334)

    23. Unstable angina pectoris. (NGC-2609)
      • Finnish Medical Society Duodecim. Unstable angina pectoris. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2002 Apr 8. Various p.

      CURRENT NGC SUMMARY: Unstable angina pectoris. (NGC-3335)

    24. Urinary incontinence in women. (NGC-2626)
      • Finnish Medical Society Duodecim. Urinary incontinence in women. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Jan 4. Various p.

      CURRENT NGC SUMMARY: Urinary incontinence in women. (NGC-3336)

    Global Initiative for Chronic Obstructive Lung Disease (GOLD)

    1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (NGC-2005)
      • Global Initiative for Chronic Obstructive Lung Disease (GOLD), World Health Organization (WHO), National Heart, Lung and Blood Institute (NHLBI). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease, World Health Organization, National Heart, Lung and Blood Institute; 2001. Various p. [547 references]

      CURRENT NGC SUMMARY: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (NGC-3777)

    Infectious Diseases Society of America

    1. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. (NGC-0691)
      • 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997 Sep;25(3):551-73. [195 references]

      CURRENT NGC SUMMARY: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. (NGC-2432)

    2. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. (NGC-0692)
      • Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 1997 Sep;27(3):574-83. [58 references]

      CURRENT NGC SUMMARY: Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. (NGC-2575)

    3. Practice guidelines for community-based parenteral anti-infective therapy. (NGC-0694)
      • Practice guidelines for community-based parental anti-infective therapy. Clin Infect Dis 1997 Oct;25(4):787-801. [101 references]

      CURRENT NGC SUMMARY: Practice guidelines for outpatient parenteral antimicrobial therapy. (NGC-3615)

    4. Practice guidelines for the management of community-acquired pneumonia in adults. (NGC-1891)
      • Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000 Aug;31(2):347-82. [218 references] PubMed

      CURRENT NGC SUMMARY: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. (NGC-3360)

    5. Practice guidelines for the treatment of candidiasis. (NGC-1896)
      • Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):662-78. [185 references]

      CURRENT NGC SUMMARY: Guidelines for treatment of candidiasis. (NGC-3359)

    6. Quality standards for immunization. (NGC-0693)
      • Quality standards for immunization. Clin Infect Dis 1997 Oct;25(4):782-6. [15 references]

      CURRENT NGC SUMMARY: Guidelines for quality standards for immunization. (NGC-2638)

    Institute for Clinical Systems Improvement

    1. Acute pharyngitis. (NGC-2386)
      • Institute for Clinical Systems Improvement (ICSI). Acute pharyngitis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Dec. 24 p. [37 references]

      CURRENT NGC SUMMARY: Acute pharyngitis. (NGC-3082)

    2. Acute sinusitis in adults. (NGC-2899)
      • Institute For Clinical Systems Improvement (ICSI). Acute sinusitis in adults. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 Dec. 30 p.

      CURRENT NGC SUMMARY: Acute sinusitis in adults. (NGC-3726)

    3. Adult low back pain. (NGC-3190)
      • Institute for Clinical Systems Improvement (ICSI). Adult low back pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Sep. 63 p. [103 references]

      CURRENT NGC SUMMARY: Adult low back pain. (NGC-3869)

    4. Ankle sprain. (NGC-2582)
      • Institute For Clinical Systems Improvement (ICSI). Ankle sprain. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 Mar. 24 p. [20 references]

      CURRENT NGC SUMMARY: Ankle sprain. (NGC-3191)

    5. Anticoagulation therapy supplement. (NGC-2346)
      • Institute for Clinical Systems Improvement (ICSI). Anticoagulation therapy supplement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Sep. 49 p. [77 references]

      CURRENT NGC SUMMARY: Anticoagulation therapy supplement. (NGC-3366)

    6. Assessment and management of acute pain. (NGC-2726)
      • Institute for Clinical Systems Improvement (ICSI). Assessment and management of acute pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Oct. 74 p.

      CURRENT NGC SUMMARY: Assessment and management of acute pain. (NGC-3517)

    7. Atrial fibrillation. (NGC-2330)
      • Institute for Clinical Systems Improvement (ICSI). Atrial fibrillation. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Oct. 69 p. [103 references]

      CURRENT NGC SUMMARY: Atrial fibrillation. (NGC-3318)

    8. Breast cancer treatment. (NGC-2896)
      • Institute for Clinical Systems Improvement (ICSI). Breast cancer treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jan. 45 p.

      CURRENT NGC SUMMARY: Breast cancer treatment. (NGC-3870)

    9. Cardiac stress test supplement. (NGC-2320)
      • Institute for Clinical Systems Improvement (ICSI). Cardiac stress test supplement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Oct. 24 p. [39 references]

      CURRENT NGC SUMMARY: Cardiac stress test supplement. (NGC-3365)

    10. Cervical cancer screening. (NGC-3192)
      • Institute for Clinical Systems Improvement (ICSI). Cervical cancer screening. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 32 p. [57 references]

      CURRENT NGC SUMMARY: Cervical cancer screening. (NGC-3851)

    11. Chronic obstructive pulmonary disease. (NGC-2371)
      • Institute for Clinical Systems Improvement (ICSI). Chronic obstructive pulmonary disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Dec. 60 p. [82 references]

      CURRENT NGC SUMMARY: Chronic obstructive pulmonary disease. (NGC-3433)

    12. Colorectal cancer screening. (NGC-3193)
      • Institute for Clinical Systems Improvement (ICSI). Colorectal cancer screening. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 48 p. [67 references]

      CURRENT NGC SUMMARY: Colorectal cancer screening. (NGC-3763)

    13. Community-acquired pneumonia in adults. (NGC-2577)
      • Institute For Clinical Systems Improvement (ICSI). Community-acquired pneumonia in adults. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 May. 41 p. [40 references]

      CURRENT NGC SUMMARY: Community-acquired pneumonia in adults. (NGC-3434)

    14. Congestive heart failure in adults. (NGC-2391)
      • Institute for Clinical Systems Improvement (ICSI). Congestive heart failure in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Jan. 71 p. [84 references]

      CURRENT NGC SUMMARY: Heart failure in adults. (NGC-3514)

    15. Diagnosis and initial treatment of ischemic stroke. (NGC-2329)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Oct. 60 p. [110 references]

      CURRENT NGC SUMMARY: Diagnosis and initial treatment of ischemic stroke. (NGC-3319)

    16. Diagnosis and management of asthma. (NGC-2633)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of asthma. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 May. 43 p. [29 references]

      CURRENT NGC SUMMARY: Diagnosis and management of asthma. (NGC-3083)

    17. Diagnosis and management of attention deficit hyperactivity disorder in primary care. (NGC-1471)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of attention deficit hyperactivity disorder in primary care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2000 Jan. 60 p. [130 references]

      CURRENT NGC SUMMARY: Diagnosis and management of attention deficit hyperactivity disorder in primary care for school age children and adolescents. (NGC-2987)

    18. Diagnosis and management of infertility. (NGC-2986)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of infertility. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Apr. 54 p. [95 references]

      CURRENT NGC SUMMARY: Diagnosis and management of basic infertility. (NGC-3764)

    19. Diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. (NGC-2581)
      • Institute For Clinical Systems Improvement (ICSI). Diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 May. 42 p. [39 references]

      CURRENT NGC SUMMARY: Diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. (NGC-3315)

    20. Diagnosis and treatment of obstructive sleep apnea. (NGC-2981)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of obstructive sleep apnea. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Apr. 53 p. [92 references]

      CURRENT NGC SUMMARY: Diagnosis and treatment of obstructive sleep apnea. (NGC-3670)

    21. Diagnosis and treatment of osteoporosis. (NGC-3195)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2003 Jul. 68 p. [172 references]

      CURRENT NGC SUMMARY: Diagnosis and treatment of osteoporosis. (NGC-3765)

    22. Diagnosis and treatment of otitis media in children. (NGC-2893)
      • Institute For Clinical Systems Improvement (ICSI). Diagnosis and treatment of otitis media in children. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 Dec. 28 p.

      CURRENT NGC SUMMARY: Diagnosis and treatment of otitis media in children. (NGC-3727)

    23. Diagnosis of breast disease. (NGC-2317)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis of breast disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Nov. 42 p. [46 references]

      CURRENT NGC SUMMARY: Diagnosis of breast disease. (NGC-3314)

    24. Diagnosis of chest pain. (NGC-2328)
      • Institute for Clinical Systems Improvement (ICSI). Diagnosis of chest pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Sep. 47 p. [85 references]

      CURRENT NGC SUMMARY: Diagnosis of chest pain. (NGC-2900)

    25. Domestic violence. (NGC-2322)
      • Institute for Clinical Systems Improvement (ICSI). Domestic violence. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Nov. 39 p. [70 references]

      CURRENT NGC SUMMARY: Domestic violence. (NGC-3316)

    26. Dyspepsia. (NGC-2890)
      • Institute For Clinical Systems Improvement (ICSI). Dyspepsia. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2003 Jan. 48 p.

      CURRENT NGC SUMMARY: Dyspepsia and GERD. (NGC-3792)

    27. Hormone replacement therapy: collaborative decision making and management. (NGC-2210)
      • Institute for Clinical Systems Improvement (ICSI). Hormone replacement therapy: collaborative decision making and management [Guideline alert]. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Aug 5. 2 p.


      • Institute for Clinical Systems Improvement (ICSI). Hormone replacement therapy: collaborative decision-making and management. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Jul. 64 p. [204 references]

      CURRENT NGC SUMMARY: Menopause and hormone replacement therapy (HRT): collaborative decision-making and management. (NGC-3321)

    28. Hypertension diagnosis and treatment. (NGC-2985)
      • Institute for Clinical Systems Improvement (ICSI). Hypertension diagnosis and treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Apr. 47 p. [92 references]

      CURRENT NGC SUMMARY: Hypertension diagnosis and treatment. (NGC-3515)

    29. Immunizations. (NGC-3196)
      • Institute for Clinical Systems Improvement (ICSI). Immunizations. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 51 p. [53 references]

      CURRENT NGC SUMMARY: Immunizations. (NGC-3728)

    30. Intrapartum fetal heart rate management. (NGC-2722)
      • Institute for Clinical Systems Improvement (ICSI). Intrapartum fetal heart rate management. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Oct. 28 p.

      CURRENT NGC SUMMARY: Intrapartum fetal heart rate management. (NGC-3320)

    31. Lipid management in adults. (NGC-2636)
      • Institute for Clinical Systems Improvement (ICSI). Lipid management in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Jul. 61 p. [96 references]

      CURRENT NGC SUMMARY: Lipid management in adults. (NGC-3197)

    32. Lipid screening in adults. (NGC-3140)
      • Institute for Clinical Systems Improvement (ICSI). Lipid screening in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jun. 21 p. [17 references]

      CURRENT NGC SUMMARY: Lipid screening in adults. (NGC-3729)

    33. Lipid screening in children and adolescents. (NGC-3141)
      • Institute for Clinical Systems Improvement (ICSI). Lipid screening in children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jun. 18 p. [16 references]

      CURRENT NGC SUMMARY: Lipid screening in children and adolescents. (NGC-3730)

    34. Major depression in adults for mental health care providers. (NGC-3198)
      • Institute for Clinical Systems Improvement (ICSI). Major depression in adults for mental health care providers. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Sep. 49 p. [148 references]

      CURRENT NGC SUMMARY: Major depression in adults for mental health care. (NGC-3624)

    35. Major depression, panic disorder and generalized anxiety disorder in adults in primary care. (NGC-2576)
      • Institute For Clinical Systems Improvement (ICSI). Major depression, panic disorder and generalized anxiety disorder in adults in primary care. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 May. 55 p. [108 references]

      CURRENT NGC SUMMARY: Major depression in adults in primary care. (NGC-3623)

    36. Management of initial abnormal Pap smear. (NGC-2984)
      • Institute for Clinical Systems Improvement (ICSI). Management of initial abnormal Pap smear. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Apr. 47 p. [69 references]

      CURRENT NGC SUMMARY: Management of initial abnormal Pap smear. (NGC-3839)

    37. Management of type 2 diabetes mellitus. (NGC-2725)
      • Institute for Clinical Systems Improvement (ICSI). Management of type 2 diabetes mellitus. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Sep. 77 p.

      CURRENT NGC SUMMARY: Management of type 2 diabetes mellitus. (NGC-3317)

    38. Migraine headache. (NGC-2667)
      • Institute for Clinical Systems Improvement (ICSI). Migraine headache. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Jul. 74 p. [117 references]

      CURRENT NGC SUMMARY: Migraine headache. (NGC-3199)

    39. Preoperative evaluation. (NGC-2583)
      • Institute For Clinical Systems Improvement (ICSI). Preoperative evaluation. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 Mar. 27 p. [34 references]

      CURRENT NGC SUMMARY: Preoperative evaluation. (NGC-3200)

    40. Prevention, diagnosis and treatment of failure to progress in obstetrical labor. (NGC-2723)
      • Institute for Clinical Systems Improvement (ICSI). Prevention, diagnosis and treatment of failure to progress in obstetrical labor. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Oct. 36 p.

      CURRENT NGC SUMMARY: Prevention, diagnosis and treatment of failure to progress in obstetrical labor. (NGC-3322)

    41. Preventive counseling and education. (NGC-3202)
      • Institute for Clinical Systems Improvement (ICSI). Preventive counseling and education. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 69 p. [127 references]

      CURRENT NGC SUMMARY: Preventive counseling and education - by topic. (NGC-3668)

    42. Preventive services for adults. (NGC-2727)
      • Institute for Clinical Systems Improvement (ICSI). Preventive services for adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Sep. 50 p.

      CURRENT NGC SUMMARY: Preventive services for adults. (NGC-3204)

    43. Preventive services for children and adolescents. (NGC-2728)
      • Institute for Clinical Systems Improvement (ICSI). Preventive services for children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Sep. 32 p.

      CURRENT NGC SUMMARY: Preventive services for children and adolescents. (NGC-3203)

    44. Rhinitis. (NGC-2388)
      • Institute for Clinical Systems Improvement (ICSI). Rhinitis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Dec. 33 p. [75 references]

      CURRENT NGC SUMMARY: Rhinitis. (NGC-3084)

    45. Routine prenatal care. (NGC-2668)
      • Institute for Clinical Systems Improvement (ICSI). Routine prenatal care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Aug. 64 p. [183 references]

      CURRENT NGC SUMMARY: Routine prenatal care. (NGC-3205)

    46. Stable coronary artery disease. (NGC-2384)
      • Institute for Clinical Systems Improvement (ICSI). Stable coronary artery disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Jan. 32 p. [38 references]

      CURRENT NGC SUMMARY: Stable coronary artery disease. (NGC-3368)

    47. Tobacco use prevention and cessation for adults and mature adolescents. (NGC-3206)
      • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for adults and mature adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 36 p. [54 references]

      CURRENT NGC SUMMARY: Tobacco use prevention and cessation for adults and mature adolescents. (NGC-3731)

    48. Tobacco use prevention and cessation for infants, children and adolescents. (NGC-3207)
      • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for infants, children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 27 p. [22 references]

      CURRENT NGC SUMMARY: Tobacco use prevention and cessation for infants, children and adolescents. (NGC-3732)

    49. Treatment of acute myocardial infarction. (NGC-2316)
      • Institute for Clinical Systems Improvement (ICSI). Treatment of acute myocardial infarction. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2001 Oct. 53 p. [88 references]

      CURRENT NGC SUMMARY: Treatment of acute myocardial infarction. (NGC-2885)

    50. Uncomplicated urinary tract infection in women. (NGC-2901)
      • Institute for Clinical Systems Improvement (ICSI). Uncomplicated urinary tract infection in women. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2002 Nov. 24 p.

      CURRENT NGC SUMMARY: Uncomplicated urinary tract infection in women. (NGC-3767)

    51. Venous thromboembolism. (NGC-2983)
      • Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Apr. 93 p. [239 references]

      CURRENT NGC SUMMARY: Venous thromboembolism. (NGC-3516)

    52. Viral upper respiratory infection (VURI) in adults and children. (NGC-2884)
      • Institute For Clinical Systems Improvement (ICSI). Viral upper respiratory infection (VURI) in adults and children. Bloomington (MN): Institute For Clinical Systems Improvement (ICSI); 2002 Dec. 31 p.

      CURRENT NGC SUMMARY: Viral upper respiratory infection (VURI) in adults and children. (NGC-3669)

    International Diabetes Center

    1. Gestational diabetes practice guidelines. (NGC-1789)
      • Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000. Gestational diabetes practice guidelines. p. 173-205. [19 references]

      CURRENT NGC SUMMARY: Gestational diabetes practice guidelines. (NGC-3188)

    2. Type 2 diabetes practice guidelines. (NGC-1788)
      • Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000. Type 2 diabetes practice guidelines. p. 63-131. [35 references]

      CURRENT NGC SUMMARY: Type 2 diabetes practice guidelines. (NGC-3187)

    3. Type I diabetes practice guidelines. (NGC-1787)
      • International Diabetes Center, Institute for Research and Education. Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000 . Type 1 diabetes practice guidelines. p. 133-71. [14 references]

      CURRENT NGC SUMMARY: Type I diabetes practice guidelines. (NGC-3186)

    Joint Council of Allergy, Asthma and Immunology

    1. Practice parameters for allergen immunotherapy. (NGC-0671)
      • Joint Council of Allergy, Asthma and Immunology. Practice parameters for allergen immunotherapy. J Allergy Clin Immunol 1996 Dec;98(6 Pt 1):1001-11. [66 references]

      CURRENT NGC SUMMARY: Allergen immunotherapy: a practice parameter. (NGC-2847)

    Kaiser Permanente-Southern California

    1. Breast cancer screening. (NGC-2342)
      • Kaiser Permanente Southern California. Breast cancer screening. Pasadena (CA): Kaiser Permanente Southern California; 2001 Apr. 4 p. [84 references]

      CURRENT NGC SUMMARY: Breast cancer screening. (NGC-3353)

    Massachusetts Department of Public Health, Bureau of Family and Community Health, Diabetes Control Program

    1. Massachusetts guidelines for adult diabetes care. (NGC-1389)
      • Massachusetts Department of Public Health--Diabetes Control Program. Massachusetts guidelines for adult diabetes care. Boston (MA): Massachusetts Department of Public Health--Diabetes Control Program; 1999 Jun. Various p. [50 references]

      CURRENT NGC SUMMARY: Massachusetts guidelines for adult diabetes care. (NGC-2655)

    National Abortion Federation

    1. Clinical policy guidelines. (NGC-2915)
      • National Abortion Federation. Clinical policy guidelines. Washington (DC): National Abortion Federation; 2003. 54 p.

      CURRENT NGC SUMMARY: Clinical policy guidelines. (NGC-3559)

    National Heart, Lung, and Blood Institute (U.S.)

    1. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. (NGC-0335)
      • National Asthma Education and Prevention Program (NAEPP). NAEPP expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 1997 Jul. 146 p.

      CURRENT NGC SUMMARY: Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics. (NGC-2721)

    2. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. (NGC-0596)
      • National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med 1993 Jan 25;153(2):186-208. PubMed

      CURRENT NGC SUMMARY: Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program. (NGC-2708)

    3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-2970)
      • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003 May 21;289(19):2560-71. [81 references] PubMed

      CURRENT NGC SUMMARY: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-3450)

    4. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (NGC-2195)
      • National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 2001 May. Various p. [1274 references]

      CURRENT NGC SUMMARY: (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2)Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (NGC-3746)

    National Institutes of Health (NIH) Consensus Development Panel on Management of Hepatitis C

    1. Management of hepatitis C. (NGC-0421)
      • Management of hepatitis C. NIH Consens Statement Online 1997 Mar 24-26;15(3):1-41. [81 references] PubMed

      CURRENT NGC SUMMARY: Management of hepatitis C: 2002. (NGC-2642)

    National Kidney Foundation

    1. Clinical practice guidelines for hemodialysis adequacy. (NGC-0444)
      • National Kidney Foundation. Clinical practice guidelines for hemodialysis adequacy. New York (NY): National Kidney Foundation; 1997. 158 p. (Dialysis outcomes quality initiative (DOQI)).

      CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. (NGC-2007)

    2. Clinical practice guidelines for peritoneal dialysis adequacy (NGC-0445)
      • National Kidney Foundation. Clinical practice guidelines for peritoneal dialysis adequacy. New York (NY): National Kidney Foundation; 1997. 213 p. (Dialysis outcomes quality initiative (DOQI)).

      CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. (NGC-2008)

    3. Clinical practice guidelines for the treatment of anemia of chronic renal failure. (NGC-0447)
      • National Kidney Foundation. Clinical practice guidelines for the treatment of anemia of chronic renal failure. New York (NY): National Kidney Foundation; 1997. 183 p. (Dialysis outcomes quality initiative (DOQI)).

      CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. (NGC-2010)

    4. Clinical practice guidelines for vascular access. (NGC-0446)
      • National Kidney Foundation. Clinical practice guidelines for vascular access. New York (NY): National Kidney Foundation; 1997. 156 p. (Dialysis outcomes quality initiative (DOQI)).

      CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. (NGC-2009)

    National Osteoporosis Foundation

    1. Physician's guide to prevention and treatment of osteoporosis. (NGC-1377)
      • National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Belle Mead (NJ): Excerpta Medica, Inc.; 1999. 28 p.

      CURRENT NGC SUMMARY: Physician's guide to prevention and treatment of osteoporosis. (NGC-3073)

    New Zealand Guidelines Group

    1. Primary care guidelines for the management of core aspects of diabetes care. (NGC-2336)
      • New Zealand Guidelines Group. Primary care guidelines for the management of core aspects of diabetes care. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2000 Jun. 19 p. [41 references]

      CURRENT NGC SUMMARY: Management of type 2 diabetes. (NGC-3363)

    Nutrition Screening Initiative

    1. Nutritional strategies efficacious in the prevention or treatment of coronary heart disease (CHD). (NGC-0591)
      • Nutrition Screening Initiative. Nutritional strategies efficacious in the prevention or treatment of coronary heart disease (CHD). Washington (DC): Nutrition Screening Initiative; 1998. 16 p.

      CURRENT NGC SUMMARY: Coronary heart disease. Nutrition management for older adults. (NGC-3230)

    2. Nutritional strategies efficacious in the prevention or treatment of hypertension. (NGC-0590)
      • Nutrition Screening Initiative. Nutritional strategies efficacious in the prevention or treatment of hypertension. Washington (DC): Nutrition Screening Initiative; 1998. 15 p. [28 references]

      CURRENT NGC SUMMARY: Hypertension. Nutrition management for older adults. (NGC-3229)

    Oncology Nursing Society

    1. Biotherapy: recommendations for nursing course content and clinical practicum. (NGC-0910)
      • Oncology Nursing Society (ONS). Biotherapy: recommendations for nursing course content and clinical practicum. Pittsburgh (PA): Oncology Nursing Society; 1995. 40 p. [93 references]

      CURRENT NGC SUMMARY: Chemotherapy and biotherapy: guidelines and recommendations for practice. (NGC-2435)

    2. Cancer chemotherapy guidelines and recommendations for practice. (NGC-0911)
      • Oncology Nursing Society (ONS). Cancer chemotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh (PA): Oncology Nursing Society; 1999. 146 p. [354 references]

      CURRENT NGC SUMMARY: Chemotherapy and biotherapy: guidelines and recommendations for practice. (NGC-2435)

    Practice Guidelines Initiative

    1. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2217)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Nov. Various p. (Practice guideline; no. 5-6c). [19 references]


      • Mackenzie RG, Hodson DI, Browman GP, Zuraw L, Head and Neck Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Curr Oncol 2001;8:16-27. [19 references]

      CURRENT NGC SUMMARY: Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2990)

    2. Adjuvant systemic therapy for node-negative breast cancer. (NGC-2506)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Adjuvant systemic therapy for node-negative breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 1-8). [50 references]

      CURRENT NGC SUMMARY: Adjuvant systemic therapy for node-negative breast cancer. (NGC-3346)

    3. Adjuvant therapy for stage II colon cancer following complete resection. (NGC-2235)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Adjuvant therapy for stage II colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 2-1). [70 references]

      CURRENT NGC SUMMARY: Adjuvant therapy for stage II colon cancer following complete resection. (NGC-3462)

    4. Adjuvant therapy for stage III colon cancer following complete resection. (NGC-2242)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Adjuvant therapy for stage III colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 2-2). [81 references]

      CURRENT NGC SUMMARY: Adjuvant therapy for stage III colon cancer following complete resection. (NGC-3463)

    5. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. (NGC-2213)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Oct [online update]. Various p. (Practice guideline; no. 7-12). [33 references]


      • Yu E, Lochrin C, Dixon P, Ung YC, Gagliardi A, Evans WK, Lung Cancer Disease Site Group, Cancer Care Ontario Guidelines Practice Initiative (CCOPGI). Altered fractionation of radical radiation therapy in the management of unresectable non-small-cell lung cancer. Curr Oncol 2000;7(2):98-109. [28 references]

      CURRENT NGC SUMMARY: Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. (NGC-2825)

    6. Baseline staging tests in primary breast cancer. (NGC-2441)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Baseline staging tests in primary breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 1-14).


      • Myers RE, Johnston M, Pritchard K, Levine M, Oliver T, Breast Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 2001 May 15;164(10):1439-44. [34 references] PubMed

      CURRENT NGC SUMMARY: Baseline staging tests in primary breast cancer. (NGC-3345)

    7. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. (NGC-0717)
      • Whelan TJ, Provincial Lung Disease Site Group, Lada BM, Laukkanen E, Perera FE, Shelley WE, Levine MN. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Cancer Prev Control 1997 Aug;1(3):228-40. [61 references] PubMed

      CURRENT NGC SUMMARY: Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery. (NGC-2426)

    8. Chemotherapy in stage IV (metastatic) non-small cell lung cancer. (NGC-2228)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Chemotherapy in stage IV (metastatic) non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Oct [online update]. Various p. (Practice guideline; no. 7-2). [21 references]

      CURRENT NGC SUMMARY: Chemotherapy in stage IV (metastatic) non-small cell lung cancer. (NGC-2422)

    9. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. (NGC-2214)
      • Bramwell VH, Anderson D, Charette ML, Sarcoma Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma 2000;4(3):103-12. [27 references]


      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Jul [online update]. Various p. (Practice guideline; no. 11-1). [28 references]

      CURRENT NGC SUMMARY: Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. (NGC-2826)

    10. Epirubicin, as a single agent or in combination, for metastatic breast cancer. (NGC-2424)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Epirubicin, as a single agent or in combination, for metastatic breast cancer [full report]. Toronto (ON): CCOPGI; 2002 Feb [online update]. Various p. (Practice guideline report; no. 1-6). [14 references]

      CURRENT NGC SUMMARY: Epirubicin, as a single agent or in combination, for metastatic breast cancer. (NGC-3344)

    11. Erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. (NGC-0727)
      • Quirt I, Micucci S, Moran LA, Pater J, Browman G. Erythropoietin in the management of patients with non-hematologic malignancies receiving chemotherapy. Systemic Treatment Program Committee. Cancer Prev Control 1997 Aug;1(3):241-8. [13 references] PubMed

      CURRENT NGC SUMMARY: The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. (NGC-2969)

    12. First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (NGC-3136)
      • Gynecology Cancer Disease Site Group. Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M. First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May [online update]. 35 p. (Practice guideline; no. 4-1-2). [62 references]

      CURRENT NGC SUMMARY: First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (NGC-3458)

    13. Fludarabine in intermediate- and high-risk chronic lymphocytic leukemia. (NGC-2232)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Fludarabine in intermediate- and high-risk chronic lymphocytic leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul 1 [online update]. Various p. (Practice guideline; no. 6-1). [7 references]

      CURRENT NGC SUMMARY: Fludarabine in intermediate- and high-risk chronic lymphocytic leukemia. (NGC-2509)

    14. Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2218)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Nov. Various p. (Practice guideline; no. 5-6b). [19 references]


      • Mackenzie RG, Hodson DI, Browman GP, Zuraw L, Head and Neck Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Curr Oncol 2001;8:6-15. [19 references]

      CURRENT NGC SUMMARY: Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2827)

    15. Management of ductal carcinoma in situ of the breast. (NGC-2423)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Management of ductal carcinoma in situ of the breast [full report]. Toronto (ON): CCOPGI; 2002 Feb [online update]. Various p. (Practice guideline report; no. 1-10). [20 references]

      CURRENT NGC SUMMARY: Management of ductal carcinoma in situ of the breast. (NGC-2927)

    16. Neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). (NGC-2225)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx) [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 5-1). [36 references]

      CURRENT NGC SUMMARY: The role of neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). (NGC-2925)

    17. Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support. (NGC-2438)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Apr [online update]. Various p. (Practice guideline; no. 6-6). [90 references]


      • Imrie K, Esmail R, Meyer RM. The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative. Ann Intern Med 2002 Apr 16;136(8):619-29. [44 references] PubMed

      CURRENT NGC SUMMARY: Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support. (NGC-3539)

    18. Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer. (NGC-2830)
      • Lung Cancer Disease Site Group. Okawara G, Ung YC, Markman BR, Mackay JA, Evans WK. Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Sep [online update]. 11 p. (Practice guideline; no. 7-1-1). [14 references]

      CURRENT NGC SUMMARY: Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer. (NGC-3262)

    19. Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer. (NGC-2234)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 2-3). [12 references]


      • Cancer Care Ontario Practice Guidelines Initiative. Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer. Curr Oncol 2000;7(1):37-51. [45 references]

      CURRENT NGC SUMMARY: Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer. (NGC-2508)

    20. Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation. (NGC-2759)
      • Lukka H, Hirte H, Fyles A, Thomas G, Gynecology Disease Site Group, Elit L, Johnston M, Fung Kee Fung M, Browman G. Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Dec. 27 p. (Practice guideline; no. 4-5). [24 references]

      CURRENT NGC SUMMARY: Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation. (NGC-3088)

    21. Prophylactic cranial irradiation in small cell lung cancer. (NGC-2685)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI), Lung Cancer Disease Site Group. Kotalik J, Yu E, Markman BR, Gagliardi A, Evans WK. Prophylactic cranial irradiation in small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 July [online update]. 14 p. (Practice guideline; no. 7-13-2). [14 references]

      CURRENT NGC SUMMARY: Prophylactic cranial irradiation in small cell lung cancer. (NGC-3347)

    22. Surgical management of early stage invasive breast cancer (stage I and II). (NGC-2425)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Surgical management of early stage invasive breast cancer (stage I and II) [full report]. Toronto (ON): CCOPGI; 2002 Jan [online update]. Various p. (Practice guideline report; no. 1-1). [20 references]

      CURRENT NGC SUMMARY: Surgical management of early stage invasive breast cancer. (NGC-2932)

    23. Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients. (NGC-2760)
      • Hodson DI, Haines T, Berry M, Johnston M, Head and Neck Cancer Disease Site Group. Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 15 p. (Practice guideline; no. 5-5). [28 references]

      CURRENT NGC SUMMARY: Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients. (NGC-3526)

    24. Systemic adjuvant therapy for patients at high risk for recurrent melanoma. (NGC-2036)
      • Cancer Care Ontario Clinical Practice Guidelines Group, Melanoma Disease Site Group. Systemic adjuvant therapy for patients at high risk for recurrent melanoma. Toronto (ON): Cancer Care Ontario (CCO); 2000 Sep. Various p. (Practice guideline; no. 8-1). [60 references]

      CURRENT NGC SUMMARY: Systemic adjuvant therapy for patients at high risk for recurrent melanoma. (NGC-2761)

    25. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer. (NGC-2222)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Oct [online update]. Various p. (Practice guideline; no. 7-13-3). [24 references]


      • Okawara G, Gagliardi A, Evans WK, Lung Cancer Disease Site Group, Cancer Care Ontario Practice Guideline Initiative (CCOPGI). The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small-cell lung cancer. Curr Oncol 2000;7(3):162-72. [21 references]

      CURRENT NGC SUMMARY: The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer. (NGC-2991)

    26. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer. (NGC-2935)
      • Gastrointestinal Cancer Disease Site Group. Figueredo A, Zuraw L, Wong RK, Agboola O, Tandan V. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Dec [online update]. 23 p. (Practice guideline; no. 2-13). [47 references]

      CURRENT NGC SUMMARY: The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer. (NGC-3461)

    27. Unresected stage III non-small cell lung cancer. (NGC-2229)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Unresected stage III non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 7-3). [28 references]

      CURRENT NGC SUMMARY: Unresected stage III non-small cell lung cancer. (NGC-2928)

    28. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. (NGC-2420)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul. Various p. (Practice guideline; no. 12-3). [0 references]


      • Warr D, Bramwell V, Anderson D, Charette M, Systemic Treatment Disease Site Group. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. Curr Oncol 2001;8(2):69-82. [41 references]

      CURRENT NGC SUMMARY: Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. (NGC-2972)

    29. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder. (NGC-2833)
      • Genitourinary Cancer Disease Site Group. Segal R, Winquist E, Lukka H, Chin L, Brundage M, Markman BR. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 12 p. (Practice guideline report; no. 3-2-1). [19 references]

      CURRENT NGC SUMMARY: Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder. (NGC-3263)

    30. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. (NGC-2226)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 12-6). [23 references]


      • Cancer Care Ontario Practice Guideline Initiative. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. Curr Oncol 2000;7(3):149-61. [23 references]

      CURRENT NGC SUMMARY: Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. (NGC-2929)

    31. Use of bisphosphonates in patients with bone metastases from breast cancer. (NGC-2427)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of bisphosphonates in patients with bone metastases from breast cancer [full report]. Toronto (ON): Cancer Care Ontario Practice Guideline Initiative (CCOPGI); 2002 Feb [online update]. Various p. (Practice guideline report; no. 1-11). [41 references]

      CURRENT NGC SUMMARY: Use of bisphosphonates in women with breast cancer. (NGC-2931)

    32. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. (NGC-2584)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Jun [online update]. Various p. (Practice guideline; no. 12-5). [23 references]

      CURRENT NGC SUMMARY: Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. (NGC-3488)

    33. Use of gemcitabine in non-small-cell lung cancer. (NGC-2254)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of gemcitabine in non-small-cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Sep [online update]. Various p. (Practice guideline; no. 7-8). [33 references]

      CURRENT NGC SUMMARY: Use of gemcitabine in non-small cell lung cancer. (NGC-2828)

    34. Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma. (NGC-2829)
      • Gastrointestinal Disease Site Group. Germond C, Maroun J, Moore M, Zwaal C, Wong S. Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Nov [online update]. 12 p. (Practice guideline; no. 2-10). [15 references]

      CURRENT NGC SUMMARY: Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma. (NGC-3348)

    35. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. (NGC-2763)
      • Rusthoven J, Bramwell V, Stephenson B, Provincial Systemic Treatment Disease Site Group. Use of granulocyte colony stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Nov [online update]. 16 p. (Practice guideline; no. 12-2). [76 references]

      CURRENT NGC SUMMARY: The role of colony-stimulating factor (CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. (NGC-3460)

    36. Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first line therapy for metastatic colorectal cancer. (NGC-2419)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of irinotecan (Camptosar, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first line therapy for metastatic colorectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Oct. Various p. (Practice guideline; no. 2-16b). [13 references]


      • Jonker D, Earle C, Kocha W, Moore M, Maroun J, Zuraw L, Gastrointestinal Cancer Disease Site Group. Use of irinotecan combined with 5-fluorouracil and leucovorin as first-line therapy for metastatic colorectal cancer. Curr Oncol 2001;8(2):60-8. [13 references]

      CURRENT NGC SUMMARY: Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer. (NGC-2989)

    37. Use of irinotecan in the treatment of metastatic colorectal carcinoma. (NGC-2233)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of irinotecan in the treatment of metastatic colorectal carcinoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 2-16). [20 references]


      • Cancer Care Ontario Practice Guidelines Initiative. Use of irinotecan in the treatment of metastatic colorectal carcinoma. Curr Oncol 2000;7(1):29-36. [21 references]

      CURRENT NGC SUMMARY: Use of irinotecan in the treatment of metastatic colorectal carcinoma. (NGC-3464)

    38. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer. (NGC-2240)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Apr [online update]. Various p. (Practice guideline; no. 7-4). [2 references]

      CURRENT NGC SUMMARY: Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer. (NGC-2507)

    39. Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer. (NGC-2227)
      • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of raltitrexed (tomudex) in the management of metastatic colorectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Aug [online update]. Various p. (Practice guideline; no. 2-17). [19 references]

      CURRENT NGC SUMMARY: Use of raltitrexed (Tomudex) in the management of metastatic colorectal carcinoma. (NGC-2926)

    40. Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastatic to bone. (NGC-0721)
      • Brundage MD, Crook JM, Lukka H. Use of strontium-89 in patients with endocrine-refractory carcinoma of the prostate metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. Cancer Prev Control 1998 Apr;2(2):79-87. [13 references] PubMed

      CURRENT NGC SUMMARY: Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastatic to bone. (NGC-2238)

    41. Use of vinorelbine in non-small cell lung cancer. (NGC-0726)
      • Goss GD, Provincial Lung Disease Site Group, Logan DM, Newman TE, Evans WK. Use of vinorelbine in non-small-cell lung cancer. Cancer Prev Control 1997;1(1):28-38. [26 references] PubMed

      CURRENT NGC SUMMARY: Use of vinorelbine in non-small cell lung cancer. (NGC-2428)

    Scottish Intercollegiate Guidelines Network

    1. Management of patients with stroke. IV: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. (NGC-2126)
      • Management of patients with stroke. IV: rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Apr. 26 p. (SIGN publication; no. 24). [90 references]

      CURRENT NGC SUMMARY: Management of patients with stroke. Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. (NGC-2764)

    Society of American Gastrointestinal Endoscopic Surgeons

    1. Guideline for diagnostic laparoscopy. (NGC-1087)
      • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for diagnostic laparoscopy. Surg Endosc 1999 Feb;13(2):202-3. [15 references] PubMed

      CURRENT NGC SUMMARY: SAGES guidelines for diagnostic laparoscopy. (NGC-3161)

    2. Guideline for surgical treatment of gastroesophageal reflux disease (GERD). (NGC-1089)
      • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). Surg Endosc 1998 Feb;12(2):186-8. [38 references] PubMed

      CURRENT NGC SUMMARY: Guidelines for surgical treatment of gastroesophageal reflux disease (GERD). (NGC-2373)

    3. Guidelines for laparoscopic surgery during pregnancy. (NGC-1090)
      • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for laparoscopic surgery during pregnancy. Surg Endosc 1998 Feb;12(2):189-90. [22 references] PubMed

      CURRENT NGC SUMMARY: SAGES guidelines for laparoscopic surgery during pregnancy. (NGC-2372)

    Society of Nuclear Medicine, Inc

    1. Procedure guideline for C-14 urea breath test. (NGC-0625)
      • Society of Nuclear Medicine. Procedure guideline for C-14 urea breath test, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 13 p. (Society of Nuclear Medicine Procedure Guidelines; version 2.0). [4 references]

      CURRENT NGC SUMMARY: Procedure guideline for C-14 urea breath test. (NGC-2173)

    2. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. (NGC-0624)
      • Bartold SP, Society of Nuclear Medicine, Donohoe KJ, Fletcher JW, Haynie TP, Henkin RE, Silberstein EB, Royal HD, Van den Abbeele A. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. J Nucl Med 1997 Jun;38(6):990-4. PubMed

      CURRENT NGC SUMMARY: Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. (NGC-2175)

    3. Procedure guideline for hepatobiliary scintigraphy. (NGC-0604)
      • Society of Nuclear Medicine. Procedure guideline for hepatobiliary scintigraphy, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 16 p. (Society of Nuclear Medicine Procedure Guidelines; version 2.0).

      CURRENT NGC SUMMARY: Procedure guideline for hepatobiliary scintigraphy. (NGC-2174)

    4. Procedure guideline for the use of radiopharmaceuticals. (NGC-0618)
      • Society of Nuclear Medicine. Reston (VA): Society of Nuclear Medicine; 1998 Jun. Procedure guideline for the use of radiopharmaceuticals, 2.0. (Society of Nuclear Medicine Procedure Guidelines; version 2.0). p. 15.

      CURRENT NGC SUMMARY: Procedure guideline for the use of radiopharmaceuticals. (NGC-2172)

    The North American Menopause Society

    1. Amended report from the NAMS Advisory Panel on postmenopausal hormone therapy. (NGC-2690)
      • North American Menopause Society. Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Menopause 2003 Jan-Feb;10(1):6-12. PubMed

      CURRENT NGC SUMMARY: Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society. (NGC-3357)

    United States Preventive Services Task Force

    1. Aspirin prophylaxis for the primary prevention of myocardial infarction (NGC-0213)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 69, Aspirin prophylaxis for primary prevention of myocardial infarction. p. 845-52. [32 references]

      CURRENT NGC SUMMARY: Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. (NGC-2305)

    2. Counseling to prevent dental and periodontal disease (NGC-0205)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 61, Counseling to prevent dental and periodontal disease. p. 711-22. [97 references]

      CURRENT NGC SUMMARY: Prevention of dental caries in preschool children: recommendations and rationale. (NGC-3184)

    3. Counseling to prevent low back pain. (NGC-0204)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 60, Counseling to prevent low back pain. p. 699-710. [87 references]

      CURRENT NGC SUMMARY: Primary care interventions to prevent low back pain in adults: recommendation statement. (NGC-3451)

    4. Counseling to prevent tobacco use (NGC-0198)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Counseling to prevent tobacco use. p. 597-609. [123 references]

      CURRENT NGC SUMMARY: Counseling to prevent tobacco use and tobacco-caused disease: recommendation statement. (NGC-3268)

    5. Counseling to promote a healthy diet. (NGC-0200)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 56, Counseling to promote a healthy diet. p. 625-42. [204 references]

      CURRENT NGC SUMMARY: Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale. (NGC-2720)

    6. Counseling to promote physical activity (NGC-0199)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 55, Counseling to promote physical activity. p. 611-624. [128 references]

      CURRENT NGC SUMMARY: Behavioral counseling in primary care to promote physical activity: recommendation and rationale. (NGC-2504)

    7. Postmenopausal hormone prophylaxis (NGC-0212)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 68, Postmenopausal hormone prophylaxis. p. 829-43. [115 references]

      CURRENT NGC SUMMARY: Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale. (NGC-2681)

    8. Screening for adolescent idiopathic scoliosis. (NGC-0191)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 47, Screening for adolescent idiopathic scoliosis. p. 517-29. [100 references]

      CURRENT NGC SUMMARY: Screening for idiopathic scoliosis in adolescents: recommendation statement. (NGC-3625)

    9. Screening for asymptomatic bacteriuria. (NGC-0175)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 31, Screening for asymptomatic bacteriuria. p. 347-59. [102 references]

      CURRENT NGC SUMMARY: Screening for asymptomatic bacteriuria: recommendation statement. (NGC-3452)

    10. Screening for asymptomatic coronary artery disease. (NGC-0146)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 1, Screening for asymptomatic coronary artery disease. p. 3-14. [85 references]

      CURRENT NGC SUMMARY: Screening for coronary heart disease: recommendation statement. (NGC-3367)

    11. Screening for bladder cancer. (NGC-0161)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 17, Screening for bladder cancer. p. 181-6. [29 references]

      CURRENT NGC SUMMARY: Screening for bladder cancer in adults: recommendation statement. (NGC-3595)

    12. Screening for breast cancer: recommendations and rationale. (NGC-2385)
      • Screening for breast cancer: recommendations and rationale. Am Fam Physician 2002 Jun 15;65(12):2537-44. PubMed

      CURRENT NGC SUMMARY: Screening for breast cancer: recommendations and rationale. (NGC-2645)

    13. Screening for cervical cancer. (NGC-0153)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 9, Screening for cervical cancer. p. 105-17. [113 references]

      CURRENT NGC SUMMARY: Screening for cervical cancer: recommendations and rationale. (NGC-2758)

    14. Screening for chlamydial infection--including ocular prophylaxis in newborns. (NGC-0173)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 29, Screening for chlamydial infection - including ocular prophylaxis in newborns. p. 325-34. [57 references]

      CURRENT NGC SUMMARY: Screening for chlamydial infection: recommendations and rationale. (NGC-1886)

    15. Screening for colorectal cancer. (NGC-0152)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 8, Screening for colorectal cancer. [113 references]

      CURRENT NGC SUMMARY: Screening for colorectal cancer: recommendations and rationale. (NGC-2511)

    16. Screening for D (Rh) incompatibility. (NGC-0182)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 38, Screening for D (Rh) incompatibility. p. 425-432. [61 references]

      CURRENT NGC SUMMARY: Screening for Rh(D) incompatibility: recommendation statement. (NGC-3455)

    17. Screening for dementia and other diseases. (NGC-0192)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 48, Screening for dementia and other diseases. p. 531-40. [68 references]

      CURRENT NGC SUMMARY: Screening for dementia: recommendations and rationale. (NGC-2916)

    18. Screening for depression. (NGC-0193)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore (MD): William & Wilkins; 1996. Screening for depression. p. 541-6. [46 references]

      CURRENT NGC SUMMARY: Screening for depression: recommendations and rationale. (NGC-2402)

    19. Screening for diabetes mellitus. (NGC-0163)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 19, Screening for diabetes mellitus. p. 193-208. [128 references]

      CURRENT NGC SUMMARY: Screening for gestational diabetes mellitus: recommendations and rationale. (NGC-2719)

      CURRENT NGC SUMMARY: Screening for type 2 diabetes mellitus in adults: recommendations and rationale. (NGC-2749)

    20. Screening for family violence. (NGC-0195)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 51, Screening for family violence. p. 555-65.

      CURRENT NGC SUMMARY: Screening for family and intimate partner violence: recommendation statement. (NGC-3341)

    21. Screening for hepatitis B virus infection. (NGC-0168)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 24, Screening for hepatitis B virus infection. p. 269-76. [56 references]

      CURRENT NGC SUMMARY: Screening for hepatitis B virus infection: recommendation statement. (NGC-3453)

    22. Screening for high blood cholesterol and other lipid abnormalities. (NGC-0147)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 2, Screening for high blood cholesterol and other lipid abnormalities. p. 15-38. [190 references]

      CURRENT NGC SUMMARY: Screening for lipid disorders in adults: recommendations and rationale. (NGC-1887)

    23. Screening for hypertension. (NGC-0148)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 3, Screening for hypertension. p. 39-51. [111 references]

      CURRENT NGC SUMMARY: Screening for high blood pressure: recommendations and rationale. (NGC-3068)

    24. Screening for lung cancer. (NGC-0155)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Screening for lung cancer. p. 135-9. [34 references]

      CURRENT NGC SUMMARY: Lung cancer screening: recommendation statement. (NGC-3370)

    25. Screening for obesity. (NGC-0165)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 21, Screening for obesity. p. 219-29. [134 references]

      CURRENT NGC SUMMARY: Screening for obesity in adults: recommendations and rationale. (NGC-3163)

    26. Screening for oral cancer. (NGC-0160)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 16, Screening for oral cancer. p. 175-80. [27 references]

      CURRENT NGC SUMMARY: Screening for oral cancer: recommendation statement. (NGC-3454)

    27. Screening for ovarian cancer. (NGC-0158)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 14, Screening for ovarian cancer. p. 159-66. [58 references]

      CURRENT NGC SUMMARY: Screening for ovarian cancer: recommendation statement. (NGC-3498)

    28. Screening for pancreatic cancer. (NGC-0159)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 15, Screening for pancreatic cancer. p. 167-73. [60 references]

      CURRENT NGC SUMMARY: Screening for pancreatic cancer: recommendation statement. (NGC-3468)

    29. Screening for postmenopausal osteoporosis. (NGC-0190)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 46, Screening for postmenopausal osteoporosis. p. 509-16. [52 references]

      CURRENT NGC SUMMARY: Screening for osteoporosis in postmenopausal women: recommendations and rationale. (NGC-2643)

    30. Screening for problem drinking. (NGC-0196)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 52, Screening for problem drinking. p. 567-82. [116 references]

      CURRENT NGC SUMMARY: Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. (NGC-3399)

    31. Screening for prostate cancer. (NGC-0154)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 10, Screening for prostate cancer. p. 119-34.

      CURRENT NGC SUMMARY: Screening for prostate cancer: recommendations and rationale. (NGC-2630)

    32. Screening for skin cancer-including counseling to prevent skin cancer. (NGC-0156)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 12, Screening for skin cancer - including counseling to prevent skin cancer. p. 141-52. [90 references]

      CURRENT NGC SUMMARY: Screening for skin cancer: recommendations and rationale. (NGC-1888)

      CURRENT NGC SUMMARY: Counseling to prevent skin cancer: recommendations and rationale. (NGC-2954)

    33. Screening for suicide risk. (NGC-0194)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 50, Screening for suicide risk. p. 547-54. [52 references]

      CURRENT NGC SUMMARY: Screening for suicide risk: recommendation statement. (NGC-3457)

    34. Screening for syphilis. (NGC-0170)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 26, Screening for syphilis. p. 287-92. [31 references]

      CURRENT NGC SUMMARY: Screening for syphilis infection: recommendation statement. (NGC-3592)

    35. Screening for testicular cancer. (NGC-0157)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 13, Screening for testicular cancer. p. 153-7. [23 references]

      CURRENT NGC SUMMARY: Screening for testicular cancer: recommendation statement. (NGC-3456)

    36. Screening for thyroid disease. (NGC-0164)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 20, Screening for thyroid disease. p. 209-18. [102 references]

      CURRENT NGC SUMMARY: Screening for thyroid disease: recommendation statement. (NGC-3266)

    37. Screening for visual impairment. (NGC-0177)
      • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 33, Screening for visual impairment. p. 373-82. [63 references]

      CURRENT NGC SUMMARY: Screening for visual impairment in children younger than age 5 years: recommendation statement. (NGC-3477)

    University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core

    1. Acute pain management. (NGC-0540)
      • Young D. Acute pain management. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1999 Apr 6. 37 p. [86 references]

      CURRENT NGC SUMMARY: Acute pain management. (NGC-1114)

    2. Hydration management. (NGC-0685)
      • The Iowa Veterans Affairs Nursing Research Consotium. Mentes JC. Hydration management. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 34 p. [76 references]

      CURRENT NGC SUMMARY: Hydration management. (NGC-3479)

    3. Prevention of falls. (NGC-0542)
      • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Prevention of falls. Iowa City (IA): University of Iowa; 1996. 37 p. (Research-based protocol; no. 1996). [67 references]

      CURRENT NGC SUMMARY: Fall prevention for older adults. (NGC-3480)

    4. Prevention of pressure ulcers. (NGC-0541)
      • Research Dissemination Core. Prevention of pressure ulcers. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center; 1997. 17 p. [39 references]

      CURRENT NGC SUMMARY: Prevention of pressure ulcers. (NGC-2684)

    5. Progressive resistance training. (NGC-0537)
      • Mobily K, Mobily P. Progressive resistance training. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 25 p. [24 references]

      CURRENT NGC SUMMARY: Progressive resistance training. (NGC-3478)

    6. Research-based protocol. Individualized music. (NGC-1418)
      • University of Iowa Gerontological Nursing Interventions Research Center. Research-based protocol: individualized music. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center Research Dissemination Core; 1999 Nov. 28 p. (Research-based protocol no. 1999). [40 references]

      CURRENT NGC SUMMARY: Evidence-based protocol. Individualized music. (NGC-2299)

    7. Treatment of pressure ulcers. (NGC-0535)
      • Gerontological Nursing Interventions Research Center (University of Iowa), Research Dissemination Core. Titler MG, editor(s). Treatment of pressure ulcers. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center; 1997. 22 p.

      CURRENT NGC SUMMARY: Treatment of pressure ulcers. (NGC-2683)

    University of Michigan Health System

    1. Acute sinusitis in adults. (NGC-1014)
      • University of Michigan Medical Center. UMMC clinical care guidelines: acute sinusitis in adults. Ann Arbor (MI): University of Michigan Health System; 1996. 6 p. [10 references]

      CURRENT NGC SUMMARY: Acute rhinosinusitis in adults. (NGC-1511)

    2. Depression. (NGC-1008)
      • University of Michigan Health System. UMHS clinical care guideline: depression. Ann Arbor (MI): University of Michigan Health System; 1998. 14 p. [14 references]

      CURRENT NGC SUMMARY: Depression. (NGC-3787)

    3. Management of diabetes mellitus. (NGC-1009)
      • University of Michigan Health System. Management of diabetes mellitus. Guidelines for clinical care. Ann Arbor (MI): University of Michigan Health System; 1998. 12 p. [7 references]

      CURRENT NGC SUMMARY: Management of type 2 diabetes mellitus. (NGC-3788)

    4. Peptic ulcer disease. (NGC-1012)
      • University of Michigan Medical Center. UMMC clinical care guideline: peptic ulcer disease. Ann Arbor (MI): University of Michigan Health System; 1997. 5 p. [4 references]

      CURRENT NGC SUMMARY: Peptic ulcer disease. (NGC-1512)

    5. Pharyngitis (in adults and children). (NGC-1013)
      • University of Michigan Medical Center. UMMC clinical care guideline: pharyngitis (in adults and children). Ann Arbor (MI): University of Michigan Health System; 1996. 8 p. [8 references]

      CURRENT NGC SUMMARY: Pharyngitis. (NGC-2183)

    University of Texas Medical Branch Correctional Managed Care

    1. Chronic COPD. (NGC-2702)
      • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Apr. 3 p. [2 references]

      CURRENT NGC SUMMARY: Chronic COPD. (NGC-3305)

    2. Hypertension. (NGC-2701)
      • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Hypertension. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Apr. 6 p. [1 reference]

      CURRENT NGC SUMMARY: Hypertension. (NGC-3304)

    Veterans Health Administration

    1. Clinical guideline for major depressive disorder. (NGC-1006)
      • Veterans Health Administration (VHA). Veterans Health Administration clinical guideline for major depressive disorder (MDD). Washington (DC): Department of Veterans Affairs (U.S.), Veterans Health Administration; 1996. 211 p. [416 references]

      CURRENT NGC SUMMARY: VHA/DOD clinical practice guideline for the management of major depressive disorder in adults. (NGC-1811)

    2. Clinical practice guideline for the management of persons with chronic obstructive pulmonary disease or asthma. (NGC-1007)
      • Veterans Health Administration (VHA). Veterans Health Administration clinical practice guideline for the management of persons with chronic obstructive pulmonary disease or asthma. Version 1.0. Washington (DC): Department of Veterans Affairs (U.S.), Veterans Health Administration; 1997 Nov 17. 323 p.

      CURRENT NGC SUMMARY: VHA/DOD clinical practice guideline for the management of chronic obstructive pulmonary disease. (NGC-1810)

    Washington State Department of Labor and Industries

    1. Cauda equina. (NGC-1118)
      • Washington State Department of Labor and Industries. Cauda equina. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

      CURRENT NGC SUMMARY: Cauda equina. (NGC-3211)

    2. Complex regional pain syndrome (CRPS). (NGC-1131)
      • Washington State Department of Labor and Industries. Complex regional pain syndrome (CRPS). Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 9 p. [1 reference]

      CURRENT NGC SUMMARY: Complex regional pain syndrome (CRPS). (NGC-3223)

    3. Criteria for ankle/foot. (NGC-1122)
      • Washington State Department of Labor and Industries. Criteria for ankle/foot. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 2 p. [1 reference]

      CURRENT NGC SUMMARY: Criteria for ankle/foot. (NGC-3215)

    4. Criteria for cervical surgery related to entrapment of a single cervical nerve root. (NGC-1120)
      • Washington State Department of Labor and Industries. Criteria for cervical surgery related to entrapment of a single cervical nerve root. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

      CURRENT NGC SUMMARY: Criteria for cervical surgery related to entrapment of a single cervical nerve root. (NGC-3213)

    5. Criteria for entrapment of a single lumbar nerve root. (NGC-1121)
      • Washington State Department of Labor and Industries. Criteria for entrapment of a single lumbar nerve root. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

      CURRENT NGC SUMMARY: Criteria for entrapment of a single lumbar nerve root. (NGC-3214)

    6. Criteria for knee surgery. (NGC-1119)
      • Washington State Department of Labor and Industries. Criteria for knee surgery. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

      CURRENT NGC SUMMARY: Review criteria for knee surgery. (NGC-3482)

    7. Criteria for MRI of the lumbar spine. (NGC-1123)
      • Washington State Department of Labor and Industries. Criteria for MRI of the lumbar spine. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

      CURRENT NGC SUMMARY: Criteria for MRI of the lumbar spine. (NGC-3216)

    8. Criteria for shoulder surgery. (NGC-2650)
      • Washington State Department of Labor and Industries. Criteria for shoulder surgery. Olympia (WA): Washington State Department of Labor and Industries; 2002 Mar. 4 p.

      CURRENT NGC SUMMARY: Criteria for shoulder surgery. (NGC-3217)

    9. Fibromyalgia. (NGC-1132)
      • Washington State Department of Labor and Industries. Fibromyalgia. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 5 p. [1 reference]

      CURRENT NGC SUMMARY: Fibromyalgia. (NGC-3224)

    10. Guideline for hospitalization for low back pain. (NGC-1117)
      • Washington State Department of Labor and Industries. Guidelines for hospitalization for low back pain. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 4 p. [10 references]

      CURRENT NGC SUMMARY: Guideline for hospitalization for low back pain. (NGC-3210)

    11. Guidelines for lumbar fusion (arthrodesis). (NGC-2649)
      • Washington State Department of Labor and Industries. Guidelines for lumbar fusion (arthrodesis). Olympia (WA): Washington State Department of Labor and Industries; 2001 Jun. 6 p.

      CURRENT NGC SUMMARY: Guidelines for lumbar fusion (arthrodesis). (NGC-3218)

    12. Guidelines for outpatient prescription of controlled substances, schedules II-IV, for workers on time-loss. (NGC-1129)
      • Washington State Department of Labor and Industries. Guidelines for outpatient prescription of controlled substances, schedules II-IV, for workers on time-loss. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 7 p. [1 reference]

      CURRENT NGC SUMMARY: Guidelines for outpatient prescription of controlled substances, schedules II-IV, for workers on time-loss. (NGC-3225)

    13. Guidelines for outpatient prescription of oral opioids for injured workers with chronic, noncancer pain. (NGC-1835)
      • Washington State Department of Labor and Industries. Guidelines for outpatient prescription of oral opioids for injured workers with chronic, noncancer pain. Olympia (WA): Washington State Department of Labor and Industries; 2000 May 1. 17 p. [29 references]

      CURRENT NGC SUMMARY: Guidelines for outpatient prescription of oral opioids for injured workers with chronic, noncancer pain. (NGC-3226)

    14. Guidelines for psychiatric and psychological evaluation of injured or chronically disabled workers. (NGC-1128)
      • Washington State Department of Labor and Industries. Guidelines for psychiatric and psychological evaluation of injured or chronically disabled workers. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 10 p. [1 reference]

      CURRENT NGC SUMMARY: Guidelines for psychiatric and psychological evaluation of injured or chronically disabled workers. (NGC-3221)

    15. Surgery for thoracic outlet syndrome (TOS). (NGC-1126)
      • Washington State Department of Labor and Industries. Surgery for thoracic outlet syndrome (TOS). Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 2 p. [11 references]

      CURRENT NGC SUMMARY: Surgery for thoracic outlet syndrome (TOS). (NGC-3219)

    World Health Organization

    1. Global initiative for asthma. Global strategy for asthma management and prevention. (NGC-2429)
      • Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI), World Health Organization (WHO). Global initiative for asthma. Bethesda (MD): Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI); 2002 Feb. 176 p. [619 references]

      CURRENT NGC SUMMARY: Global strategy for asthma management and prevention. (NGC-3442)